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Some components o f an in vivo m odule1 that are ‘nonessential’ in normal laboratory 
conditions are likely to have important roles in the assembly, fidelity, robustness and dynamic 
characteristics o f modules that produce small advantages in long-term survival probability of 
an organism. It may be very difficult, however, to measure such contributions directly.
Hartwell et al. (1999): From molecular to modular cell biology. Nature 402 (supplement), 
p.047-52.
1Discrete biological functions can rarely be attributed to an individual molecule, but arise 
from interactions among many components (protein, DNA, RNA, small molecules) in func­
tional modules.
Voor mljn Ouders.
CONTENTS
Chapter 1:
1.1
1.2
1.3
1.4
1.5
1.6
Chapter 2: 
Chapter 3:
page:
Introduction 9
Cellular metabolism and generation o f ATP 11
Cellular metabolism and the phosphoryl transfer network 13
1.2.1 The creatine kinase/phosphocreatine system 13
1.2.2 The adenylate kinase system 17
1.2.3 The nucleoside-diphosphate kinase system 17 
Compartmentation and (regulation of) design in the cellular 
network for energy homeostasis 18
1.3.1 Compartmentation in muscle facilitates efficient ATP supply 20
1.3.2 Heterogeneity in muscle design: oxidative and glycolytic muscles 21
1.3.3 Changes in ultrastructural design result from metabolic signals 22
1.3.4 How is metabolic homeostasis regulated? 26
1.3.5 Mitochondrial biogenesis and uncoupling 27 
Studies on cellular energetics: in vitro and in vivo studies o f mice 
with targeted disruptions o f CK genes 29 
Experimental approaches 30
1.5.1 Proteome and transcriptome analyses 31
1.5.2 Techniques to study spatio-temporal behavior o f metabolites, 
signaling molecules and proteins 3 2
1.5.3 The use ofcultured stable cell lines for studies o f biological 
system 33 
Aim and outline o f this thesis 33
Changes in glycolytic network and mitochondrial design in
creatine kinase-deficient muscles 43
Changes in mRNA expression profile underlie phenotypic
adaptations in creatine kinase-deficient muscles 61
page:
Chapter 4:
Chapter 5:
Chapter 6: 
Chapter 7:
7.1
7.2
7.3
7.4
Summary
Samenvatting
Abbreviations
Epiloog
Curriculum vitae 
Publications
Presence of (phospho)creatine in developing and aging
skeletal muscle of mice with or without mitochondrial
and cytosolic muscular creatine kinase isoforms 79
Immortalized myogenic cell lines derived from
creatine kinase-deficient mice show normal
differentiation characteristics 97
The creatine kinase system is essential for optimal refill of
2+the sarcoplasmic reticulum Ca store in skeletal muscle 121
Discussion: Creatine kinases and plasticity in metabolic
design 143
CK deficiency is coupled to the expression profile o f nuclear 
and mitochondrial genes 145
CK deficiency influences the (supra)molecular design of 
functional modules 149
Finding possible regulatory mechanisms involved in genetic 
stress-induced remodeling o f muscle design 150
Concluding remarks 154
159
161
163
165
167
169

Chapter 1
Introduction

Introduction
1.1 Cellular metabolism and generation of ATP
All living organisms require energy to survive and carry out the multitude o f tasks that 
characterize biological activity (1). Cellular processes like cell division, muscle movement 
and motility, neurotransmission, and maintenance o f electrochemical gradients are driven by 
the hydrolysis o f adenosine 5’ tri-phosphate (ATP: ATP4- + H2O ^  ADP3- + P i2- + H+), the 
key currency o f energy in all living cells as an immediate donor o f free energy. To produce 
this metabolic energy, polysaccharides, proteins and fats in food are broken down into small 
metabolic compounds (sugars, amino acids, fatty acids) by the enzymes in the digestive tract, 
taken up by epithelial cells and transported into circulation. Subsequently, these small mole­
cules are metabolized within the cells o f the body to form ATP, or converted to larger mole­
cules for long-term storage o f energy (fat and glycogen). Glucose, glycogen, pyruvate and 
lactate (non-oxidative sources) as well as keton bodies, acetoacetate and medium chain fatty 
acids (oxidative sources) are converted into acetyl coenzyme A (acetyl-CoA), the most impor­
tant carbon source for aerobic ATP production in mitochondrial oxidative phosphorylation 
(OXPHOS) (2). Acetyl-CoA serves as a starting point for the citric acid cycle (or tricarboxic 
acid [TCA] cycle). In the TCA cycle, electron carriers NADH and FADH2 are generated, 
which fuel ATP production by supplying reducing equivalents to the electron transport chain 
(ETC) in the mitochondrial inner membrane. The ETC comprises four multi-subunit enzyme 
complexes (complex I-IV ), which ultimately transfer electrons from the hydrogens o f NADH 
and FADH 2 to oxygen. NADH and FADH 2 are energy-rich molecules because they contain 
pairs o f electrons with a high transfer potential (2). This high transfer potential is gradually 
lost as the electrons pass along the ETC. The energy is used to translocate respectively four 
(complex I), four (complex III), and two (complex IV) protons per electron from the matrix 
space to the intermembrane space, creating a proton motive force (PMF). This PMF is com­
posed o f a pH gradient (A pHm) and membrane potential component (A ^ m). The back-flow of 
protons down this gradient drives the membrane bound ATP synthase (F0F 1-ATPase, complex 
V) which catalyzes the synthesis o f ATP from ADP + Pi (inorganic phosphate) (3-5). These 
metabolic conversions are depicted in Figure 1.1.
Apart from the oxidative production in mitochondria, ATP is also rapidly generated by 
cytosolic glycolysis. In glycolysis, glucose (imported by cell-type-specific glucose 
transporters (6), or generated from glycogen) is anaerobically converted into pyruvate and 
NADH (Glucose + 2Pi2- + 2 ADP3- + 2 NAD+ ^  2 Pyruvate- + 2 ATP4- + 2 NADH + 2 H+ + 2 
H 2O). Under conditions o f extreme exercise, where oxygen supply via circulation is limiting 
for OXPHOS, NADH formation by glycolysis exceeds its oxidation by the respiratory chain 
in mitochondria, which activates regeneration o f NAD+ by lactate dehydrogenase (LDH: 
Pyruvate- + NADH + H+ ^  Lactate- + NAD+). In this way, accumulation o f both NADH and 
pyruvate is prevented (7). The complete oxidation o f one glucose molecule yields 38 ATP 
molecules along the entire pathway. Two ATPs originate from anaerobic glycolysis, an
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Figure 1.1 Schem atic representation of m etabolic con version s and the phosphoryl transfer 
network (after (5, 13, 16)).
Eukaryotic cells have developed specialized intracellular compartments for energy production (glyco­
lysis, oxidative phosphorylation [OXPHOS]) and consumption, as well as phosphoryl transfer system s 
(CK, AK) to couple these compartments metabolically. For further explanation of metabolic conver­
sions: see  text. Abbreviations: AK1: adenylate kinase 1; ANT: adenine nucleotide translocator; CACT: 
carnitine/acylcarnitine transporter; CK: creatine kinase; ETC: electron transport chain; F0F1: F0F1-ATP 
synthase; G-P: glucose phosphate shuttle; Mal/Asp: malate/aspartate shuttle; MCT: mono-carboxylate 
transporter (pyruvate carrier); PiC: inorganic phosphate carrier; TCA: citric acid cycle; UCP: uncou­
pling protein; VDAC: voltage-dependent anion channel. Note: The cross-link between glycolysis and 
the CK/AK circuits is not depicted in this figure, see  Figure 1.2. Lactate can be transported into mito­
chondria via the MCT, which is not depicted. The NDPK phosphoryl transfer is not shown in this figure.
additional two ATPs from cytosolic NADH that is transported into mitochondria via the 
malate-aspartate shuttle or the glycerol phosphate shuttle (8), two ATPs from the citric acid 
cycle, and 32 ATPs from NADH and FADH2 generated during OXPHOS (2) (Fig. 1.1). R e­
cently, the role o f lactate as fuel for mitochondria earned renewed attention because muscles 
also produce lactate under well-oxygenated conditions, rejecting the hypothesis that glycoly­
sis and lactate production solely reflect cellular anoxia (9). Lactate is now thought to be a use­
ful regulatory metabolic intermediate that can be exchanged rapidly among tissues (from 
muscle to liver in the Cori cycle) and tissue compartments (from glycolytic to oxidative fi­
bers). The ‘lactate shuttle hypothesis’, developed by Brooks (10), holds that lactate formation
12
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and its subsequent distribution throughout the body is a major mechanism whereby the coor­
dination o f intermediary metabolism in different tissues and cells within those tissues can be 
accomplished (10, 11).
1.2 Cellular metabolism and the phosphoryl transfer network
A single cell carries out many chemical reactions that require ATP, and metabolic 
fluxes through ATP producing and consuming reactions differ with cell type. For instance, 
muscles can increase ATP consumption more than 100-fold above basal resting level (12). 
Moreover, there are substantial differences in ATP need in different subcellular 
compartments. A fundamental problem faced by all cells is that they must continuously match 
energy production and consumption. This cannot be achieved by simply increasing cytosolic 
ATP (production) levels, which is an impossible alternative in cells with a high and 
fluctuating energy demand. Therefore, production, transport, conversion and utilization of 
energy are facilitated via metabolic pathways, which involve a large number o f tightly 
regulated enzyme-catalyzed reactions in separate subcellular compartments (13). This 
network for cellular energetics is largely similar to the phosphoryl transfer network, which 
comprises enzyme systems that help to optimally couple ATP production and consumption. 
The most prominent system in brain and muscle is the creatine kinase/phosphocreatine 
(CK/PCr) system (13, 14). Other systems that, in combination with CKs, maintain a highly 
efficient ATP usage and buffering are the adenylate kinase (AK) system and the nucleoside- 
diphosphate kinase (NDPK) system (15, 16) (Fig. 1.1). The high degree o f intracellular 
compartmentation o f these phosphoryl transfer systems prevents high intracellular 
concentrations o f ADP and local disturbance o f the [ATP], [ADP], [AMP], and the ATP/ADP 
ratio, which are known to be key allosteric regulators influencing many fundamental 
metabolic processes (13, 14). W hat follows in this introduction is an overview o f recent 
literature data on components (paragraph 1.2.1-1.2.3) and design (1.3.1-1.3.5) o f the high 
energy phosphoryl (~P) transfer network.
1.2.1 The creatine kinase/phosphocreatine system
Genes, proteins and tissue distribution
This paragraph gives a concise overview o f our current knowledge on CK genes and 
proteins, relevant for the studies described in this thesis. For comprehensive reviews, see Wal- 
limann et al. (13) and W yss and Kaddurah Daouk (14).
The creatine kinase gene family in mammals consists o f four functional members, the 
sarcomeric (ScCKmit, (17, 18)) and ubiquitous (UbCKmit, (19)) mitochondrial CK genes, the 
cytosolic muscle M -CK (20) and the cytosolic brain B-CK (21) genes and -  in some species -  
several non-functional pseudogenes. The B- and M -type genes encode three cytosolic en­
zymes, which are dimers with a molecular weight o f approximately 86 kilo-Dalton (kDa):
13
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MM-, BM- or BB-CK. M M-CK is predominantly expressed in mature skeletal and cardiac 
muscle. BB-CK activity is high in brain, neuronal tissues, embryonic tissues and other cell 
types and tissues such as photoreceptor cells, kidney, smooth muscle, placenta, spermatozoa, 
epithelial cells and intestine. The heterodimeric BM  isoform is present in heart and in devel­
oping skeletal muscle, where a transition from BB-CK to M M-CK takes place. CKs are not 
expressed in liver (22-24). The transcription-regulatory elements that confer cell type speci­
ficity in both the M -CK and B-CK gene involve complex series o f (partially overlapping) m o­
tifs in the gene-upstream area and in intronic regions (25-28). Heart and skeletal muscle also 
express the mitochondrial ScCKmit gene, whereas neuronal tissues, stomach and smooth 
muscle express the mitochondrial UbCKmit gene (13, 14). Also for the ScCKmit gene, up­
stream regulatory elements that govern expression and tissue distribution have been character­
ized (29). M olecular X-ray structures o f all four homo-oligomeric CK isoenzymes have been 
solved (30-33). Dimeric creatine kinases, which dimerize via their NH 2-terminal regions, 
show a banana-shaped structure. Subsequent studies revealed that a conserved negatively 
charged cluster in the active site o f CK is essential for enzymatic activity (34).
Proposed functions based on metabolic and biochemical studies
The CK/PCr system was already extensively studied using classical biochemical and 
(cell) physiological approaches, reviewed by W allimann et al. (13) and Wyss and Kaddurah
Daouk (14). The creatine kinase (CK: EC 2.7.3.2) reaction (M gADP- + PCr2- + H+ ^  Cr +
2 +MgATP -) balances ATP, ADP, Pi and H  at cellular sites o f energy production and consump­
tion (35). PCr provides a ‘temporal energy buffer’ during periods o f ATP hydrolysis, because 
PCr is rapidly converted into ATP and Cr, with a regeneration capacity that is much higher 
than the maximal rate o f ATP synthesis by OXPHOS and glycolysis. The CK/PCr system also 
functions as a ‘spatial energy buffer’ mechanism, or ‘PCr shuttle’, because it couples ATP 
utilization by ATPases to ATP production in mitochondria (36, 37). Figure 1.2 shows a sche­
matic representation of these processes. The CK/PCr system prevents a rise in intracellular 
free ADP and keeps local ATP/ADP ratios high (38). It also acts as a proton buffer, where the 
CK/PCr system prevents local and overall cellular acidification. In summary, the CK/PCr sys­
tem effectively couples ATP hydrolysis to ATP production in the eukaryotic cell.
ATP hydrolysis and subsequent regeneration by CK cause a net increase in cellular 
[Pi], which activates glycolysis and glycogenolysis. Pi is also transported back into mitochon­
dria via the Pi carrier protein for ATP synthesis. CK- and AK-catalyzed phosphoryl transfer 
events take place via intracellular chains o f enzyme molecules that catalyze sequential near­
equilibrium reactions and thereby link ATP consumption and production sites (16, 39, 40) 
(Fig. 1.1).
Cellular localization of CK isoforms
The cellular localization o f cytosolic CKs is isoenzyme dependent and involves rout­
ing o f mRNA (41) as well as formation o f supramolecular protein complexes (42, 43). In this
14
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thesis, the subcellular distribution o f CK enzymes in skeletal muscle is discussed in detail. 
Jost et al. (44) studied subcellular distribution o f BB-CK and UbCKmit. For further data on 
cellular distribution o f CK isoenzymes in different cell types, see (13, 14, 45).
Studies by W ilson et al. (41) suggested that the localization o f mRNA o f the cytosolic 
CK enzymes is regulated by the 3 ’ UTR (untranslated) sequence. This mechanism may 
therefore also be involved in the determination o f the localization o f the enzyme. MM-CK
specifically localizes on the sarcoplasmic reticulum (SR) membrane together with SR/ER
2+Ca -ATPase (SERCA) pumps (46), on the muscle myofibrillar M-line, and on the 
myofibrillar I-band (47). MM-CK is functionally coupled to SERCAs and myosin ATPases, 
which means that these ATPases preferentially use ATP supplied by the CK reaction and do 
not touch the bulk cytosolic ATP for functioning. In particular, local ATP regeneration in 
muscle by MM-CK improves Ca2+ uptake by the SR (46, 48, 49) and myofibrillar CK can 
rephosphorylate all o f the ADP produced by myosin ATPase via PCr. In this way, the system 
can provide enough energy for maximal force production and normal myofilament sliding 
kinetics, even in the absence o f ATP (50). N H 2-terminal lysine charge clamps mediate 
isoenzyme-specific interactions o f muscle-type creatine kinases with the sarcomeric M-line 
(42). This direct interaction at the M-band differs from the indirect coupling o f MM-CK to 
glycolytic enzymes at the sarcomeric I-band, where binding to the glycolytic enzymes 
phosphofructokinase (PFK) and aldolase is essential for CK localization (43). Possibly, there 
is a role for phosphorylation o f the cytosolic enzymes. Ponticos et al. (51) showed that MM- 
CK enzyme activity is partially regulated by phosphorylation via AMP-activated kinase 
(AMPK).
The mitochondrial CKs form inactive dimers or active octamers (52-56). M itochon­
drial membrane translocation o f mitochondrial isoenzymes is regulated by NH 2-terminal pro­
tein targeting sequences (14). The active enzyme is localized in mitochondrial cristae and in 
the intermembrane space, where the octameric enzyme binds to the membranes and function­
ally interacts with the transmembrane proteins adenine nucleotide translocator (or transporter, 
ANT) o f the inner membrane, and porin (voltage-dependent anion channel, VDAC) o f the 
outer membrane. The complexes o f mitochondrial CK, ANT and VDAC are enriched in the 
contact sites between the outer and inner mitochondrial membranes (56-59). The functional 
coupling between mitochondrial CK, VDAC and ANT results in the formation o f the perme­
ability transition pore (PTP), a pore that regulates exchange o f substrates and products o f the
CK reaction (PCr/Cr, ATP/ADP) between cytosol and mitochondria. Mitochondrial CK and
2+VDAC show a structural interaction that is regulated by Ca2+ (60). The PTP and mitochon­
drial permeability transition play an important role in apoptosis (61).
Muscle-type-specific expression levels of CK isoforms
Fast-twitch glycolytic muscles exhibit rapid and brief activity patterns, whereas slow- 
twitch oxidative muscles are designed for prolonged, sustained activity. These differences in 
metabolic properties are reflected in their PCr and CK content, and isoenzyme expression pat-
15
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Figure 1.2 Schem atic representation of the CK/PCr circuit for intracellular energy h om eostasis  
(after (1, 37)).
The mitochondria and the glycolytic compartments in the cytosol are the sites of energy production, 
which are coupled to the energy consuming compartments, myosin ATPases (in muscle) and ion 
pumps (muscle, brain). Intramembraneous MitCK (right part) is functionally coupled to the VDAC 
(porin) and the ANT, thereby forming the permeability transition pore (57). Cytosolic CK is sem i­
soluble; it dynamically interacts with components of the glycolytic machinery as well as the ATP con­
suming proteins (such as the SERCA pumps). The high energy phosphoryls, produced in mitochondria 
and glycolysis, are rapidly transferred to Cr by mitochondrial and cytosolic CKs. Upon stimulation of 
cellular activity, the large PCr pool in the cell can immediately buffer ATP levels. The CK/PCr system  
also couples increased ATP consumption to production (see text). On the left site, the direct diffusion 
of ATP and ADP is depicted. The relative pool sizes of PCr and Cr are much larger than of ATP and 
ADP (notice size of the boxes), because diffusion of these nucleotides is thought to be limited due to 
their size and negative charge. Abbreviations: s e e  Figure 1.1.
tern. Glycolytic muscles such as gastrocnemius and psoas major are high in PCr and show 
mainly cytosolic CK activity (98% M M-CK activity), but low mitochondrial CK activity (1­
2% ScCKmit). Oxidative muscles, soleus and diaphragm, have less PCr and lower overall CK
16
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activity, however, here ScCKmit activity represents approximately 10%-25% of total activity 
(55, 62-64).
Creatine transporter
Creatine is a natural compound o f meat and fish, but can also be synthesized in the 
body. The biosynthesis o f creatine is thought to involve formation o f guanidinoacetate in the 
kidney, which is subsequently methylated to creatine in the liver and transported via the blood 
to different creatine requiring tissues (14). Uptake o f creatine into cells in tissues o f the body 
is an active transport regulated by the Na+/Cl--dependent creatine transporter (65). The 
creatine transporter is mainly associated with the sarcolemmal membrane in all muscle types 
(66) and has recently also been found in the mitochondrial membrane (Th. Wallimann, ETH 
Zurich, personal communication). Creatine transporter protein content, localization and gene 
expression in rat skeletal muscle is fiber type dependent. Total creatine (Cr + PCr) is higher in 
fast-twitch than in slow-twitch muscles, but creatine transporter content is higher in slow- 
twitch than in fast-twitch muscles (66).
1.2.2 The adenylate kinase system
Adenylate kinases (AK, EC 2.7.4.3) catalyze the reaction ATP3- + AM P- ^  2 ADP2- 
and thereby regulate cellular adenine nucleotide levels (67). Currently, five AK isoenzymes 
with different expression levels and subcellular localization have been characterized (68-70). 
O f these, the cytosolic AK1 is the most prominent isoform in muscle and brain. AK2 and 
AK3 are found in the mitochondrial intermembrane space or matrix and are less abundant in 
muscle. As already mentioned, the AK system locally buffers ATP/ADP levels and facilitates 
high energy phosphoryl transfer from mitochondria to myofibrils in a similar way as the 
CK/PCr system does (see Fig. 1.1). This makes AK an important component o f the integrated 
intracellular high energy phosphoryl network (16). Targeted disruption o f the AK1 gene leads 
to a reduction in energetic efficiency o f  contractile performance, in combination with adaptive 
metabolic remodeling in the creatine kinase, guanine nucleotide phosphotransfer and 
glycolytic systems (15). Recently, a new variant o f AK1, AK1^, was found as a gene product 
responding to p53 activation. This AK1^ protein localizes at the plasma membrane via a NH 2- 
terminal myristoylation signal (71). AK1^ might play a role in (tumor) growth control or in 
the regulation o f  ATP-sensitive K+ channels (72).
1.2.3 The nucleoside-diphosphate kinase system
Nucleoside diphosphate kinases (Nm23/NDPK) catalyze the exchange o f a phosphoryl 
between a nucleoside triphosphate (where ATP is the phosphoryl donor) and a (deoxy) 
nucleoside diphosphate (ATP + (d)NDP ^  ADP + (d)NTP). At least eight different genes 
have been found in humans (Nm23H1-8) with a tissue-specific expression pattern and with
17
Chapter 1
products that are targeted to specific intracellular compartments (73), including the nucleus 
(Nm23H2) and mitochondria (Nm23H4/H6). Corresponding mouse genes have also been 
characterized (Nm23M1-M7). These enzymes serve a variety o f cellular functions, including 
maintenance o f  the cellular NTP pool, tumor suppression, protein kinase activity and 
transcription activation. Xenopus cardiac cytosolic Nm23 protein is associated with the 
intermediate filament vimentin and with the metabolic enzymes glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), pyruvate kinase (PK) and CK (74). Originally, the Nm23/NDPK 
gene was identified as a differentially-expressed gene in a non-metastatic melanoma cell line 
(75, 76). Nm23 thus functions in a variety o f cellular processes, including signal transduction, 
growth control and differentiation, cell motility, tum or metastasis, and apoptosis (77). These 
activities may be associated with efficient function o f different signal transduction pathways 
controlled by GTP/GDP-regulated proteins, such as Rad and Rho-family GTPases and 
guanine nucleotide exchange factors (GEFs) (78, 79).
1.3 Compartmentation and (regulation of) design in the cellular 
network for energy homeostasis
Cannon (81) defined homeostasis as the capacity o f multicellular organisms to main­
tain a relatively stable internal environment (“milieu interieur”, a term introduced by Claude 
Bernard (80), cited by Cannon) in changing external environments (82). Energy homeostasis 
refers to the capacity o f multicellular organisms to maintain energy (ATP) levels during peri­
ods o f  (intense) cellular activity. The cellular machinery involved in energy homeostasis is 
highly complex, because many metabolites and enzymatic reactions are involved, which con­
centration and activity are regulated in accordance with fluctuating physiological demand. A 
detailed overview on ‘metabolic pathways’ is available in physiology textbooks and at 
http://www.genome.ad.jp/kegg/kegg2.html#pathway.
This paragraph gives an overview o f  (i) compartmentation o f  energy production and 
consumption processes within a (muscle) cell; (ii) differences in metabolic design o f muscle 
cell types; and (iii) regulatory mechanisms that are capable o f sensing and affecting the cellu­
lar energetic status, the key regulatory principle in homeostasis. Regulation usually involves 
changes o f fluxes through enzymatic reactions, without changes in ultrastructural design of
Figure 1.3 Muscle fiber ultrastructure and filament sliding (facing page).
(A) The muscle ultrastructure. T: T-tubule system; 1: myofibrils; 2: sarcoplasmic reticulum; 3: triad 
forming terminal cisternae of the SR; 4: intermyofibrillar mitochondria; 5: T-tubule system; 6: 
sarcolemma; 7: basal lamina; 8: thin collagen fibrils. Adapted from (191) with permission. (B) 
Schematic representation of the molecular structure of three important muscle proteins: actin, 
tropomyosin and troponin (Tnl, TnC and TnT). Figure taken from (191) with permission. (C) ATP 
hydrolysis during sliding of actin and myosin filaments. The myosin-bound ATP is hydrolyzed (top left). 
Subsequently, myosin loosely binds to actin (top right), and binds tightly after Pi release (bottom right). 
Now the filaments slide (bottom left), ADP is released and new ATP binds. Figure taken from (192) 
with permission.
18
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the cell. In addition, a remodeling in cellular ultrastructure can help to optimally balance en­
ergy requirements and production in the cell in response to changes in the extracellular envi­
ronment.
1.3.1 Compartmentation in muscle facilitates efficient ATP supply
The skeletal muscle cell is one o f the most highly organized cells in the body. It is 
composed o f several functionally different compartments, which are shown in Figure 1.3 A
The sarcomeres in striated muscle are the contractile units, which consist o f structural 
components, sliding filaments composed o f actin and myosin and regulatory molecules like 
the troponins and tropomyosins (83). The sliding o f actin and myosin filaments, a cyclic asso­
ciation and dissociation process that is driven by the hydrolysis o f ATP, is initiated and regu- 
2+lated by Ca . In resting muscle, the myosin binding site on the actin molecule is blocked by
2+the troponin-tropomyosin complex. Ca2+ binding to troponin C causes a conformational 
change within this protein in such a way that binding o f actin and the S1 head o f myosin is 
facilitated. During this process, ATP is hydrolyzed to ADP and Pi (84). Now the filaments 
will slide and the muscle cell will contract. Detachment o f the myosin head will occur after 
binding o f an ATP molecule (see Fig. 1.3, B  and C).
Glycolytic complexes located at the M- and I-band (43, 47) and intermyofibrillar mito­
chondria located between the myofibrils (85, 86) provide ATP for muscle contraction. The 
cellular localization o f  these ATP producing units in the vicinity o f  sites o f  ATP hydrolysis by 
myosin ATPase facilitates efficient muscle contraction. The balance between glycolytic and
mitochondrial energy supply varies with fiber type (see paragraph 1.3.2).
2+Calcium is the physiological regulator o f muscle contraction. Ca is released from the 
sarcoplasmic reticulum (SR), which is also strategically located between the myofibers (see
Fig. 1.3^). Upon neuronal stimulation o f the muscle cell and subsequent acetylcholine release
2+at the neuromuscular junction, an action potential will activate the L-type Ca channel (dihy­
dropyridine receptor, DHPR) o f the T-tubule membrane. The a-subunit o f the DHPR and the
ryanodine receptor (RyR) connect the sarcolemma and the SR membrane. Upon activation,
2+ 2+Ca will be released from the SR into the sarcoplasm. Ca is re-sequestrated from the cyto­
sol back into the SR by SERCA pumps. Fast release from, and re-uptake in, the SR are essen-
2+tial for normal muscle function. This global mechanism for control o f cytoplasmic Ca and
the regulation o f force development by the contractile apparatus is called the excitation-
2+contraction coupling (ECC) mechanism (87). Re-uptake o f Ca into the SR is critically
dependent on ATP provided by glycolytic compartments and mitochondria in close vicinity o f
2+the SERCA pumps (88, 89). Furthermore, mitochondria buffer Ca during fast transients and
2+slowly release Ca2+ in the cytosol after the transient (90). Calcium buffering proteins in the 
cytosol such as parvalbumin have a similar role (91). Figure 1.3^ shows that close contacts 
exist between SR, mitochondria and the contractile apparatus, which is advantageous for op-
20
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2+timal cell function. Ca will simultaneously regulate muscle contraction and mitochondrial 
metabolic responses (92).
The plasma membrane (in muscle, sarcolemma) is an important compartment in excit­
able cells, since restoration o f the membrane potential (Na+/K+-ATPase activity) after depo­
larization is an ATP consuming process. Here, subsarcolemmal mitochondria (SSmt, which 
are thought to have different biochemical properties from intermyofibrillar mitochondria 
[IMFmt]) and glycolytic compartments are present to provide the ATP needed (86). IMFmt 
are thought to have a higher maximum rate o f oxygen consumption and a greater capacity to 
oxidize fatty acids (85).
Functional structures and organelles in the cell are surrounded by the cytoplasm (in 
muscle, sarcoplasm). In some studies, the muscle cell is regarded as a ‘bag o f w ater with 
floating enzymes’. It is now more and more accepted that there is a high degree of 
organization with distinction/separation between microenvironments (called compartmen- 
tation), which leaves not much space for reaction events as in a test tube (see Fig. 1.3^). So- 
called soluble enzymes in fact dynamically associate with the different subcellular 
components, most likely in macromolecular complexes. This influences their structural and 
functional behavior and thereby optimizes cell function (93). An example o f such a dynamic 
macromolecular complex is the glycolytic complex on the I-band (43). W ojtas et al. (94) 
showed that disturbance o f macromolecular complexes influences Drosophila flight muscle 
functional characteristics, and that co-localization o f  glycolytic enzymes is essential for 
muscle function. Similarly, there is also evidence for compartmentation o f high energy 
phosphoryl metabolites and creatine pools (13, 47). The implications o f this higher-order 
cellular organization for regulation o f energy homeostasis are discussed in paragraph 1.3.4. 
The phenomenon o f  compartmentation also applies to other cell types, such as smooth muscle 
and brain (95, 96).
1.3.2 Heterogeneity in muscle design: oxidative and glycolytic muscles
At the tissue level, skeletal muscles are organized as bundles o f muscle fibers, which 
consist o f multinucleated cylindrical myotubes (Fig. 1.3^). The fibers within a bundle vary 
considerably in their metabolic, morphological, biochemical and physiological properties, 
which influences their functional features such as rate o f  force production and resistance to 
fatigue (91, 97). The most prominent features that differ between fiber types are the relative 
importance o f  anaerobic glycolytic (glucose as primary metabolic substrate) and oxidative 
mitochondrial ATP production (fatty acid oxidation), and their performance profile, with fast, 
b rie f contraction in glycolytic and slow, fatigue-resistant contraction in oxidative muscles. 
Fiber type classification can therefore be based on physiological and metabolic properties (91, 
98). Histochemical and ultrastructural (i.e. protein composition) properties also differ between 
fiber types (Table 1.1) and are helpful in classification.
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Table 1.1 Mouse skeletal muscle fiber types and metabolic properties.
Histochemical/Ultrastructure I IIa IId/IIx IIb
Metabolic/Physiological SO FO FOG FG
Half relaxation time slow fast
Force production (indication) >30 min min min sec
Abbreviations: SO, slow oxidative; FO, fast oxidative; FOG, fast oxidative glycolytic; FG, fast glycolytic. 
Oxidative m uscles are rich in mitochondria; glycolytic m uscles have primarily anaerobic energy pro­
duction (91, 98).
The differences in metabolic properties o f muscle cells result from the molecular di­
versity found for several essential muscle proteins. Gradation in functional differentiation is 
regulated at the level o f gene transcription (isogenes or isoforms), alternative splicing (vari­
ants), or by translational and posttranslational modifications. It fits in an evolutionary view 
wherein protein structures with very specific functions at defined cellular locations (i.e. in 
protein complexes) have evolved. This molecular diversity involves spatio-temporal timing o f  
expression o f isogenes and variants best suited to meet cellular needs, which are remarkably 
different in different developmental stages. Diversity is present in the myosin heavy chain 
(MHC) expression patterns (98, 99) and in the expression o f genes involved in actin-myosin
sliding (troponins, tropomyosins). Also in ATP production (glycolytic and mitochondrial en-
2+zymes such as LDH, aldolase, cytochrome c oxidase (COX) subunits), in Ca release and se­
questration (SERCA and RyR) proteins and in many other functions, such diversity in protein 
expression is displayed. This can involve both regulation at the level o f production o f differ­
ent isoforms o f distinct genes (SERCA1-SERCA2) and different splice variants o f the same 
gene (SERCA1a-SERCA1b) (91).
The characteristics o f a typical skeletal muscle, a mosaic o f different fiber types, is a 
reflection o f its fiber type composition, i.e. the relative contribution o f slow aerobic and fast 
anaerobic fibers. Soleus muscle is rich in MHC type I and type IIa fibers, whereas gastrocne­
mius and psoas major are relatively rich in IId and IIb fibers (98, 99). These characteristics 
are dynamic, since altered muscle use induces changes in fiber type distribution and metabolic 
properties (see below). Although fiber type transitions have been well described at the histo­
logical, protein and RNA level, the molecular mechanisms that control these changes are in­
completely understood (100).
1.3.3 Changes in ultrastructural design result from metabolic signals
“Mammalian skeletal muscle shows an enormous variability in its functional features 
such as rate o f force production, resistance to fatigue and energy metabolism, with a wide 
spectrum from slow aerobic to fast anaerobic physiology. In addition, muscle exhibits high 
plasticity that is based on the potential of muscle fibers to undergo changes of their cytoarchi- 
tecture and composition o f specific muscle protein isoforms.” (91)
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The formation o f  distinct differentiation variants o f  muscle fibers and the muscle 
metabolic machinery involve many intrinsic and extrinsic regulatory principles, including 
hormonal, physiological and genetic regulation. The determination o f design is based on mo­
lecular cross talk between metabolic activity and the machinery that regulates differentiation 
characteristics. M uscle is a dynamic organ that responds with adaptive changes to a variety of 
stimuli, such as growth factors (anabolic steroids), differentiation factors, hormones, or nerve 
signals (91). Chronic changes in muscle activation can also evoke alterations in cellular ultra­
structure. This phenotypic adaptation to exercise has been well described in experimental 
chronic stimulation o f fast-twitch skeletal muscle (97, 100, 101). Changes occur at all possi­
ble different levels: transcription, translation, protein folding and complex formation, in both 
the ATP consuming (ATPases, MHC isoform transitions) and producing (glycolysis, mito­
chondria) machinery. These adaptations serve a functional goal: the muscular ultrastructure
will alter until a new steady state that meets the functional needs has been achieved.
2+All muscle fibers use Ca as their main regulatory and signaling molecule (91). Apart
2+from Ca , also AMPK (102) and oxygen (103) are important in regulating adaptive re­
sponses. Recently, the role o f NAD+/NADH in metabolic signaling (redox regulation) earned 
renewed attention.
Calcium as a signaling molecule in skeletal muscle
2+Different shaping o f Ca signals can be linked to contraction, regulation o f metabo-
2+lism and nuclear and mitochondrial gene expression. Ca2+ sensitive proteins involved in these 
processes decipher information in the transients. This control is achieved by amplitude and 
frequency modulation o f signals, called the AM/FM of calcium signaling (reviewed in (104, 
105)).
The role o f calcium in the contraction cycle was already described in paragraph 1.3.1.
It is important to note that neuronal signals that stimulate muscle contraction, thus the
2+frequency and duration o f  Ca2+ signals, are remarkably different between oxidative and 
glycolytic muscles. Oxidative muscles undergo sustained, low frequency stimulation, whereas 
glycolytic muscles are stimulated by brief, high frequency signals. It is well established that
chronic muscle stimulation induces a series o f  orchestrated fast-to-slow transitions in fast-
2+twitch muscles. The isoform patterns o f  myofibrillar and Ca2+ regulatory proteins shift 
towards the slow phenotype, and also the profile o f  metabolic enzymes shifts to aerobic
metabolism (100, 101).
2+The Ca2+ sensitive proteins glycogen phosphorylase (cytosolic) and mitochondrial de­
hydrogenases regulate metabolism (glycolysis, glycogenolysis and OXPHOS) (106, 107). Mi-
2+tochondrial metabolism is activated by oscillatory Ca2+ signals transferred from the cytosol to
mitochondria (92). In this way, ATP production is accelerated in periods o f muscle use, safe-
2+guarding the normal progress o f contraction. The activation o f metabolism via Ca is further 
described in paragraph 1.3.4.
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Differences in gene transcription pattern between different fiber types in skeletal mus-
2+cle are governed by different patterns of motor nerve activity (108). The Ca signals in toni- 
cally active motor neurons activate the phosphatase calcineurin (PP2B). Calcineurin exerts its 
downstream effects via dephosphorylation and subsequent nuclear translocation of the signal­
ing molecule nuclear factor of activated T-cells (NFATc) and via members of the MEF2 fam­
ily of transcription factors (108, 109). Nuclear NFAT proteins and other transcription factors 
bind to consensus DNA sequences, thereby activating gene expression. Calcineurin-regulated 
expression has been shown for a variety of slow-fiber-specific genes, including myoglobin 
(oxygen buffer), ScCKmit and Troponin I (110). Calcineurin is also involved in the MHC iso­
form switch towards oxidative isoforms and isoform switches in SR proteins, LDH and CK 
(109, 111). Furthermore, calcineurin-dependent pathways regulate growth and differentiation 
of multinucleated muscle fibers via NFAT proteins (112, 113) and are involved in skeletal 
muscle hypertrophy (114, 115).
Besides responses related to differences in motor nerve stimulation pattern, gene tran-
2+scription in muscle cells is also influenced by Ca via retrograde signaling in response to mi­
tochondrial genetic and metabolic stress (100, 116-118). Disturbance of cellular ATP levels
(resulting from metabolic activation or from mutations in mitochondrial genes) results in rises
2+in intracellular Ca levels, which in turn results in activation or inactivation of specific signal 
transduction pathways, leading to up- and downregulation of specific nuclear and mitochon­
drial genes (see paragraph 1.3.5).
Regulation by adenosine levels: AMPK
The AMP-activated kinase (AMPK) is involved in muscle metabolic design via ‘sens­
ing’ altered levels of ATP/ADP/AMP. The enzyme is suggested to be the ‘fuel gauge’ of the 
mammalian cell (102). AMPK is activated by cellular stresses that deplete ATP, such as mus­
cle stimulation and hypoxia. The available pool of ATP is converted into ADP and subse­
quently into AMP by adenylate kinase. This ‘low fuel’ situation in the cell is sensed by 
AMPK, which subsequently activates fatty acid oxidation as an alternative pathway for ATP 
generation. AMPK phosphorylates acetyl-CoA carboxylase P, resulting in decreasing levels 
of malonyl-CoA. Malonyl-CoA is an allosteric inhibitor of carnitine palmitoyltransferase 
(CPT) 1, the enzyme that controls the transfer of long-chain fatty acyl-CoA across the outer 
membrane into the mitochondrial intermembrane space. This relieves the inhibition o f fatty 
acid oxidation (102). Furthermore, AMPK is regulated by phosphorylation by AMPK kinase 
(AMPKK), by pH and by the PCr/Cr ratio (51). Recent work suggests that chronic AMPK 
activation may be partially involved in adaptational signaling in response to contractile activ­
ity (119). AMPK activation is also associated with increased uncoupling protein 3 (UCP3) 
gene expression in rats (120). Mu et al. (121) showed that AMPK is involved in contraction- 
and hypoxia-regulated glucose transport in skeletal muscle.
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Regulation by NAD+/NADH levels
The coenzyme NAD+/NADH is the major acceptor or donor of hydrogen in metabolic 
reactions and can therefore be regarded as an important regulatory intermediate in cellular
metabolism. Interestingly, NAD+/NADH also play an important role in cellular signaling via
2+protein modifications (ribosylation) and as a precursor of Ca mobilizing compounds (via
cyclic ADP ribose, cADPR). This implies that alterations in cellular metabolic state can be
2+translated directly into changes in a protein’s biological function and in Ca signaling. Mono- 
ADP-ribosylation and poly-ADP-ribosylation of proteins is catalyzed by ADP- 
ribosyltransferases, which attach the ADP-ribose of NAD+ to the acceptor protein (122). An 
example of such a poly-ADP-ribosyltransferase is poly(ADP-ribosyl) polymerase 1 (PARP1). 
This enzyme is involved in DNA repair, transcription and apoptosis in brain. Another exam­
ple is the SIR2 protein, which is involved in transcriptional silencing and longlivity (123). 
This protein has both ADP ribosyltransferase and NAD-dependent deacetylase activity. The 
ADP-ribosyltransferase activity of SIR2 is essential for gene silencing in vivo. The NAD re­
quirement of SIR2 for deacetylation suggests that this protein may be a sensor of the energy 
or oxidation state of cells. The ADP-ribosyl cyclases are enzymes that catalyze the synthesis
of cADPR. The cADPR is a ligand for the ryanodine receptor and as a consequence, cellular
2+redox state and Ca2+ homeostasis are directly coupled. An example o f  such an enzyme is
CD38. CD38 ADP-ribosyltransferase activity has been linked to the activation of nucleoplas-
2+ 2+ mic Ca signaling (124) and to Ca signaling in control of bone resorption (125). Further-
2+more, cADPR acts as a second messenger for Ca2+ release to stimulate insulin secretion in 
pancreatic P cells via a mechanism whereby ATP produced by glucose metabolism and
cADPR compete for the binding site Lys-129 of CD38 (126). Accumulation of cADPR
2+caused by high [ATP] and subsequent inhibition of cADPR hydrolysis causes Ca release via 
the RyR.
Oxygen sensing and gene regulation
Although the mammalian cellular oxygen sensor is not known at the molecular level, 
we do know that virtually all cell types respond to small reductions in normal molecular 
oxygen levels (hypoxia) (127, 128). Hypoxia induces expression of several different genes 
involved in oxygen transport (erythropoiesis and angiogenesis, vascular tone) and anaerobic 
energy production (glycolysis and glucose uptake), reviewed by Wenger (129) and Semenza 
(130). The expression of hypoxia-induced genes is mediated by the hypoxia-inducible factors 
(HIFs), which are the downstream targets of the hypoxia-induced signaling cascade. HIF-1 is 
a ubiquitously and constitutively expressed heterodimeric basic helix-loop-helix (bHLH) 
transcription factor, composed of two subunits, a  and p. Above critical intracellular oxygen 
tension, HIF-1 a  is ubiquitinated and rapidly degraded in proteasomes. The protein contains an 
oxygen-dependent degradation domain within which a highly conserved region with a binding 
site for the tumor suppressor von Hippel-Lindau (pVHL) is present (128). Mutations in 
pVHL, which are found in some tumors, cause constitutive expression of the HIF-1 a  and its
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target genes, which results in increased angiogenesis in tumors (131). HIF-1P was originally 
identified as the dioxin receptor/aryl hydrocarbon receptor (AhR) and was therefore named 
AhR nuclear translocator ARNT (132). Its expression is induced by hypoxia. Under hypoxic 
conditions, HIF-1 a  and HIF-1 P dimerize and dimeric HIF-1 translocates to the nucleus and 
binds the hypoxia-response elements (HRE) of many HIF-1 target genes (summarized by 
Semenza (130)). The activation of HRE-containing genes will result in an orchestrated 
upregulation of erythropoiesis (erythropoetin, EPO), vascularization (vascular endothelial 
growth factor, VEGF), in compensation of reduced mitochondrial ATP production by 
anaerobic glycolysis (hexokinase I and II, phosphofructokinase PFK-L, phosphoglycerate 
kinase PGK-1, pyruvate kinase PK-M, GAPDH, enolase-1, aldolase A and C, LDH-A) and in 
upregulation of glucose import (glucose transporters GLUT1, GLUT3). Hypoxia-responsive 
elements are found in the promoters o f  specific glycolytic isoenzymes, but are absent in 
promoters o f  other isoenzymes.
Recently, several groups have further described the involvement of HIF-1 a  and pVHL 
in sensing cellular oxygen levels. Ivan et al. (133) and Jaakkola et al. (134) provided evidence 
that a HIF-1a prolyl hydroxylase (HIF-PH) in cells is involved in sensing oxygen. In the 
presence of oxygen and iron, this enzyme targets to a highly conserved residue in human HIF- 
1a (proline 564) and attaches an -O H  group to it. This hydroxylation is necessary and suffi­
cient for the binding of pVHL to HIF-1a (128). Epstein et al. (136) and Bruick and McKnight 
(135) found a family of HIF prolyl hydroxylases that are responsible for regulation of HIF.
Muscle differentiation factors
Differentiation o f myoblasts into multinucleated myotubes involves cell cycle with­
drawal, differentiation, and cell fusion. This process is regulated by the MyoD family of 
bHLH transcription factors including MyoD, MRF4, Myf5, myogenin, and the MEF2 family 
of transcription factors. Myogenin is a transcription factor that is strongly regulated by elec­
trical activity (137) and by calcineurin (138). Over-expression of myogenin in muscle cells of 
transgenic mice induces a shift towards increased expression of oxidative enzymes and reduc­
tion of glycolytic enzymes (137).
1.3.4 How is metabolic homeostasis regulated?
Tissues with fluctuating work output undergo dramatic changes in ATP turnover rates 
upon stimulation (12). On the other hand, metabolic turnover can be down-regulated in peri­
ods of hypoxia and ischemia (139). This remarkable dynamic range of metabolic activity is 
regulated with use o f  the same cellular infrastructure. Moreover, most o f  the metabolites in 
the cell are perfectly or relatively homeostatic over this wide range o f metabolic activity (93). 
A clear detailed explanation for these two phenomena is not available yet, but the dynamic 
status o f  macromolecular complexes, with both energy consuming and producing mechanisms 
at specific subcellular sites (see paragraph 1.3.1), seems to be important to achieve large-scale
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changes in metabolic rate without disturbing overall cell metabolite concentrations. The trans­
fer of the reaction product of one enzyme to the next enzyme in the metabolic pathway often 
occurs without the intermediate equilibrating with the bulk solution, in a process called mo­
lecular channeling (140, 141). Moreover, intracellular circulation (cytoplasm streaming) is 
metabolically controlled and increases with ATP turnover (93). Directional substrate channel­
ing instead o f free diffusion o f molecules within the cytoplasm in skeletal muscle was already 
suggested by Wegmann et al. (47). Organization o f cellular ultrastructure and regulation o f 
metabolic homeostasis are thus closely intermingled.
The buffering roles o f  myoglobin and the CK system are thought to be essential to 
achieve homeostasis of O2 and ATP levels (12). Apart from substrate channeling and buffer­
ing o f  ATP and oxygen levels, metabolic regulation in muscle is also optimized by the fact
2+that the signaling molecule for muscle contraction, Ca2+, simultaneously activates cellular me­
tabolism (see below).
Examples of regulation via ATP and ADP + Pi are numerous. The activity of ATPases 
is regulated by the local ATP/ADP + Pi ratio (38) and this ratio will decrease immediately 
after cellular stimulation, assuming that buffering by the CK circuit is absent. On the other 
hand, the putative rate-controlling enzyme of glycolysis, PFK, is stimulated by a decrease in 
ATP/ADP ratio (142, 143). In the mitochondrion, the ANT is also stimulated by a decrease 
in ATP/ADP ratio. Pi stimulates both glycolysis and OXPHOS. Thus, a decrease in local 
ATP/ADP + Pi ratios directly influences aerobic and anaerobic energy production and 
indirectly also oxygen consumption. Maintained function o f ATPases is warranted by the 
presence of the CK system. AMPK is activated when cellular AMP levels rise due to AMP 
production via AK, subsequently inducing an increased phosphorylation state of acetyl-CoA 
carboxylase. The subsequent fall in malonyl-CoA concentration in the cytosol increases fatty 
acid uptake and oxidation in the mitochondrion (102).
Apart from stimulation by ADP and Pi, which can be regarded as substrate-feedback
2+ 2+ activation, Ca also activates ATP generation. Ca stimulates both glycolysis (via stimula­
tion of glycogenolysis via phosphorylase) and OXPHOS directly. Inactive phosphorylase b 
undergoes shift to active phosphorylase a via calcium-activated phosphorylase b kinase (106).
In mitochondria, the calcium-regulated pyruvate-, isocitrate- and 2-oxoglutarate dehydro-
2+genases are stimulated (90, 107, 144, 145). Furthermore, Ca directly regulates alpha- 
glycerophosphate dehydrogenase (GDPH, part of the glycerol phosphate shuttle for oxidation 
o f cytosolic NADH) and maybe ATP synthase (107).
1.3.5 Mitochondrial biogenesis and uncoupling
Hypermetabolic stress can lead to mitochondrial proliferation (85). Mitochondrial bio­
genesis is a phenotypic hallmark of a muscle fiber type shift towards an oxidative phenotype, 
such as evoked by chronic electrical stimulation. It is now well accepted that mitochondria are 
dynamic organelles that undergo changes in their composition and morphology upon changes
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in cellular activity. This requires cooperation of and communication between the nuclear and 
mitochondrial genomes. Nuclear transcription of genes encoding mitochondrial proteins is 
activated via a variety of transcription factors including nuclear respiratory factor 1 (NRF-1), 
NRF-2, Sp1, and recognition of OXBOX/REBOX and Mt motifs (117). The upstream pro­
moter elements differ remarkably between different respiratory genes, even if they are in the 
same functional complex (85, 100, 117). The expression of respiratory genes and other impor­
tant factors involved in mitochondrial biogenesis is transcriptionally controlled by a combina­
tion of constitutive promoter-specific transcription factors that warrant appropriate levels of 
expression. In addition, a second level of regulation involves a more limited group of regula­
tory proteins that coordinate the expression of key nuclear-encoded mitochondrial genes in­
volved in the replication and transcription of mtDNA. These latter proteins may be especially 
important in energy demanding tissues and in regulating the response to environmental 
changes (117). Mitochondrial transcription is activated by the nuclear-encoded mitochondrial 
transcription factor A (mTFA, Tfam). An increase in Tfam mRNA expression levels precedes 
the elevation of its protein levels, mtDNA binding, the appearance of mitochondrial tran­
scripts and oxidative enzyme activity (146).
Cells modulate the expression of nuclear genes in response to changes in the 
functional state of mitochondria, an interorganellar communication pathway called retrograde 
regulation (147). As mentioned in paragraph 1.3.3, Biswas et al. (116) showed that partial 
depletion of mitochondrial DNA in C2C12 myoblasts (genetic stress) or treatment with
mitochondria-specific inhibitors (metabolic stress) induces a stress signaling response that is
2+associated with increased cytosolic free Ca . Disruption of A is associated with elevated
2+cytosolic [Ca ] and activation of genes via a calcineurin-dependent pathway. The yeast 
protein CIT2, which encodes a peroxisomal isoform of citrate synthase, gives another 
illustration of retrograde regulation. This enzyme catalyzes the first step in the glyoxylate 
cycle, which coverts two carbon compounds into intermediates such as succinate that can 
enter the TCA cycle. Activation of the CIT2 retrograde response upon changes in the 
functional state of mitochondria allows for a more efficient use of carbon for biosynthetic 
processes. Three proteins, Rtg1, Rtg2 and Rtg3, are involved in control of this signaling 
pathway (147).
Alterations in mitochondrial biogenesis and respiration have been reported in adipo­
cytes and myotubes that express the thermogenic co-activator PGC-1. In myotubes, PGC-1 
stimulates NRF-1 and NRF-2 gene expression, and expression of Tfam. PGC-1 also induces 
expression of uncoupling proteins, which uncouple ATP synthesis from the activity of the 
ETC, thereby generating heat. This mechanism links cold-induced stress to changes in mito­
chondrial morphology, composition and respiration. Upon PGC-1 expression, a shift between 
the two modes of mitochondrial respiration occurs, from OXPHOS (ATP production) to un­
coupling (generation of heat) (148-150).
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1.4 Studies on cellular energetics: in vitro and in vivo studies of mice 
with targeted disruptions of CK genes
In 1989, the embryonic stem (ES) cell culture and the knockout methodology were 
introduced to create mouse model systems with targeted disruptions in specific genes (151). 
Using this technique, it is possible to manipulate and inactivate a specific gene by mutating its 
coding sequence in a defined region on the DNA. This experimental strategy has also been 
applied in the study of the CK/PCr circuit in muscle and brain. At present, knockout mouse 
models are available for all individual muscle CK genes (M-CK, ScCKmit) and the 
combination M-CK; ScCKmit (throughout this thesis CK---- will be used for these muscle 
double knockout mice) (17, 152, 153). Also for brain B-CK, UbCKmit and the combination 
B-CK, UbCKmit, knockout models are available (44, 154). In other studies, the biological 
function of the CK/PCr circuit has been assessed by substrate interference via feeding creatine 
analogs (PGPA) that reduce substrate (Cr) availability for CK (155-160). The knockout 
methodology uses gene inactivation as a starting point for studies, which also facilitates study 
of the different isoenzymes in different organs. It is important to realize, however, that 
knockout mice have a heterogeneous background, since the blastocysts and the ES cells used 
to create chimeric mice are not from the same mouse strains (C57Bl/6 and 129/Sv 
respectively). Therefore, effects caused by differences in genetic background complicate 
studies on the phenotypes of knockout mice, especially behavioral studies (161, 162).
Studies on CK-deficient mouse muscles
Contrary to the expectation, all muscle CK knockout mice are viable and phenotypic 
consequences of CK gene ablation only become apparent when strenuous physiological chal­
lenges are applied. Both M-CK- - and CK---- mice lack burst activity (152, 153). Interestingly, 
ablation o f  CK genes in muscle is associated with a remarkable change in cytoarchitectural 
and metabolic characteristics of primarily fast-twitch skeletal muscles (152, 153, 163). Cy- 
toarchitectural changes include changes in MHC fiber type composition towards slow-twitch 
fiber types in fast muscles (163), and an 1.5 to 2-fold increased mitochondrial volume and ac­
tivity in these fibers (152, 153). Metabolic changes are reflected in increased fluxes through 
the glycolytic and mitochondrial pathways, which suggests that the potential for glycolysis, 
glycogenolysis and aerobic energy generation in the limb musculature o f  mutants has in­
creased. CK deficiency leads to altered calcium homeostasis (153) and changes in fatigue re­
sistance (153, 164). ScCKmit-- mice show now overt phenotypic defects or ultrastructural 
changes (17).
Physiological consequences of CK gene ablation have been tested by In ‘t Zandt et al. 
(165) by applying transient ischemia on hind limb muscles as a physiological challenge.
31Metabolic responses were monitored using 31P nuclear magnetic resonance (NMR) before, 
during and after a 25-minute period of ischemia. The single ScCKmit- - and M-CK- - mutants 
showed responses that were in general similar to wild-type. Remarkably, M-CK-- mice
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showed a significantly faster recovery of PCr after ischemia, which possibly reflects the rela­
tive increase o f  the mitochondrial compartment in these muscles. CK--/-- mice, however, 
showed a 30% decline in ATP levels during ischemia. This illustrates the ATP buffering role 
of the CK/PCr system, which is facilitated by both the mitochondrial and the cytosolic iso­
forms, since in single knockouts ATP levels remained constant. Both the M-CK-/- and the 
CK---- mice showed increased levels of phosphomonoesters, reflecting an upregulation of gly­
colysis and glycogenolysis. Pi levels in CK--/-- muscles increased much more slowly and cellu­
lar pH declined faster, reflecting that the CK reaction causes a net increase in Pi and buffers 
H+ levels. These experiments emphasize the importance of ATP production via aerobic glyco­
lysis and OXPHOS as an alternative strategy to buffer cellular energy levels in CK---- mus­
cles.
Changes in muscle architecture at the molecular level have been reported for the MHC 
isotype composition (163). Alterations in enzyme composition and quality have been de­
scribed for the enzyme AMP deaminase (AMPD). Studies of Tullson et al. (166) showed a 
tissue-specific downregulation of AMP deaminase, the enzyme that produces IMP and NH3 
from AMP from the adenylate kinase reaction. AMPD protein levels are reduced in fast- 
twitch but not in slow-twitch muscle of M-CK- - and CK---- mice.
The changes in mitochondrial volume and activity in CK--/-- mice appear to be associ­
ated with altered ADP sensitivity of mitochondria in saponin skinned fibers (50, 63, 64). Gly­
colytic mitochondria have a Km of respiration for ADP that is 20-25 times lower than those 
from oxidative tissues, which makes these mitochondria highly sensitive to ADP. In normal 
mitochondria, the apparent Km for ADP will decrease in the presence of creatine, because of 
the creatine kinase reaction. Mitochondria from M-CK-/- soleus show two times lower Km, 
(i.e. a higher affinity) for ADP. In the M-CK- - mice, impairment of energy transport function 
in slow-twitch muscle is compensated by an increased transport o f  adenine nucleotide be­
tween mitochondria and the cytosolic compartments where ATP is hydrolyzed. In glycolytic 
gastrocnemius, a decrease rather than an increase in mitochondrial sensitivity to ADP occurs, 
together with a marked increase in oxidative capacity (63). These remarkable results show 
that ablation of CK isoenzymes not only results in absence of CK-mediated ~P-transfer, but 
also induces changes in the metabolic design o f mitochondria in the highly plastic muscle cell.
1.5 Experimental approaches
The observation that the metabolic system as a whole adapts to deficiency in one o f  its 
components implies that we should study the creatine kinase system in the context o f  all other 
components o f  the cellular energy production/consumption machinery. In this way, underly­
ing metabolic signaling pathways responsible for the remodeling responses can be identified. 
This implicates a shift from a ‘single gene approach’ to a more global study o f the cellular 
energy production/consumption system. This paragraph describes the techniques that were
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used in this thesis to obtain data about proteome, transcriptome, metabolic and physiological 
responses in CK-deficient mice.
1.5.1 Proteome and transcriptome analyses
Genome-wide analysis of gene expression (and protein expression) are relatively new 
approaches to find (yet uncharacterized) genes that are co-regulated in the same cellular proc­
esses. After having found all individual genes via genome sequencing in many species includ­
ing man and mouse, the challenge is now to find out which genes are cooperating in cellular 
(metabolic) pathways.
The transcriptional response of genes to a perturbation in cellular metabolism can be 
identified using recently developed genome-wide expression profiling techniques (167, 168). 
The availability of the complete sequence of the human genome (169) has stimulated the de­
velopment of this technique. Screening of the whole ‘transcriptome’ is a useful technique to 
simultaneously elucidate possible changes at the mRNA expression level between wild-type 
and CK-deficient mice. However, present day microarray techniques still have many practical 
and technical limitations. Practical limitations involve the requirement of large amounts of 
mRNA (i.e. of tissue material) for labeling (which sometimes requires mRNA amplification 
techniques (170)), the availability of cDNA arrays or oligonucleotide arrays with the complete 
set of transcripts (i.e. the whole human/mouse genome) and the specificity (genes encoding 
different isoenzymes will show cross-hybridization, depending on the degree of sequence 
similarity. This makes identification of different isogenes and especially splice variants very 
difficult). Furthermore, isolation of polysome-bound instead of total mRNA could be of influ­
ence on the expression pattern, since polysome-bound mRNA will give a representation of 
mRNA that is actually engaged in the translation process, whereas total mRNA patterns only 
shows the balance between mRNA transcription and degradation (171). Technical limitations 
involve the quality of the arrays (reproducibility of the spots, reliability of the cDNA bank or 
of the oligonucleotide synthesis), the efficiency of labeling of the cDNA and the detection 
limits that are remarkably different between high abundant versus low abundant mRNAs. All 
these aspect have to be fully appreciated when applying this technique (172).
Ultrastructural changes in cells are directly related to changes in protein composition 
inside the cell. By applying of quantitative Western blotting techniques, using antibodies di­
rected against the proteins of interest, we can study changes in steady-state levels of proteins. 
High-throughput techniques for quantitative protein analysis using mass spectroscopy are cur­
rently being developed but as a whole the methodology for proteome analysis is still in its in­
fancy (173).
It is of note that a variety of underlying mechanisms such as (i) mRNA transcription 
regulation; (ii) post-transcriptional regulation (splicing, mRNA stability); (iii) translational 
regulation (free mRNA versus polysomal mRNA); (iv) post-translational modifications (gly- 
cosylation, phosphorylation, ubiquitination, ADP-ribosylation, acetylation, methylation, pro­
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teolytic clipping and other factors regulating protein conformation and breakdown); and (v) 
subcellular localization, and the assembly into macromolecular complexes determine protein 
quantity and activity. The study of physiological adaptations thus requires an inventory of 
changes occurring at the mRNA, protein and protein activity level.
1.5.2 Techniques to study spatio-temporal behavior of metabolites, 
signaling molecules and proteins
In the previous paragraphs, the importance of regulation of the cellular design and me­
tabolite signaling has been detailed. For full understanding of the regulatory principles behind 
this signaling, it now becomes important to adequately measure the dynamic compartmenta- 
tion of relevant metabolites like ATP, GTP, NAD+/NADH, O2 and Ca2+. Levels of biologi­
cally active proteins can be detected by enzymatic assays, or sometimes by Western blot. 
Several techniques are available to monitor levels of metabolites such as ATP and PCr, in­
cluding high-pressure liquid chromatography (HPLC) and nuclear magnetic resonance 
(NMR). P-, C- and H-metabolites can be visualized in mice in vivo using NMR techniques
(174). Levels of intracellular ions are studied in living cells using fluorescent (ratiometric)
2+probes and Ca responsive fluorescent proteins such as aequorins (175, 176).
2+Development of small organic cell-permanent fluorescent Ca probes such as Indo-1
2+and Fura-2 has facilitated the study of Ca2+ homeostasis in living cells since these indicators
report on the concentration of the Ca2+ molecule (177, 178). The use of these probes in com-
2+bination with (real time) microscopy facilitates detailed spatial and temporal analysis of Ca 
signals that underlie a variety of biological responses in virtually all cell types. Development 
of targeted aequorins for localized calcium measurement (traditional calcium indicators are
trapped in the cytosol) facilitates the study of differences between compartments in the cell
2+(176, 179-182). The importance of amplitude and frequency of Ca signals and their biologi­
cal effect at specific subcellular locations has been studied in detail with these techniques.
The use of the (enhanced) green fluorescent protein EGFP from Aequorea has become 
widespread since 1996. EGFP has three possible applications: study of translocation of 
proteins in the cell, study of biochemical modulation of GFP spectra upon alterations in the 
cellular environment (pH sensing) and fluorescence resonance energy transfer (FRET) (183). 
Tagging proteins of interest with EGFP mutants (blue, green, cyan, yellow) facilitates detailed 
intracellular localization of proteins in living cells (184, 185). This opens the possibility to 
study translocation of proteins upon cellular stimulation, studies that used to be difficult to 
perform because antibodies can only be used after fixation of cells. Furthermore, 
simultaneous localization of different proteins in living cells is now possible and the dynamic 
behavior of proteins and their preferential binding sites in the cell can be studied. Moreover, 
these proteins are used as pH indicator (186) and for co-localization of proteins in the cell
(intermolecular FRET). So-called cameleon constructs, composed of a calmodulin domain
2+between a CFP and a YFP, are currently used as Ca indicators, making use of intramolecular
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2+FRET. Upon binding of Ca to the calmodulin domain, the CFP and YFP come in close 
proximity, thereby facilitating energy transfer between CFP and YFP (187). Similar 
approaches have been used to create a cAMP indicator (188) and a cGMP indicator (189).
1.5.3 The use of cultured stable cell lines for studies of biological systems
The study of biological processes cannot be carried out in living organisms only. To 
finally elucidate the function o f a gene or protein o f  interest in its cellular environment, and to 
facilitate the use of transfection studies and studies using fluorescent or other indicators, it is 
necessary to establish cell model systems. Derivation of cell lines is, however, not an easy 
task, since primary cells in culture die after a few passages. Therefore, immortalizing genes 
such as the SV40 large T antigen have been used to create immortalized cells from virtually 
every tissue in the body (190). The combined approach of cell culture, transfection, and ma­
nipulation facilitates in vitro study of the regulation of cellular (metabolic) pathways in great 
detail. In combination with data obtained in vivo, this can give final clues on the function of 
specific protein or genes inside the cell.
1.6 Aim and outline of this thesis
The well-characterized phenotype in CK-deficient muscles suggests that yet undefined 
compensatory mechanisms in the cell are responsible for the remarkable plasticity observed in 
glycolytic and in mitochondrial activity and in ultrastructural composition. A more specific 
inventory of changes is necessary to find the underlying regulatory mechanisms. The genetic 
studies on CK ‘knockouts’ introduced three interesting new aspects in the CK/PCr circuit. 
First, genetic stress in this system induces increased fluxes of metabolites through alternative 
pathways (AK, glycolysis, OXPHOS), which partly compensate for the genetic defect. 
Second, genetic stress induces changes in composition o f  cellular compartments 
(cytoarchitecture), which also partly compensate for the loss o f  function o f the CK/PCr 
system. For example, the increase in mitochondrial volume (and activity) can be explained as 
an adaptation necessary to reduce distances between sites o f  ATP production and 
consumption. Third, CK deficiency induces changes at the molecular level in energetic 
regulation, as can be concluded form the altered expression o f AMPD and changes in the 
affinity for ADP of mitochondria. These observations suggest a form of regulatory cross talk 
between different cellular systems involved in energy homeostasis, which is likely to be 
different between different muscle cell types because o f their different metabolic demands. 
This also suggests that the CK/PCr system is coordinately regulated, together with other 
components of the cellular metabolic network. However, we do not know which regulatory 
mechanisms and signaling pathways are involved at the molecular level.
In this thesis, I (i) summarize components involved in (the plasticity of) the cellular 
machinery for energy homeostasis, including possible regulatory mechanisms (this chapter);
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(ii) develop methods to study adaptational changes in these cellular components at the protein 
and the RNA level in muscle (chapters 2, 3); (iii) study possible differences in cell types with 
different metabolic demands such as oxidative versus glycolytic muscle (chapters 2 and 3);
(iv) develop cell lines derived from CK-deficient animals for in vitro study of the CK/PCr
2+system (chapter 5 and 6); (v) study the possible relationship between changes in Ca homeo­
stasis and cellular remodeling using real-time confocal laser scanning microscopy in combina­
tion with different stimulation protocols (chapter 6); and (vi) further investigate the changes in 
levels of PCr and Cr during development (chapter 4).
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Adaptations in CK-deficient mice
ABSTRACT
Skeletal muscles respond with high plasticity to pathobiological conditions or changes 
in physiological demand by remodeling cytoarchitectural and metabolic characteristics of 
individual myocytes. We have previously shown that muscles of mice without mitochondrial 
and/or cytosolic creatine kinases (ScCKmit-- and/or M-CK--) partly compensate for the de­
fec ts) by redirecting metabolic pathways and ultrastructural characteristics. Here, we show 
by semiquantitative Western blot analysis that the compensatory changes involve mutation- 
and fiber-type-specific coordinated regulation of divergent but functionally coupled groups of 
proteins. Fast-twitch gastrocnemius muscle of CK---- mice display a two- to fourfold upregu- 
lation of mitochondrial cytochrome c oxidase, inorganic phosphate carrier, adenine nucleotide 
translocator, and voltage-dependent anion channel proteins. In parallel, cytosolic myoglobin is 
upregulated. Slow-twitch soleus muscle responds with changes in the glycolytic enzyme pat­
tern, including a shift in lactate dehydrogenase isoenzyme composition. Adaptations in the 
network for oxidative adenosine triphosphate (ATP) production are already apparent at 17 
days of age.
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INTRODUCTION
Cellular structure and three-dimensional order are important parameters in the regula­
tion of metabolic activity in muscle (1). Much less is known about the converse relationship, 
that is, the effects o f  metabolic activity on cytoarchitectural and enzymatic organization. 
There must, however, be a highly plastic and complex connection, as the composition and 
activity of the multiprotein structures involved in metabolic pathways vary dynamically with 
physiological status, cell type, and metabolic demand (1-4). Studies in various cell types favor 
models of multienzyme complexes in the cytosol (‘metabolons’) or highly organized super­
structures in the mitochondria (‘respirasomes’) that allow catalytic sequestration of energy- 
transfer intermediates through sequential enzymes (1, 5, 6). How the composition of these 
supramolecular complexes relates to metabolic energy flux is less clear. In muscle and heart, 
profound remodeling responses have been demonstrated in animals treated with metabolic 
inhibitors or in transgenic animal models (7-10). These latter studies, in particular, have sup­
ported the notion that genetic stress in the energy network may be an important internal factor 
in determining the ultrastructural and enzymatic design o f  muscle.
In muscle, metabolic demand is determined, to a large extend, by the nature and com­
position of its myosin heavy chain (MHC) adenosine triphosphatase (ATPase) isotypes, which 
dictate the dynamic behavior and thermodynamic effectiveness of crossbridge cycling during 
contraction. Muscles can be slow (type I), for long-term performance, or fast (type II), for 
rapid and high force production. Adenosine triphosphate (ATP) turnover is higher in fast fi­
bers than in slow fibers, and fast skeletal muscles, such as gastrocnemius and psoas major, 
have metabolism that is primarily based on glycolysis. Slow muscles, such as soleus, or in­
termediate type muscles, such as diaphragm and cardiac muscle, are mainly oxidative. Differ­
ences between fiber types are also reflected in the expression patterns of energy consuming 
2+ion pumps (SR/ER Ca -ATPase [SERCA] isoforms), glycolytic isoenzyme composition, and 
in their mitochondrial content and composition (for review see Pette and Staron (11) and Mo- 
yes et al. (12)).
Previously, we have studied remodeling responses in muscles of mice that completely 
lack creatine kinase (CK: EC 2.7.3.2) isoenzyme subunits, created by targeted mutagenesis of 
the genes encoding the mitochondrial and/or cytosolic isoenzymes ScCKmit and M-CK (13­
15). Creatine kinases are dimeric or octameric enzymes that catalyze the reaction MgADP- +
2 + 2 PCr2- + H+ ^  Cr + MgATP -. In this way, the creatine kinase/phosphocreatine (CK/PCr) cir­
cuit helps to balance [ATP], [ADP], [Pi] (inorganic phosphate), and [H+] at cellular sites of 
energy production and consumption by providing a pool of PCr as ‘temporal energy buffer’ 
and by serving as ‘energy transport’ mechanism (16-18). The CK/PCr system thus couples 
ATP utilization by ATPases to ATP production in mitochondria and in this way (co)- 
determines the rate of oxidative phosphorylation (OXPHOS) or glycolysis (19). The equilib­
rium in the CK reaction differs between distinct compartments in the cell and can fluctuate 
considerably due to local imbalance between ATP production and consumption, or physio­
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logical effects on the activity of other kinases such as adenylate kinase (8, 20, 21). Interest­
ingly, the aforementioned heterogeneity in the degree o f  energetic need and extent o f  coupling 
between energy production and consumption of type I and II fibers is mirrored in their CK 
isoenzyme composition. The gastrocnemius and psoas major are high in PCr and show mainly 
cytosolic CK activity (98% MM-CK activity), but low mitochondrial CK activity (1-2% 
ScCKmit). In the soleus and diaphragm there is less PCr and lower overall CK activity, but 
ScCKmit activity represents approximately 10% or 25% o f total activity, respectively (22-24). 
Ultimately, it is the composition of the CK and other high energy phosphoryl (~P) circuits and 
the way in which they are combined that determines the cytosolic and mitochondrial ~P flux 
rates and, indirectly, variability in physiological performance. In our earlier studies we noted 
that physiological consequences of single M-CK or double (M-CK--; ScCKmit--, henceforth 
referred to as CK--/-- ) gene mutations in muscle were only visible when strenuous ex vivo con­
ditions were applied (13-15). Yet, distinct changes in the cytoarchitectural composition of 
type II fibers were apparent in muscles of animals maintained under standard laboratory con­
ditions. Also, global alterations in the machinery for glycolysis and OXPHOS were evident in 
muscles at rest.
In the present study, we focus on the precise nature o f  remodeling in CK-deficient 
mice and analyze the changes in more detail. Specifically, we address the following questions: 
(i) Do the adaptive rearrangements affect merely levels of individual enzymes, or do they in­
volve coordinated regulation of groups of proteins that are tightly clustered on the metabolic 
flow chart (thereby affecting the design of mitochondria or metabolic complexes in the cyto­
plasm for which coordinated regulation o f  several gene products is required)? (ii) Do identical 
genetic lesions in the CK/PCr-ATP/ADP circuit evoke similar responses in muscles with dif­
ferent fiber types? (iii) Are these phenotypic changes indeed mutation-type dependent? And 
(iv), i f  changes exist, when during development do they occur?
MATERIALS AND METHODS
Preparation of mouse muscle protein extracts
Individual soleus, diaphragm, gastrocnemius, and psoas major muscles from female 
M-CK- - (15), ScCKmit- - (13) and CK---- mice (14), or pure inbred C57Bl/6 and 129/Ola wild­
type controls, aged 3-5 months, were collected, frozen in liquid nitrogen, and stored at 
-135°C. Prior to analysis, two separate sets of pools, consisting of distinct types of muscles 
from 3 or 4 mice each, respectively (in total seven animals from each genotype), were assem­
bled. Frozen muscle was sectioned in 30-^m slices in a Cryostat at -25°C and immediately 
transferred into 10 volumes of TES buffer containing 50 mmol/L Tris-HCl (pH 6.8), 20 
mmol/L ethylene-diamine tetraacetic acid (EDTA), 5% sodium dodecyl sulfate (SDS) and a 
mixture of protease inhibitors (Boehringer Mannheim, Germany) (25). Protein was solubi­
lized completely overnight by continuously rotating the mixture at room temperature. The 
solution was then placed on ice and sonicated to shear the DNA. Protein concentration was
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determined using a modified Lowry procedure (26), after which samples were diluted to equal 
concentrations in TES buffer. For calibration in quantitative Western blot analysis, a series o f  
samples from different C57Bl/6 muscles with 0.25-, 0.5-, 1-, and 2-fold concentrated protein 
extract was employed.
To obtain independent information on quantitative differences between individual 
animals, and to perform lactate dehydrogenase (LDH) isoenzyme analysis, we isolated soleus 
and gastrocnemius from four individual 100-day-old female C57Bl/6, 129/Ola, CK-M--, and 
CK---- mice. Each muscle was directly homogenized in 10 volumes SETH buffer (250 
mmol/L sucrose, 2 mmol/L EDTA, 10 mmol/L Tris-HCl [pH 7.4] (27)) at 4°C in a Teflon- 
glass Potter-Elvehjem homogenizer. Homogenates were stored at -80°C until use in LDH 
isoenzyme analysis (detailed later), or directly diluted in denaturing buffer for Western blot 
analysis.
For analysis o f  changes in protein expression during development, extracts o f  gas­
trocnemius, plantaris, and soleus (GPS complexes) of female C57Bl/6 and CK---- animals of 
17, 28, 60, and 100 days of age were prepared.
Protein profiling by semiquantitative western blot analysis
After addition of twofold concentrated denaturation buffer (0.062 mol/L Tris-HCl [pH 
6.8], 2.5% SDS, 10% glycerol, 0.7 mol/L P-mercaptoethanol, 0.01% bromophenol blue), the 
protein concentration in each sample was set to that of the concentrated wild-type C57Bl/6 
standard sample. Depending on muscle type and the nature of the enzymes assayed, samples 
containing 2.0-20 ^g of total protein (in equal volume to prevent volume-related effects on 
band morphology) were loaded on 5%, 8%, 12%, or 15% (w/v) PAA-SDS gels, resolved by 
electrophoresis, and blotted onto a Hybond-C pure nitrocellulose membrane (Amersham, Ar­
lington Heights, Illinois) in a Bio-Rad miniblot apparatus (Bio-Rad, Hercules, California). For 
each assay, a representative gel was stained with Coomassie Brilliant Blue R-250 to confirm 
equal loading of protein. Electroblots were blocked in TBST (10 mmol/L Tris-HCl [pH 8.0], 
150 mmol/L NaCl, 0.05% (v/v) Tween-20) containing 5% (w/v) fat-free dry milk powder.
Characteristics of the antibodies used are listed in Table 1. The primary antibody and 
the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody were diluted in 
TBST containing 3% (w/v) fat-free dry milk powder. Blots were incubated for 1 h at room 
temperature or overnight at 4°C. Labeled bands were visualized using freshly prepared 
chemiluminescent substrate (100 mmol/L Tris-HCl [pH 8.5], 1.25 mmol/L p-coumaric acid 
[Sigma, St. Louis, Missouri], 0.2 mmol/L luminol [Sigma] and 0.009% H2O2) and subse­
quently exposed to Kodak X-Omat AR films (Kodak, Rochester, New York) for periods vary­
ing from 5 s to 5 min. For each primary antibody, both the optimum amount of total protein 
sample (2-20 ^g/lane) and the optimum dilution of the antibody were determined in a pilot 
experiment. After probing, signals were scanned in a Bio-Rad GS-690 densitometer and ana­
lyzed using Molecular Analyst software (Bio-Rad). The signal intensity o f  each antibody- 
stained band was computed as the optical density x mm , and compared with intensities of
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Table 1. List of primary antibodies used for quantitative W estern blotting.
A ntibody A ntigen
M olecular w eigh t
(kDa) R eferen ce/S ou rce
CK-MM Chicken m uscle creatine kinase 43 T. Wallimann, Zurich
ScCKmit Sarcomeric mitochondrial creatine kinase,
rat peptide 43 Friedman and Perryman (28)
ANT Adenine nucleotide translocator, bovine m uscle 30 A. Janssen, University of Nijmegen
COX Cytochrome c  oxidase, holoenzym e 5-4C A. Janssen, University of Nijmegen
Pi carrier Inorganic phosphate carrier 32 A. Janssen, University of Nijmegen
VDAC Voltage dependent anion channel
(anti-porin31HL, human) 35 Calbiochem, La Jolla, CA
GAPDH Glyceradehyde-3-phosphate dehydrogenase,
human peptide ss Trevigen, Gaithersburg, MD
PFK-M Phosphofructokinase, rat sc M. Bigl (29)
LDH Lactate dehydrogenase, rabbit muscle 35 Rockland, Gilbertsville, PA
Aldolase Aldolase, rabbit m uscle 41 Rockland, Gilbertsville, PA
PK Pyruvate kinase, rabbit m uscle 55 Rockland, Gilbertsville, PA
Myoglobin Myoglobin, human 17 Dako, Denmark
SERCA1 SR calcium A TPase (CaF2-5D2) 110 Hybridoma Bank, John Hopkins 
University
GLUT4 Insulin regulatable glucose transporter,
rat peptide 55 Calbiochem, La Jolla, CA
Desmin Desmin 57 G. van Eys, University of Maastricht
AMPKß2 AMP-activated kinase, rat peptide 34 D. Carling (30)
AK1 M ouse adenylate kinase 1 23 E. Janssen (8)
bands in  the (0 .2 5 -2 -fo ld  concentrated) standard C 5 7 B l/6 -d er iv ed  calibration  series, u sin g  
linear regression . F or each  m u sc le  type, scores for protein  le v e ls  in  the h o m o g en a tes  o f  either  
on e  or both  p o o ls  o f  m u sc le s  (n  =  1 or n  =  2 ) and/or m u sc le s  iso la ted  from  ind iv id u al an im als  
(n  =  4 )  w ere  com b in ed .
Lactate dehydrogenase isoenzyme analysis
L D H  iso e n z y m e s  in  m u sc le  h o m o g en a te  (eq u iv a len t o f  5 ^ g  o f  total protein ) in  SE T H  
b u ffer  w ere  load ed  onto a 0.7%  w /v  Seak em  M E  agarose g e l (FM C  B iop rod u cts, R ock land , 
M a in e) and iso e n z y m e  activ ity  w a s su b seq u en tly  determ ined  (b u ffers and reagents: S igm a  
procedure 7 0 5 -E P ). A fter  separation  (1 2 0  V  for 3 0  m in ), iso e n z y m e  activ ity  w a s  v isu a lized  
u sin g  a co lorim etric  procedure and in ten sities  o f  stained bands w ere  d irectly  q uantified  in  a 
B io -R a d  G S -6 9 0  desitom eter. E x p ressio n  p ro files  o f  L D H  H - and M -su b u n its w ere  estab ­
lish ed  for  ind iv id u al so leu s and gastrocn em iu s m u sc le s  o f  four d ifferen t m ice .
Analysis of MHC isoprotein composition
M H C  isop rote in s w ere  quantified  b y  sta in in g  and scan n in g  P A A -S D S  g e ls  as d e­
scribed  b y  T alm ad ge and R o y  (3 1 ).
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Statistics
The results are presented as mean ± SEM. The unpaired two-tailed student's t-test was 
used to compare expression levels in wild-type and CK-deficient muscles. Results from ho- 
mogenates of single (n = 4) muscles from different mice, or distinct pools of (n = 2) muscles 
of mice with the same genotype, were regarded as independent observations. P < 0.05 was 
considered statistically significant.
RESULTS
It has previously been established that ScCKmit deficiency does not affect cytosolic 
M-CK protein expression, which was confirmed in this study (the M-CK level is 85% for so- 
leus, n = 2; and 85% for gastrocnemius, n = 2) (14). Conversely, a non-quantified increase in 
ScCKmit level was found in M-CK- - animals. In the present study, using the semiquantitative 
blotting methodology, a 2.3-fold (Table 2) increase of ScCKmit expression was found in gas­
trocnemius of M-CK- - mice, whereas no change was observed in soleus of these mice.
Using the antibodies listed in Table 1, we first compared concentrations of various mi­
tochondrial and cytosolic proteins in pooled samples of soleus, diaphragm, gastrocnemius, 
and psoas muscles from M-CK--, ScCKmit--, and CK---- mutants, and the parental strains 
C57Bl/6 and 129/Ola. A representative series of Western blots with the antibody directed 
against the Pi carrier is shown in Figure 1. Densitometric analysis of this series and a large 
collection of blots with other antibodies (not shown) indicated that the changes in expression 
level for particular proteins in (i) gastrocnemius and psoas and (ii) soleus and diaphragm (i.e. 
representatives of slow- and fast-twitch muscles, respectively) always categorized together. 
Intensities of signals in ScCKmit-- mice were never different from those in controls. There­
fore, and because only soleus and gastrocnemius provided enough muscle mass for multiple 
analyses on individual animals, data are restricted to these two types of muscles for M-CK-/-
and CK--/-- mice only (Table 2).
Mitochondrial proteins
Genetic stress in the CK system led to marked alterations in the levels of mitochon­
drial proteins, COX (cytochrome c oxidase), ANT (adenine nucleotide translocator), Pi carrier, 
and VDAC (voltage-dependent anion channel). Clearly, the increases in expression level were 
not similar for all enzymes, and were dependent on both fiber type and CK genotype. A sig­
nificant 4.3-fold increase in the level of COX was found in the gastrocnemius of CK---- mice 
whereas the COX level in this muscle in M-CK-- mice was doubled. In soleus, COX levels 
were significantly elevated in CK----, but not M-CK- - mice. It is noteworthy that, although 
only subunit IV of COX is listed in Table 2, other (mitochondrial and nuclear encoded) COX 
subunits showed similar upregulation.
For ANT, levels were increased 1.8 to 2.5-fold in gastrocnemius of M-CK- - and CK---- 
mice, respectively. Although these values clearly reached significance, it must be stressed that
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Table 2. Summary of results of quantitative W estern blot analysis of so leu s and
gastrocnem ius m uscles.
C57BI/6 129/Ola M-CK'"
*
C
SOLEUS
VDAC 100 ± 4 105 ± 19 98 ± 11 124 ± 21
ScCKmit 100 ± 12 99 ± 12 99 ± 5 ND
ANT 100 ± 2 95 ± 26 89 ± 4 137 ± 23
Pi carrier 100 ± 13 90 ± 4 97 ± 8 214 ± 16*’#
COX 100 ± 4 91 ± 5 105 ± 4 182 ± 16*’#
LDH 100 ± 2 85 ± 2+ 74 ± 10 58 ± 5M
Aldolase 100 ± 1 87 ± 4+ 68 ± 7+’§ 52 ± 7M
Pyruvate kinase 100 ± 7 116 ± 11 125 ± 15 119 ± 19
Myoglobin 100 ± 4 121 ± 8 91 ± 10 100 ± 3
GLUT4 100 ± 6 173 ± 27* 145 ± 18* 155 ± 17*
GASTROCNEMIUS
VDAC 100 ± 11 142 ± 12* 158 ± 16* 271 ± 32*’^
ScCKmit 100 ± 10 94 ± 16 233 ± 16+’1 ND
ANT 100 ± 6 1 4 6 ± 9+ 181 ± 12* 251 ± 10*’#
Pi carrier 100 ± 4 107 ± 8 197 ± 16M 238 ± 14*’#
COX 100 ± 1 121 ± 8* 197 ± 18M 427 ± 58*’#
LDH 100 ± 5 99 ± 10 126 ± 12 76 ± 9
Aldolase 100 ± 7 113 ± 11 100 ± 8 75 ± 5*’§
Pyruvate kinase 100 ± 8 96 ± 25 169 ± 8*’§ 118 ± 11
Myoglobin 100 ± 7 126 ± 12 130 ± 7* 185 ± 13+’§
GLUT4 100 ± 2 161 ± 10* 160 ± 14+ 204 ± 21 +
Values ± SEM indicate average content of protein in extracts of soleus and gastrocnemius of 129/Ola 
wild-type control and different CK mutants. All values are com pared with those from C57BI/6 extracts, 
which were se t to 100%. For ScCKmit, COX, ANT and P , carrier, n = 6, for other proteins n = 5. ND, 
not detectable.
*C57Bl/6 versus mutant significantly different (p < 0.05). fC57Bl/6 versus mutant significantly different 
(p < 0.01). *C57Bl/6 versus mutant significantly different (p < 0.001). §129/Ola versus mutant signifi­
cantly different (p < 0.05). 1129/Ola versus mutant significantly different (p < 0.01). * 129/Ola versus 
mutant significantly different (p < 0.001).
the background strains C57B1/6 and 129/Ola differed substantially in ANT expression. The 
levels of the outer-membrane pore molecule, VDAC, were increased similarly, ranging from 
2.7-fold in CK---- to 1.6-fold in M-CK-- gastrocnemius; however the latter increase is only 
evident if  compared with C57Bl/6, but not with 129/Ola controls. No significant changes 
were seen in soleus muscle.
About 2 to 2.4-fold augmented levels were observed for the mitochondrial Pi carrier in
gastrocnemius of M-CK-/- and CK--/-- mice, and in soleus of CK--/-- mice, thus confirming the
initial findings in the pooled samples (Fig. 1) (difference between M-CK-- and CK---- ap­
proaches significance at p  = 0.08; n = 6). Strikingly, in soleus muscle, we consistently ob­
served broadening of the Pi carrier signal with appearance of a slower migrating band (Fig. 1).
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Figure 1 Q uantitative W estern blot im a g es for Pi carrier (32 kDa).
Pooled m uscle protein extracts were analyzed as described in Materials and Methods. Sam ples were 
loaded in duplicate and compared with a linear range of C57Bl/6 sam ples (dilutions indicated). Note 
that the knockout mice have a mixed background of C57Bl/6 and 129/Ola, as indicated with different 
gray levels above. SOL, soleus; DIA, diaphragm; GAS, gastrocnemius; PSO, p soas major. Results of 
densitometric analysis are shown as percentages of wild-type C57Bl/6 band intensity (100%).
Because not much is presently known about the biology of Pi carrier, we did not attempt to 
correlate this phenomenon with posttranslational modification or appearance of other iso­
forms of the protein.
Glycolytic proteins
Testing of glycolytic enzymes on blots from the pooled sample sets revealed promi­
nent (1.4 to 1.8-fold) downregulation of aldolase, 6-phosphofructo-1-kinase-M (PFK-M) and 
LDH in soleus and diaphragm from M-CK- - and CK---- mice. In contrast, pyruvate kinase and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels did not vary between mutants 
(not shown). Assessment of enzyme levels in the muscle samples is shown in Table 2. The 
level of antigenic LDH appeared consistently but statistically insignificant reduced (-24%) in 
gastrocnemius of CK----, but not in M-CK- - animals. In the soleus, the level of LDH reactive 
with the rabbit muscle LDH-specific antibody showed a significant, twofold reduction. Be­
cause we anticipated that a change in the M- and H-subunit composition of the tetrameric 
LDH enzyme could underlie this observation, a zymogram analysis was performed under na­
tive conditions (Fig. 2, A and B). Determination of in situ gel-staining activity revealed that 
the fractional percentage of LDH-5 (M4) was indeed reduced in gastrocnemius of CK---- mice 
(-13.2% compared with C57Bl/6; and -10.2 % compared with 129/Ola). In contrast, the frac­
tion of LDH-4 (HM3) is increased in these mice (+7.8% compared with C57Bl/6, +6.1% 
compared with 129/Ola). Isoenzymes LDH-3, -2 and -1 are expressed at low levels in gas­
trocnemius, but also here a fractional increase from 10-11% to 15.2% (for H2M2 + H3M + H4
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combined) was evident in CK---- mice, but not in M-CK-- mice. The five distinct LDH 
tetramers were more equally represented in the soleus. Although changes in this muscle were 
already significant in M-CK-/- mice, they were most dramatic in CK--/-- mice. The fractional 
content of LDH-5 and -4 was reduced by more than twofold compared with C57Bl/6 (LDH-5: 
-12.3%; and LDH-4: -9.5% ) and 129/Ola controls (LDH-5: -9.2%; and LDH-4: -10.7%). 
The LDH-3 content in both single and double CK mutants was virtually unchanged, whereas 
LDH-2 and LDH-1 isoenzymes appeared at 1.5 to 1.8 higher abundance (combined increase 
from 33-35% in controls to 53% in CK--/-- and 43% in M-CK-/- mice, respectively).
Due to methodological constraints, we were not able to determine whether a shift in 
isoenzyme expression could also explain the reduction in antigenic signal for the two other 
glycolytic enzymes, aldolase and PFK-M. However, data from Table 2 demonstrate that aldo­
lase-antigenic content in CK---- and M-CK- - soleus and CK---- gastrocnemius was reduced to 
50-75% of normal wild-type values. Similarly, the PFK-M level was about 40% (n = 2; not 
shown) lower in CK---- soleus than in control mice.
Miscellaneous metabolic enzymes and cytoskeletal proteins
Included in Table 2 is a series of enzymes not intimately linked to glycolysis or OX- 
PHOS. Figure 3A illustrates that myoglobin content was significantly increased in fast-twitch 
psoas major and gastrocnemius (1.8-fold; Table 2) muscles, but not soleus, of CK---- mice. 
Interestingly, the level of adenylate kinase 1 (AK1), an enzyme directly connected to the 
phosphoryl transfer circuit (8), was unaffected. Complete CK absence also led to a moderate 
(twofold) increase in the level of the muscle-specific glucose transporter GLUT4. However, 
here conclusions can only be drawn with decreased significance (p < 0.01 compared with 
C57Bl/6; and p  = 0.14 compared with 129/Ola; n = 5) due to the 1.6-fold difference in expres­
sion level between the C57Bl/6 and 129/Ola background strains. Our analysis for SERCA1 
was hampered by the same phenomenon ([SERCA1] in 129/Ola > in C57Bl/6, data not 
shown). As the signal from SERCA antibodies was not higher or lower than that in the 
129/Ola or C57Bl/6 controls, respectively, for all of the M-CK-/- and CK--/-- mice examined 
herein, we conclude that the CK mutation is without significant effect on SERCA protein ex­
pression.
Likewise, no differences were found for the cytoarchitectural components or energy 
metabolism regulatory proteins, such as the intermediate filament desmin and AMP-sensitive 
protein kinase subunit AMPK^2 (data not shown). In contrast, changes did occur in MHC 
protein composition, with a loss of 25% of total MHC protein quantity in CK---- gastrocne­
mius and 45% in soleus (n = 2) (gel pictures available upon request). Earlier, we noted quali­
tative changes in MHC isoprotein composition in fast extensor digitorum longus (EDL), psoas 
major, and gastrocnemius in M-CK- - and CK---- mice (14, 15, 32). Thus, remodeling was lim­
ited to a selective subset of proteins from the muscle proteome.
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Figure 2 Lactate d eh y d ro g en a se  iso en zy m e  profiles in m u sc le s  with different CK g e n o ty p e s .
(A) Soleus. (B) Gastrocnemius. Values ± SEM indicate relative expression (in percentage of total LDH 
activity) of the different isoenzym es. *, p < 0.05, **, p < 0.01, ***, p < 0.001 (n = 4 for all genotypes).
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Developmental timing
Finally, we questioned when the adaptations in the protein network for energy homeo­
stasis take place during development. Analysis of extracts of the whole GPS complex (gas­
trocnemius, with minor contributions of soleus and plantaris) of mice at 17 and 28 days of age 
(Fig. 3B) revealed that changes in the profile of myoglobin and Pi carrier in the CK---- GPS 
complex are already apparent at day 17 after birth. Also, COX and ANT expression profiles 
had already attained this appearance already at day 17. Subsequently, differences between 
CK---- and control muscle persisted into adulthood as demonstrated by the analysis of muscles 
at 60 and 100 days after birth (data not shown).
DISCUSSION
Our results show that targeted disruption of CK genes results in muscle-type and geno­
type-specific changes in expression levels of enzymes that connect to the cellular energetic 
network. One conspicuous observation was that the changes in mitochondrial enzymes occur 
primarily in fast-twitch gastrocnemius (and psoas major), whereas shifts in glycolytic enzyme 
profiles are mainly confined to slow-twitch soleus (and diaphragm). Another striking feature 
is that most prominent changes in protein expression level occurred in muscles of animals 
without both M-CK and ScCKmit. Muscles from M-CK-- animals showed intermediate ef­
fects, ScCKmit-- muscles were normal. Although we did observe genetic background- 
dependent variability in the level of certain enzymes (GLUT4, VDAC, and ANT in C57Bl/6 
versus 129/Ola gastrocnemius; Table 2) we could rule out trivial lineage-related differences as 
an explanation for our observations. For the majority of proteins, very little variation was 
found in samples from individual animals in a large breeding colony over a >2-year period 
(data not shown); moreover, multiple rounds of mixed background crossbreeding in the M- 
CK/ScCKmit-heterozygous state were involved prior to establishing our different colonies. 
We will limit our discussion to findings that showed significance in comparison to both pa­
rental strains.
Upregulation of mitochondrial enzymes was not absolutely coordinated in the sense 
that similar increments in the level of proteins were seen for all enzymes tested. In M-CK-/- 
gastrocnemius the levels of ScCKmit, COX, Pi carrier, and ANT approximately doubled, 
whereas the change in VDAC was less pronounced. Likewise, the average increase in COX 
content in CK--/-- mice was 4-fold, but the increase determined for Pi carrier, ANT, and VDAC 
was significantly less, averaging 2.5-fold. Earlier, from assessment of succinate dehydro­
genase and citrate synthetase activity and morphometric analyses on electron microscopic 
images (14, 15), we estimated that the average increase in mitochondrial volume in gas­
trocnemius of M-CK- - and CK---- mice, compared with wild-type, was approximately 1.6- and
2-fold, respectively. Taken together, our data are consistent with a model in which, besides 
global proliferation of mitochondrial mass, there is architectural plasticity and fine regulation 
of the mitochondrial design in distinct CK-deficient mice. This plasticity may involve coordi­
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nate as well as discordant regulation of structural and metabolic proteins that build up mito­
chondria in different tissues, and at different cellular locations, the principles of which are 
only partly understood (for review, see Moyes et al. (12)). Blurring of our data may have oc­
curred, however, due to the existence of distinct subpopulations of mitochondria in muscle 
fibers (i.e. subsarcolemmal and intermyofibrillar mitochondria), which may respond differen­
tially to variation in the CK genotype (12, 15, 33).
In discussing our findings it is of note that VDAC, ScCKmit and ANT (nuclear- 
encoded proteins) are thought to associate in one large (pore) complex connecting the mito­
chondrial outer and inner membrane (5). Clearly, in the ScCKmit- - and CK---- animals, where 
ScCKmit is completely lost, there must be an absolute stoichiometrical imbalance in the as­
sembly of this complex. To our surprise, however, this does not lead to a decrease, but rather 
an increase of ANT and VDAC in the mitochondria of these mutants. A decrease would occur 
if posttranscriptional or proteolytic regulation safeguarded complex integrity or composition. 
Clearly, further studies are needed to obtain more insight into the nature of the functional and 
physical coupling of ANT, VDAC and ScCKmit.
Many of the enzymes that transfer metabolic intermediates in the glycolytic pathway 
are clustered in highly organized metabolic complexes (metabolons) (1). For example M-CK, 
aldolase and AK1 are found to be in close association on the muscular I-band (34). For Dro­
sophila flight muscle, it has been demonstrated that glycerol-3-phosphate dehydrogenase, 
GAPDH, and aldolase may bind to MHC and/or actin, and are highly organized at Z-discs and 
M-lines (35). It is thus conceivable that subgroups of these enzymes undergo coordinated 
regulation.
In this study, we showed that LDH and aldolase (and PFK-M) undergo the most sig­
nificant shift in protein expression level in slow-twitch soleus, when completely deprived of 
CK. GAPDH and pyruvate kinase levels were changed little or not at all. For LDH, a 
tetrameric enzyme composed of M(uscle) and H(eart)-subunits thought to reversibly associate 
with subcellular structures such as myofibrils and mitochondria (36), we showed that a unidi­
rectional change in subunit composition occurs in soleus and gastrocnemius. This can be ex­
plained by a shift in the H- over M-subunit expression ratio, presumably regulated at the level 
of transcriptional induction or repression. It has been suggested that muscle LDH-5 (M4) fa­
vors the production of lactate in anaerobic glycolysis, whereas heart LDH-1 (H4) favors for­
mation of the mitochondrial substrate pyruvate, sustaining oxidative conversion of lactate 
from the cytosol or circulation (36).
Interestingly, a small shift toward overrepresentation of the M-rich LDH-4 and -5 en­
zymes was noted in ScCKmit- - soleus, but not in gastrocnemius (22). This shows that genetic 
disruptions of the ScCKmit gene, the M-CK gene, or both genes, have different phenotypic 
effects. We conclude that the CK---- phenotype is not simply a summation of the defects of 
single knockouts. In M-CK- - and CK---- mice, the unidirectional change in LDH subunit dis­
tribution in both fiber types could be a component of a complex ultrastructural/metabolic ad­
aptation aimed at more efficient aerobic production of ATP via mitochondrial respiration,
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Figure 3 Q uantitative W estern blot im ages.
(A) Myoglobin (17 kDa) and AK1 (24 kDa) in psoas major and (B) myoglobin and Pi carrier (32 kDa) in 
total G PS com plex of 17- and 28-day-old mice with different CK genotypes. Results of densitometric 
analysis are shown as percentages of wild-type C57Bl/6 band intensity (100%).
with prevention of accumulation of lactate, and possibly NADH.
Consistent with this, we found a more than 1.5-fold increased capacity of CK---- gas­
trocnemius to bind and buffer molecular oxygen via myoglobin. Earlier, we showed that 
M-CK-/- muscles have increased flux through the glycogenolytic pathway (15), and recently, 
Dahlstedt et al. (37) showed that neither oxidative CK-- -- soleus nor glycolytic extensor digi- 
torum longus accumulate lactate (and Pi) upon fatiguing muscle stimulation. These observa­
tions are strong arguments for metabolic adaptations aimed at more efficient aerobic ATP 
generation.
Perhaps, the observed changes in composition (32) and the decrease in absolute con­
tent of MHC isoforms in the soleus and gastrocnemius of CK---- mice (this study), should be 
interpreted in the same context. Based on our findings it is tempting to speculate that changes 
in binding/scaffolding domains in filament components of the A-, I- and M-band regions (35, 
38, 39) may, directly or indirectly, affect the (self)assembly and composition of the glycolytic 
machinery, including enzymes such as aldolase and PFK-M. To obtain further support for this 
hypothesis, we will need to study the effects on aldolase and PFK enzyme composition and 
activity in more detail.
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In summary, our results suggest that genetic stress in the CK/PCr circuit leads to up- 
regulation of oxidative metabolism, requiring concerted responses in the mitochondrial ma­
chinery and cytosolic oxygen supply pathway(s). This remodeling already becomes apparent 
early during growth and maturation. It is likely that the infrastructural differences give this 
remodeling a distinct character in slow- and fast-twitch fibers. Because different CK geno­
types provoke different remodeling responses, most of which resemble normal physiological 
changes, these responses appear to serve an adaptive purpose. Future study must be aimed at 
elucidating the metabolic signaling principles involved in this remodeling.
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mRNA expression profile in CK-deficient mice
ABSTRACT
We have studied the mechanisms that regulate the remodeling of the glycolytic, mito­
chondrial and structural network of muscles of creatine kinase M-/ScCkmit knockout mice by 
comparison of wild-type and mutant mRNA profiles on cDNA arrays. The magnitude of 
changes in mRNA levels were most prominent in M-CK/ScCKmit (CK----) double mutants 
but did never exceed those of previously observed changes in protein level for any protein 
examined. In gastrocnemius of CK---- mice we measured a 2.5-fold increase in mRNA level 
for mitochondrial-encoded COX-III which corresponds to the increase in protein content. The 
level of the nuclear-encoded mRNAs for COX-IV, H -A T P  synthase-C, ANT1 and GLUT4 
showed a 1.5-fold increase, also in agreement with protein data. In contrast, no concomitant 
upregulation in mRNA and protein content was detected for the mitochondrial Pi carrier, 
VDAC and certain glycolytic enzymes. Our results reveal that regulation of transcript level 
plays an important role, but it is not the only principle involved in the remodeling of mito­
chondrial and cytosolic design of CK---- muscles.
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INTRODUCTION
Muscle tissue has a high plasticity and is capable of re-organizing its metabolic and 
structural features along with internal and environmental needs (1, 2). Thus, dynamic 
regulation of mRNA and protein expression is of fundamental importance. Gene expression in 
muscle is known to respond to chronic low-frequency stimulation, caloric restriction, 
hyperthyroidism, or feeding of metabolic inhibitors (3-6). Also genetic stress in cellular 
energy metabolism can evoke significant changes in muscle biogenesis (7). Many of these 
responses are thought to serve as adaptations to counteract the adverse effects of physiological 
challenge or gene mutation (1, 7-9).
Previously, we have studied changes in the biogenesis of the glycolytic, mitochondrial 
and structural network in muscles of knockout mice that lack the creatine kinase (CK) isoen­
zyme subunits ScCKmit and M-CK (10-12). By understanding the mechanisms that regulate 
this metabolic and cytoarchitectural remodeling, one can gain insight into the signaling sys­
tems that sense the physiological consequences of mutation and help to coordinate the re­
sponse. Whether these regulatory principles involve alterations in de novo synthesis or altered 
turnover of gene products, or both, is not known.
CKs (EC 2.7.3.2) are cytosolic and mitochondrial enzymes that catalyze the reaction 
MgADP- + PCr2- + H+ ^  Cr + MgATP2-. The CK/Phosphocreatine (PCr) system balances 
adenylates at cellular sites of energy production and consumption by providing PCr as ‘tem­
poral energy buffer’ and serving as ‘high-energy phosphoryl shuttle’ (13, 14). Thus, the sys­
tem protects against effects of ischemia and anoxia, and couples mitochondrial oxidative 
phosphorylation (OXPHOS) and glycolysis to metabolic demand (15). The composition and 
function of the CK circuit differs between different muscle types and functional redundancy 
with other pathways for high energy phosphoryl transfer, such as the adenylate kinase, the 
nucleoside diphosphate kinase (NDPK), and the glycolytic system has been demonstrated (13, 
16, 17).
Using mRNA expression profiling on cDNA arrays, the transcriptional response of 
clusters of genes to a perturbation in the cellular state can be measured (18). In this study, we 
use this technique to examine mutation and cell-type dependent changes in the levels of indi­
vidual mRNAs and correlate our findings to previous data on the content of key metabolic 
enzymes in normal and CK-deficient muscles. The analysis enabled us to assess the relative 
importance of transcript level regulation in the response to metabolic stress induced by CK 
deficiency.
MATERIALS AND METHODS
Animals and RNA isolation
Animal breeding and housing conformed to the Guidelines for the Care and Use of 
Laboratory Animals of the Dutch Council, with approval of the Institutional Animal Care and
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Use Committee at the University of Nijmegen. Individual gastrocnemius muscles from each 
of four 100-day-old C57Bl/6 or 129/Ola female control mice, or four female M-CK-- single- 
and CK--/-- double knockout mice were dissected and total RNA was prepared using the 
LiCl-urea method (19). Soleus muscles from these animals were combined in one sample for 
RNA preparation. One additional set of RNA samples was prepared from either pooled gas­
trocnemius or soleus muscles from four 100-day-old female mice (for each different geno­
type).
RNA preparations of the total gastrocnemius/plantaris/soleus (GPS) complex and liver 
of female C57Bl/6 and CK---- animals of 17 and 100 days of age (two animals of each strain 
per age class) were used to study developmental effects on mitochondrial and nuclear gene 
expression.
cDNA probe synthesis
For synthesis of mixed cDNA probe, 2 ^g of total RNA was reverse transcribed for 90 
min at 42°C in a mixture containing 10 ng/^l oligo(dT) (Eurogentech, Seraing, Belgium), 0.5 
mM d(A,T,G)TP, 4 |iM dCTP, 5 mM DTT, 30U RNAse Out, 250U Superscript II (Life 
Technologies, Breda, The Netherlands) and 75 ^Ci [a-32P] dCTP (3000 Ci/mmol, Amersham 
Pharmacia, Roosendaal, The Netherlands) in a final volume of 20 ^l (in duplicate). The quan-
32tity of P-labeled total cDNA was assessed after purification over a Sephadex G-50 column 
(Amersham Pharmacia). cDNA length distribution was routinely monitored by electrophore­
sis on agarose gels. Before hybridization, the cDNA was treated with 20 ^g/ml RNAse A in 
TES buffer (20) and diluted to 0.8-2.4 x 106 cpm (counts per minute)/ml Church hybridization 
buffer (21). Marker probe was generated by random primed synthesis of a 1 kb mouse insulin- 
regulatable aminopeptidase vp165 ds cDNA template. Specific activities of different cDNA 
probe preparations ranged between 1-10 x 106 cpm per ^g.
cDNAs and EST collections
Our collection of cDNA and expressed sequence tag (EST) clones comprises a selec­
tion of 134 different mouse DNA sequences for glycolytic enzymes, mitochondrial enzymes
and transporters, fatty acid metabolism enzymes, muscle regulatory factors, proteins active in
2+Ca signaling, glucose transport, tissue oxygenation as well as cytoskeletal components and 
transcription factors. Detailed information on the ESTs and construction of the cDNAs is 
available at http://www.ncmls.kun.nl/celbio. Plasmid DNAs were grown in E. Coli HB101, 
DH10B, DH12S, AG1 and SOLR host cells, isolated, and purified on silica-gel membranes 
using the Qiagen miniprep procedure (Qiagen, Hilden, Germany).
Preparation of gridded cDNA arrays on membranes
Plasmid DNAs, diluted at 0.25 ^g/^l in 10 mM Tris-HCl/5 mM EDTA supplemented 
with sucrose (1.5%) and cresol red (0.025%), were gridded on Hybond N+ membranes (sized
11 x 3 cm; Amersham Pharmacia). Empty plasmids served as negative controls. Macroarrays
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were generated using a home-built arrayer (see http://cmgm.stanford.edu/pbrown/ 
mguide/index.html), with some modifications from the Brown group. The printhead contained
12 adjustable quilted pens (custom made) with the width of a 384 wells plate (11 cm). The 
machine was programmed to yield arrays on nylon filters with duplicate spotpatterns of each 
cDNA. Speed of movements of the printhead combined with the adjustment of the pens set 
the delivered amount of DNA on the filter to 60-80 nl per spot (15-20 ng). With spot sizes of
32700-800 |im and a large heart-to-heart distance (3 mm) P can be used without the risk of 
overlapping signals.
Membrane-bound DNAs were denatured in 0.5 N NaOH/1.5 M NaCl, renatured in 
0.25 N HCl, and washed in 50 mM phosphate buffer pH 7.2, before the DNA was UV cross­
linked at 2 mJ/cm (Stratalinker, Stratagene, La Jolla, CA). Membranes were pre-hybridized 
overnight at 65 °C in Church buffer (21) supplemented with 5x Denhart’s reagent (20) and 100 
^g/ml single-stranded herring sperm DNA (Boehringer Mannheim, Germany).
32 /
Figure 1 (A) P Images of arrays from C57BI/6 wild-type and CK"""" gastrocnem ius m uscles. B9: 
ScCKmit; B11: M-CK; B20: actin; B28: COX-III; C2: COX-IV; C3: isocitrate dehydrogenase; C32: 
GLUT4; D3: H+-ATP synthase-C . (B) (facing page) Scatter graph representation of array data of 
C57BI/6 (x-axis) and CK--/-- gastrocnem ius (n = 4). A xes show  signal intensities after normalization. 
The dark solid line represents equal expression levels in wild-type and CK--/-- sam ples, the gray solid 
lines mark 40% difference in signal intensity. (C) (facing page) Order of appearance representation of 
comparative data of C57Bl/6 (x-axis) and CK--/-- gastrocnem ius (n = 4). UCP3 (16,3); NDPK-M2 
(19,39); UCP2 (40,22); GAPDH (61,72); GLUT4 (62,73); H+-ATP synthase-C  (67, 75); isocitrate dehy­
drogenase (70,74); COX-IV (75,77); COX-III (81, 84); ANT1 (85,86).
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Hybridization, washing and autoradiography
Arrays were hybridized for 4 days at 65 °C to the cDNA probe mixture in 5 ml Church 
hybridization buffer, supplemented with 90,000 cpm of aminopeptidase vp165 cDNA marker 
probe. Subsequently, the arrays were washed to a final stringency of 0.1x SSC/0.1% SDS at 
68°C. Signals were captured and analyzed on a Bio-Rad GS 363 Imaging system (Bio-Rad, 
Hercules, CA) after an exposure period of 30 min to 96 h. Signal intensity was expressed as 
the mean cpm of the duplicate spots (Fig. 1A) minus the intensity of the empty vector. Values 
at least 2-fold above background were collected at the maximum exposure time. Problems 
with signal saturation were avoided by determining signal intensities at shorter exposure, after 
which all values were normalized for exposure time.
Analysis of hybridization results
All values for signal intensities were divided by the value for the mean marker signal 
intensity. Based on the results of these initial analyses, a designated subset of genes was iden­
tified for which no up- or downregulation was evident. Signal intensities for these cDNAs 
were subsequently used for normalization (22).
Quantitative Western blot
Total protein extracts were prepared from colateral GPS complexes of C57Bl/6 and 
CK---- mice used for RNA analysis. Preparation of these extracts and semi-quantitative West­
ern blots were performed as described by de Groof et al. (2001) (12).
Statistical analysis
We used a Student t-test for comparison between wild-type, M-CK- - and CK---- gas­
trocnemius muscles (four individual samples, plus pooled sample: n = 5). Results were con­
sidered significant when p  < 0.05 compared to either wild-type strain (C57Bl/6 and 129/Ola), 
unless stated otherwise. No statistical tests were applied to soleus data, since we used n = 2 
pooled samples.
RESULTS
In order to correlate known changes in protein levels in muscles of CK-deficient ani­
mals to changes in corresponding mRNA levels, a specially designed array with 134 different 
cDNA/ESTs was used. Prior knowledge on gene function, cell-type-specific distribution, 
isoenzyme expression, and transcript abundance was used in the selection of cDNAs and 
ESTs for the array. Based on the observation that there was only a 2 to 4-fold change in the 
level of mitochondrial and glycolytic proteins in gastrocnemius of mice with M-CK or com­
bined M-CK/ScCKmit deficiency (12), we expected that also the corresponding mRNA levels 
would vary within rather narrow margins. Therefore, we decided to refrain from use of
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Table 1. RNA expression changes in gastrocnemius. Values represent percentage ± SEM (n = 5).
EST/cDNA
C57BI/6
RNA Protein1
M-CK'
RNA Protein1
CK ' 
RNA Protein1
129/Ola
RNA Protein1
COX-III 100 ±5.6 nd 142 ± 5.1*'* nd 248 ± 37*’§ nd 123 ±6.5* nd
Isocitrate dehydrogen. 100 ±8.7 nd 129 ± 16 nd 145 ±11+,1T nd 103 ±9.9 nd
H+ ATP synthase-C 100 ±7.3 nd 127± 12* nd 166 ± 20+’11 nd 101 ± 14 nd
COX-IV 100 ± 10 100 116 ± 13 197 134±8.3+’11 427 96 ± 11 121
ANT1 100 ± 1.2 100 107 ±6.4 181 133 ± 7.2*’1 251 98 ± 11 146
GAPDH 100 ±8.2 nd 152 ± 11*.# nd 157 ± 19+ # nd 104 ± 19 nd
GLUT4 100 ±8.7 100 101 ± 5.6 160 161 ± 19*’11 204 116 ±5.6 161
NDPK-M2 100 ±6.0 nd 113 ± 10 nd 158± 12* nd 126 ± 14 nd
*p<0.01 vs. C57BI/6; Tp<0.05 vs. C57BI/6; fp<0.10 vs. C57BI/6; 
sp<0.01 vs. 129/Ola; *p<0.05vs. 129/Ola; *p<0.10vs. 129/Ola 
1Data from de Groofet at. (2001) (12); nd: not done
C \
VO
mRNA 
expression 
profile 
in 
CK-deficient m
ice
Chapter 3
cDNA amplification procedures commonly used for high-density microarray hybridization 
(23).
mRNA profile of fast-twitch gastrocnemius is changed by CK absence
A representative array comparison for mRNAs from gastrocnemius muscles of 
C57Bl/6 and CK---- mice is shown in Figure 1A. As anticipated, we still detected residual 
ScCKmit and M-CK mRNA in CK---- mice in our assay. For both genes, the gene targeting 
strategy used led to the formation of aberrant mRNAs and complete loss of M-CK and 
ScCKmit enzyme coding capacity as demonstrated earlier (10, 11).
Normalized profiling data for fast-twitch gastrocnemius of wild-type and CK--/-- mice 
are depicted in the scatter graph of Figure 1B. Strikingly, 5 out of 8 affected signals in gas­
trocnemius muscle represented mRNAs encoding mitochondrial proteins (see also Table 1). 
Mitochondrial DNA encoded cytochrome c oxidase-III (COX-III) showed a 2.5-fold upregu- 
lation. Nuclear DNA encoded mRNAs for COX-IV, H -A T P synthase-C, adenine nucleotide 
translocator 1 (ANT1), isocitrate dehydrogenase (all mitochondrial), glyceraldehyde
3-phosphate dehydrogenase (GAPDH), NDPK-M2 and insulin-regulatable glucose transporter 
(GLUT4) were 1.3 to 1.6-fold increased in CK---- muscles. No significant effects were seen 
for these mRNAs in M-CK single-mutant mice, except for the COX-III and GAPDH signals. 
Quantitative measurements on single RNA preparations and on pooled gastrocnemius muscle 
samples yielded identical results (not shown), data are therefore presented in a combined fash­
ion in Table 1.
Because all values ranged within 96-248% of those in C57BL/6 wild-type mice, we 
decided to analyze mRNA quantities also by inter-comparison in an ‘order of signal-intensity’ 
plot (Fig. 1C), which renders comparison independent of the normalization procedure used. 
One caveat with this approach is that the magnitude of the shift in ranking position will 
be rather small for (the few) transcripts with a relatively high expression level (such as 
COX-III), and rather large for transcripts with a low expression level (where many transcripts 
cluster together). Consistent increases in signal intensity ranking position were again observed 
for all genes mentioned in Table 1. In addition, the uncoupling protein 2 (UCP2) mRNA level 
showed a drastic shift in ranking order. However, this observation may be non-significant as 
the shift was based on a decrease of only 35% at low signal intensity (p =  0.12; n = 4 com­
pared to C57Bl/6 and 129/Ola). Also the UCP3 transcript level showed a 33% decrease, but 
with substantial differences between wild-type strains C57Bl/6 and 129/Ola (not shown). Ef­
fects of genetic background variation can therefore not be fully excluded for this latter 
mRNA.
mRNA profile of slow-twitch soleus is changed by CK absence
We have previously shown that the nature and magnitude of the compensatory adapta­
tions in muscles of CK-deficient mice is strongly cell-type dependent (10-12). Changes in 
mRNA transcript profiles of M-CK--, CK----, C57Bl/6 and 129/Ola mice from pooled slow-
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Table 2. RNA expression changes in soleus (mean values of two sets of pooled samples).
C57BI/6 M-CK' CK ' 129/Ola
RNA Protein1 RNA Protein1 RNA Protein1 RNA Protein1
COX-III 100 nd 97 nd 247 nd 123 nd
Isocitrate dehydrogenase 100 nd 73 nd 117 nd 87 nd
H+ ATP synthase-C 100 nd 84 nd 125 nd 94 nd
COX-IV 100 100 92 105 123 182 101 91
ANT1 100 100 91 89 138 137 91 95
GLUT4 100 100 101 145 136 155 106 173
MLC2v 100 nd 132 nd 180 nd 98 nd
SERCA1 100 nd 89 nd 55 nd 105 nd
SERCA2 100 nd 125 nd 133 nd 105 nd
'Data from de Groofet al. (2001) (12); nd: not done
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twitch soleus RNA (2 sets) were therefore also determined. Although values for a conspicu­
ously higher number of signals were closer to background than in the gastrocnemius arrays 
(not shown), again several EST/cDNAs displaying a 1.2 to 2.5-fold change in signal intensity 
were identified (Table 2), including COX-III, nuclear-encoded mitochondrial transcripts and 
GLUT4. Consistently, changes were only evident in CK---- and not in M-CK- - soleus, the only 
notable exception being ventricular myosin light chain 2 (MLC2v) mRNA which displayed a 
30% and 80% increase in these mutant muscles, respectively. Interestingly, converse changes 
in SR/ER Calcium ATPase-1 (SERCA1; -45% decrease) and SERCA2 (+33% increase) 
mRNA levels resulted in a relative shift in favor of SERCA2 expression in CK---- soleus.
Developmental timing of adaptive changes in muscle mRNA profile
CK isoenzyme expression profiles in normal muscles change during maturation and 
growth to adulthood (13). Adaptations in mRNA levels in response to CK deficiency may 
therefore have a flexible character during the first months of life. Comparison of RNA 
expression levels between whole GPS muscles of CK---- and wild-type animals at 17 and 100 
days of age (Table 3) demonstrated that upregulation of mRNAs encoding mitochondrial pro­
teins, MLC2v and GLUT4 is already evident early in life. Strikingly, at 17 days we found an 
increase in mRNA content for voltage-dependent anion channel-3 (VDAC3), the inorganic 
phospate (Pi) carrier, and the 2-oxoglutarate/malate carrier. Increase in mRNA content for 
these proteins was not seen in animals at 100 days of age.
Are organ-related effects involved in CK-related changes in mRNA profile?
To ascertain that changes in mRNA profile are not an effect of altered endocrine sig­
naling or whole-body metabolism, and are confined to CK-deficient muscles only, we also 
performed mRNA array analysis of livers from 100 day-old CK---- and wild-type mice. Liver 
was chosen because it is central in whole-body energy metabolism (14), but should not be 
affected by ‘internal’ metabolic stress as CKs are not expressed in this organ. Comparison of 
mutant and control livers yielded no significant differences (Fig. 2A; quantitative data not 
shown). Unlike in muscle, also the balance in expression levels for COX-IV and COX-III, 
representatives for the nuclear and mitochondrial transcript populations, respectively, was 
essentially unchanged (Fig. 2B).
Linear relationship between changes in mRNA and protein levels?
Relative changes in protein (values taken from (12)) and mRNA content in CK- 
deficient gastrocnemius are compared in Table 1 and 2. There was a simultaneous change in 
protein and mRNA levels for ANT, COX-IV (see below) and GLUT4, but not for VDAC, and 
Pi carrier. To analyze this phenomenon in more detail we assessed the relationship between 
mitochondrial COX-III and nuclear COX-IV mRNA and protein levels in greater detail. 
Semi-quantitative Western blot analysis of the protein content in two wild-type and two mu­
tant GPS muscles (Fig. 2C) showed a 2.6-fold upregulation of COX-III protein content, in
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Table 3. RNA expression changes in G PS com plexes of 17-day-old and 
100-day-old mice (wild-type C57BI/6 = 100%) .
EST/cDNA CK”/” 17 d a y s1 CK”/” 100 d a y s2
COX-III 142 234
Isocitrate dehydrogenase 148 154
H+ ATP synthase-C 1 45 152
COX-IV 1 20 150
ANT1 130 1 24
GAPDH 98 1 28
GLUT4 1 42 138
VDAC3 1 48 107
Pi carrier 1 45 114
2-oxoglutarate/malate carrier 1 45 118
MLC2v
T T T - T - •— T — T T T T T — T — r - — — — — r - —
199 1 29
„ ____ ,____ _____17 days: results of pairwise comparison of 2 pooled C57BI/6 and 2 pooled CK GPS complexes.
2 /100 days: results of comparisons betw een two C57Bl/6 and two C K """ GPS complexes.
line with the 2.5-fold increase in the level of COX-III mRNA in the CK---- mouse. By con­
trast, no strict coupling between the increase in COX-IV protein and mRNA content was seen 
(2.6-fold vs. 1.5-fold upregulation, respectively).
DISCUSSION
We used conventional mRNA profiling on cDNA arrays to obtain insight into mecha­
nisms that play a role in sensing of -  and the response to -  metabolic stress in the CK- 
mediated high energy phosphoryl shuttle. Earlier our group had already uncovered important 
functional and structural differences between M-CK--, CK---- and wild-type muscles (10, 11, 
15), most of which were associated with rather subtle changes in the level of a diverse series 
of mitochondrial, cytoarchitectural and glycolytic proteins (12). Based on these findings we 
have postulated that most -  if  not all -  of these changes may in fact have a compensatory 
character, serving to ameliorate the adverse physiological effects of gene ablation (10, 11). 
Similar compensatory remodeling, involving an increased mitochondrial density or altera­
tion in O2 diffusion pathway(s), has meanwhile been observed in ANT1 (7, 24) and myoglo­
bin (8, 9, 25) knockout mice and is a normal response to physiological challenge (1).
We demonstrate here that part of this plasticity is regulated by adaptation in the steady 
state level of mRNAs. As might have been anticipated, the magnitudes of changes in mRNA 
levels did never exceed those of the changes in protein level. Moreover, for most mRNAs the 
effects are significantly more prominent in CK--/-- than in M-CK-/- mice, in accordance with 
the protein findings. For COX-IV, ANT, and GLUT4, changes in mRNA and protein content 
were significantly correlated, albeit not in a 1:1 relationship. Strikingly, although Pi carrier 
and VDAC protein content were significantly (2 to 4-fold) increased, we did not detect 
changes in mRNA level for these proteins in 100-day-old CK---- gastrocnemius. Only in 17-
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day-old GPS complex we did see a modest (1.5-fold) increase in the level of mRNAs for these 
proteins. Moreover, with the exception of GAPDH mRNA, we did not find an effect on the 
expression levels of glycolytic mRNAs like those for lactate dehydrogenase, aldolase or pyru­
vate kinase-M. Earlier, we demonstrated that lactate dehydrogenase (and possibly aldolase) 
undergoes an isoenzyme shift which is most notable in soleus of CK---- animals (12). We may 
therefore have to use isoform-specific probes in future cDNA array analyses to identify any 
effects at the transcript level for these proteins.
For COX-IV mRNA we saw that a moderate (34%) increase in mRNA level still al­
lowed a greater than 2-fold increase in protein product in CK--/-- mice. Between changes in 
COX-III mRNA and protein content, a better correlation was found. Similar discrepancies 
between responses in nuclear and mitochondrial transcripts after electrical stimulation in mus­
cle were reported by Williams et al. (26). The cellular concentration of mitochondrial COX 
mRNAs (COX-I, -II, -III) is largely determined by mtDNA copy number, and is higher than 
that of nuclear-encoded COX mRNAs (COX-IV) (27). Both transcriptional and posttranscrip- 
tional regulatory principles have been proposed to explain how ultimately equimolar ratios of 
translation products assemble as subunits into the COX holoenzyme (28), and how protein 
expression levels of OXPHOS genes are adjusted to changes in energy requirements (29, 30). 
Taken together, our data suggest that both transcriptional and translational control of nuclear- 
encoded mitochondrial transcripts are involved in the remodeling of muscle in our CK- 
mutants, whereas mitochondrial-encoded genes are mainly controlled by transcriptional regu­
lation.
We found no effects on steady state levels of the mRNAs for muscle transcription fac­
tors MyoD and MRF4, whereas myogenin and Myf5 mRNAs were not reliably detectable 
(data not shown). Also the mitochondrial transcription factor A (Tfam) showed no change in 
mRNA level, whereas NRF1, NRF2a and NRF2b could not be quantified reliably. For cal- 
cineurin, a key regulatory factor linking calcium homeostasis to gene expression, we observed 
no change in mRNA levels. Of course, our results do not exclude the possibility that these 
factors themselves do have an active role in regulating the phenotypic adaptations, but effects 
at the transcript level are not evident.
Whatever the regulatory principle(s) involved, our profiling data give further support 
to the contention that the mRNA and protein changes have a compensatory role. The increase
Figure 2 (facing page) (A) Representative arrays from C57Bl/6 and CK--/-- liver (100 days) and C57Bl/6 
so leu s muscle. A6 : M-CK; A7: adenylate kinase 1; A8 : ScCKmit; A12: fatty acid synthase; A27: ANT2; 
A33: SERCA1; A39: COX-IV; A41: COX-III; B13: hexokinase 1; B45: actin. (B) COX-III and COX-IV 
mRNA expression levels in C57Bl/6 (white bars) and CK--/-- liver and G PS m uscle of two 100-day-old 
mice. Error bars indicate SEM of the signals in two hybridization experiments. The expression level of 
COX-IV in C57Bl/6 liver and G PS m uscle w as arbitrarily se t to 1 for comparison. (C) Quantitative 
W estern blot for COX-III (22 kDa) and COX-IV (17 kDa). Two wild-type sam ples (WT: 1-fold and 2-fold 
protein concentration) were loaded to facilitate densitometric analysis of band intensities (WT=100%).
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1 2 CK 7 WT CK 7 WT
COX-III 100 200 264 96 253 83
COX-IV 100 200 245 139 303 107
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in mRNA content for several mitochondrial proteins could reflect the increased mitochondrial 
density and the greater need for mitochondrial ATP production (11). A further compensatory 
mechanism might involve the mitochondrial proton homeostasis, reflected in the 1.6-fold 
upregulation of H+-ATP synthase-C and 0.65-fold downregulation of UCP2 (and UCP3). Al­
though further study is necessary, we envisage a model where proton leak via UCP is prohib­
ited and more protons enter the mitochondrion via the H+-ATP synthase complex, thereby 
providing greater efficiency in ATP production (31). The increase in MLC2v expression 
could reflect a changed isoenzyme composition of MLC2 (a possible isoenzyme shift from 
MLC2f to MLC2v), leading to altered energy consumption in the contractile apparatus.
In conclusion, our array data show that the observed phenotypic adaptations in CK- 
deficient mice are caused by a concerted remodeling of different muscle characteristics, with 
an important role for regulation of transcript levels.
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Phosphocreatine in CK-deficient muscles
ABSTRACT
We assessed the relationship between phosphocreatine (PCr) and creatine (Cr) content, 
and creatine kinase (CK) enzymatic activity in skeletal muscle of mice with or without the 
cytosolic and mitochondrial isoforms of muscle creatine kinase (wild-type or CK---- mice) 
during postnatal maturation, growth and aging. Starting from one week after birth, PCr-Cr 
levels and CK activities were assessed by in vivo MR Spectroscopy, or biochemical meas­
urements of tissue extracts. In wild-type muscle, the PCr/ATP ratio and CK activity increased 
until about four weeks of age, and leveled off thereafter. Total muscular Cr increased in paral­
lel, but reached a plateau value somewhat later. Surprisingly, CK--/-- mice showed a similar 
increase in PCr/ATP ratio during this first four weeks, but in the presence of only minor CK 
activity (< 1%). The increase in total Cr content was similar to wild-type muscle and thus ap­
peared to be the limiting parameter in setting PCr levels. At older age, CK---- muscle showed
13a decreasing PCr/ATP ratio. Using a new in vivo MR approach with the application of C la­
beled Cr, also a lower PCr/Cr ratio was observed. Although Cr could still be converted to PCr 
in mature CK--/-- muscle, the PCr availability decreased, and PCr became partly inert with in­
creasing age. Our results are compatible with a model where residual brain-type BB-CK, pre­
sent in myoblast satellite cells, which are most prominent early in life, can assist in slow Cr to 
PCr conversion in resting CK--/-- muscle. Apparently, this CK activity is not sufficiently wide­
spread to ensure rapid and complete PCr depletion (PCr to Cr conversion) when muscle is 
challenged under ischemic conditions. Existence of significant immobile or MR-invisible 
pools of Cr and the presumed role of CK in this phenomenon were not hit upon as important 
factors in our findings, as the total muscular Cr content and the PCr/Cr ratio assessed by MR 
and by chemical means were almost identical in all mice.
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INTRODUCTION
Creatine kinases (CKs; EC 2.7.3.2) form a small family of isoenzymes which catalyze 
the reaction Creatine (Cr) + MgATP2- ^  Phosphocreatine (PCr2-) + MgADP" + H+. These 
proteins play a key role in the energetics of excitable tissues, such as muscle, by keeping 
ATP/ADP ratios balanced and the ATP pool highly charged (1, 2). Apart from forming a spa­
tial and temporal energy buffer, the CK circuit may also act as an intracellular regulator of pH 
and of inorganic phosphate (Pi) levels (3).
To study the overall physiological significance of the CK/PCr system, we have gener­
ated mice with null mutations in the muscle-specific cytosolic M-CK and mitochondrial
31ScCKmit genes (4-7). Surprisingly, P magnetic resonance (MR) spectroscopy of skeletal 
muscle of adult mice with combined null mutations for M-CK and ScCKmit (M-CK -/-  x 
ScCKmit-/- further referred to as CK--/-- ) showed the presence of substantial amounts of PCr 
(about 70% of wild-type). However, this pool could not be used for energy buffering (5, 8) 
and moreover, the exchange flux of phosphate between the PCr and ATP pools in the CK re­
action measured in MR transfer experiments had dropped to below detection levels in adult 
animals (9).
The main purpose of the present study was to obtain a more precise characterization of 
the PCr pool in muscle of CK --/-- double knockout mice as compared to muscle of wild-type 
mice. It is of particular interest to know what happens with the muscular PCr content as a 
function of age in relation to CK activity and total Cr levels, as these are key elements in the 
setting of PCr tissue levels and are expected to change during postnatal development and ag­
ing. Moreover, early in life the initially dominating BB-CK isoform becomes repressed and is 
taken over by the MM-CK isoform in wild-type muscle (10), but -  for obvious reasons -  this
does not occur in CK--/-- muscle.
To address how these factors might affect PCr levels in wild-type and CK--/-- mice, the 
muscular content of (P)Cr was assessed by in vivo MR spectroscopy, in parallel with 
biochemical determinations of muscular Cr levels and CK activity as a function of age. To 
identify whether phosphorylation of creatine indeed occurs in muscle of adult CK---- mice, we
13introduce a new approach using C labeled Cr to monitor its uptake and phosphorylation in
13vivo by C MR spectroscopy. Finally, we also compared the potential to de-phosphorylate 
PCr in muscle of wild-type and of double knockout mice as a function of age. The results 
provide further clues as to why skeletal muscles of mice lacking both M-CK and ScCKmit 
contain PCr. Moreover, the data also have interesting implications for views on Cr mobility 
and visibility as seen by MR spectroscopy in skeletal muscle.
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MATERIALS AND METHODS
Animals
Mice lacking cytosolic M-CK and sarcomeric mitochondrial ScCKmit were compared 
to wild-type C57Bl/6 controls. Animals were anesthetized with 1.2% isoflurane in a gas mix­
ture of 50% O2/ 50% N2O delivered through a facemask. The temperature of mice was moni­
tored during the experiments using a fluoroptic thermometer (Luxtron 712, Luxtron, CA) and 
body temperature was maintained at 36.8 ± 0.5°C using a warm water circuit.
Magnetic Resonance (MR) equipment
The MR experiments were performed on a 7.0 T magnet (Magnex Scientific, Abing­
don, UK) interfaced to a SMIS (Surrey Medical Imaging Systems, Surrey, UK) spectrometer 
operating at 300.22 MHz for 1H, at 121.53 MHz for 31P and at 75.49 MHz for 13C. The hori­
zontal magnet was equipped with a 150 mT/m shielded gradient set and had a free bore size 
of 120 mm. The receiver channel was slightly modified by using home-built ultra-low noise 
preamplifiers and a low-loss active transmit/receive switch.
Phosphorus MR study of postnatal development
31For non-localized P MR measurements, a three-turn solenoid coil with a diameter of 
8 mm and an Alderman-Grant type of 1H MR coil at the outer side was utilized (11). For 
small mice, a special plastic insert was used to ensure that only the hind limb muscles were 
measured. After the shimming procedure, a scout image was obtained in three perpendicular 
directions to ensure that only the hind limb was situated in the R Ffield  of the coil. 
Experiments on a phantom (100 mM Pi solution) showed that the field of view of the proton 
coil corresponded to that of the phosphorus coil (data not shown). This was verified by the 
combination of ISIS localized 31P MR spectroscopy (12) and 1H MR imaging. No 31P MR 
signals were detected outside the part of the phantom visible by MRI. Phosphorus MR spectra 
were acquired using a conventional 90° RF pulse of 40 ^s with a repetition time of 7 seconds 
and were obtained from the hind limb of mice at ages of 7, 14, 20, 21, 26, 28, 33, 42, 80 and 
300 days (n = 4 each).
Post mortem study
31P MR spectra were acquired from wild-type mice aged 21 days and 12 months (n = 2 
each), and CK---- mice aged 21 days (n = 3) and 6, 9 and 12 months (n = 1 per time point).
31The P MR spectra (Tr = 7 s, 128 scans) were acquired using the same coil setup as used in 
the postnatal development study. After the acquisition of a reference spectrum, the animal 
was sacrificed with an overdose isoflurane and the PCr resonance was monitored until its 
level became constant.
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13In vivo C labeled creatine studies
CK---- (n = 5) and wild-type (n = 5) mice between 3 and 6 months of age were injected
13intravenously with 100% C4 -labeled Cr (11.25 mg/ml, 200 ^1), three times a week, for 
three weeks. The labeled Cr was obtained from Mercachem (Mercachem, Nijmegen, The
13Netherlands (13)). Hind limb muscles of these mice were analyzed weekly by C MR spec-
13troscopy, using a 4-turn solenoid C coil with a diameter of 8 mm surrounded by an Alder-
1 13man-Grant coil for H. C MR spectra (1500) were acquired using a 90° RF pulse of 40 ^s
13with a repetition time of 3 seconds at the C-MR frequency, with Waltz-4 proton decoupling 
(40W, duty cycle 0.7%) at the 1H MR frequency to ensure that the resonance position for the
13PCr/Cr peaks was maximally resolved from lipid C MR signals. Heating caused by decoup­
ling power was monitored in a pilot experiment by controlling the temperature of the hind 
limb and of the body a two-channel fluoroptic thermometer (Luxtron 712); no warming of the 
animal could be detected during 1.5 hours.
Quantification of the total Cr pool in muscle using localized *H MR spectroscopy
Creatine levels were determined by quantitative localized 1H MRS in gastrocnemius 
muscle, oriented at 55° with respect to the Bo direction (magic angle) to avoid complications 
due to dipolar coupling (14). Localized 1H MRS was performed using the STEAM sequence 
(15) at TE = 10 ms and TM = 15 ms, with a repetition time of 5000 ms, 2500 Hz spectral 
width and averaging of 512 scans (42 minutes). Water suppression was achieved using 
CHESS (16) with a saturation pulse length of 15 ms. Typical voxel size was 2 x 2 x 2 mm 
located in the gastrocnemius muscle. The localization of this voxel was guided by gradient 
echo images acquired in three oblique, perpendicular directions (TE = 5 ms, Tr = 200 ms, slice 
thickness 0.5 mm, matrix size 256 x 256, 12 slices). Localized shimming on this (oblique) 
voxel was performed until a line width (FWHM) of less than 22 Hz (0.08 ppm) was reached. 
Creatine levels were estimated from the peak area of its methyl protons using the proton sig­
nal of water as an internal reference and assuming a water content of 75%. Corrections were 
made for T2 relaxation times. The relaxation time T2 for Cr methyl and water proton spins 
was estimated by the acquisition of proton MR spectra at different echo times and applying a 
mono-exponential fit to the signal intensities obtained at increasing echo times. At a repetition 
time of 5 seconds, the proton spin system was considered to be fully relaxed and hence no 
correction for T1 was applied. The creatine content was determined at the age of 200 days 
(n = 3).
Ischemia protocol
The MR probe construction was provided with a diaphragm plate, which allowed re­
versible and reproducible occlusion of the hind limb to make the skeletal muscle ischemic (8).
13The C MR experiment to verify the metabolic activity of the labeled Cr pool was essentially
13done with the same settings as in resting state C MR experiments, except that the number of
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scans w as reduced to 600 w ith a repetition tim e o f  one second. The experim ents w ere per­
form ed on m ice betw een  3 and 6 m onths o f  age.
Biochemical determination of CK activity and metabolite levels
M ice w ere sacrificed after the experim ent and hind limb m uscles w ere stored at -80°C . 
M uscles w ere hom ogenized  in a T eflon-glass Potter-Elvehjem  hom ogenizer in 10 volum es o f  
an ice  cold buffer containing 200  m M  sucrose, 2 m M  E D T A , 10 m M  Tris-HCl (pH  7.4), sup­
plem ented w ith heparin (50 units/m l) and protease inhibitors (Boehringer M annheim , Ger­
many). The suspension w as diluted 1:1 in a 30 m M  phosphate buffer (pH  7.4), containing 0.2  
m M  DTT and 0.05%  (v /v) Triton X -100  and protease inhibitors. Extracts w ere incubated at 
room  temperature for 20 m inutes and subsequently centrifuged at 14,000 rpm in an Eppendorf 
centrifuge at 4°C  for 20 minutes. Total CK activity w as m easured using a C K -N A C  activated  
kit (Boehringer). For zym ogram  analysis, total protein extracts (5 ^g) w ere resolved on a
0.7%  (v /v ) Seakem  M E agarose gel (FM C Bioproducts, Rockland, M E). E nzym e activities  
w ere v isualized  using the CK isoen zym e colorim etric detection kit (Sigm a, Zwijndrecht, The 
Netherlands; (5)).
For further chem ical analysis o f  the Cr content, tissues w ere extracted by 0 .6  M  H C lO 4 
and neutralized by 3M  KOH. Total Cr leve ls  w ere essayed  v ia  coupled enzym atic reactions 
using a spectrophotom eter operating at 340 nm (17). Cr leve ls  w ere determined in ^m ol/gr  
dry w eight and converted to m m ol/l tissue, assum ing a protein/dry w eigh t ratio o f  0.71 and a 
protein content per vo lum e o f  tissue o f  25%. PCr leve ls  w ere determined as described previ­
ously (4, 5).
MR data analysis
M R  spectroscopic data w ere evaluated in the tim e dom ain using M R U I 97.1 software
(18). W ater suppressed 1H  M R  spectra w ere autom atically zero-order phased by point w ise  
division  w ith the unsuppressed water signal. This also com pensates for possib le eddy current 
effects (19). The residual water signal w as rem oved using H L SV D  filtering (20), and the 
creatine peak at 3.03 ppm w as fitted assum ing a Gaussian line shape m odel function. R eso-
31nances in the P M R  spectra w ere also fitted assum ing a Gaussian line shape m odel function. 
N o  further prior know ledge w as used.
13In C M R  spectra, all signals originating from carbons in lipids w ere filtered using  
H L SV D  (20), leaving v isib le  resonances for Cr and PCr around 157 ppm. A s prior 
know ledge, a chem ical shift difference o f  0.8 ppm (13) and equal dam ping for these  
resonances w as assum ed.
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RESULTS
Postnatal development of (phospho)creatine levels
Energy metabolites in developing hind limb muscles of control and CK-- /- -  mice aged 
7-80 days were monitored by 31P MR spectroscopy. All 31P MR spectra (Fig. 1A) showed 
resonances for PCr, y-, a - and P-ATP, Pi and phosphomonoesters (PME). During the first four 
weeks of life the PCr/ATP ratio gradually increased, with a similar progression for wild-types 
and mutants (Fig. 1B). Thereafter, this ratio gradually declined in CK---- mice but remained 
virtually constant in controls during the entire first year of life.
As the size of the cellular Cr pool may determine the ratio of PCr over ATP, we meas-
31ured total Cr levels as a function of age in the same cohort of mice as studied by P MRS, 
using a biochemical assay. The creatine content appeared to increase similarly in both wild­
type and CK- - /- -  mice during postnatal development, and became constant after about 3 months 
of age at a tissue level between 30 and 35 mM (Fig. 2). Creatine levels were also determined 
by quantitative localized 1H MRS, with the muscle oriented at the so-called magic angle (14), 
from the peak area of its methyl protons and using the water peak as a reference. The T2 re­
laxation times used for signal correction were estimated to be 80 ms for creatine methyl pro­
tons and 21 ms for water proton spins. In this way, creatine levels were calculated to be 35 ± 1 
mM in controls and 36 ± 1 mM in CK---- muscles at 200 days of age. These values are not 
significantly different from the chemically determined creatine levels (Fig. 2).
Postnatal changes in creatine kinase activity
During postnatal development of mammalian skeletal muscles, a transition in CK 
isoenzyme subunits from BB-CK to MM-CK takes place, which reflects a gradual repression 
of B-CK gene expression (10). In order to test the possible involvement of this CK family 
member in PCr pool build-up and depletion, we quantified the residual level of BB-CK isoen­
zyme in CK---- muscles in relation to normal wild-type CK activity over time. The zymogram 
assay confirmed complete absence of MM-CK and ScCKmit in double mutant muscle, 
whereas the BB-CK isoenzyme was clearly visible in both wild-type and mutant muscle ex­
tracts at 7 and 14 days of age (Fig. 3A). During further progression to adulthood, iso-enzyme 
staining on zymograms dropped to undetectably low levels, but the corresponding residual 
BB-CK enzyme activity could still be assessed with spectroscopic-photometric analysis of 
tissue lysates. In 7-day-old CK--/-- muscles, this activity was 4% of the total normal CK activ­
ity (combined BB-CK, MM-CK and ScCKmit activities in wild-type controls), but decreased 
to values below 1% after 20 days (Fig. 3B).
13Uptake and phosphorylation of C-labeled creatine in muscle of adult mice
To asses the uptake, visibility and phosphorylation of creatine in mature wild-type and
CK - - /- -  mice, we used a new approach by which we could assess Cr and PCr simultaneously in
13 13muscle in vivo using C MR spectroscopy, after injection of C-labeled Cr. After one week
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31Figure 1 (A) P MR spectra of hind limb skeletal muscle as a function of age for a wild-type (left 
panel) and a CK--/-- mouse (right panel) showing postnatal development of high energy phosphates. 
Spectra are vertically scaled to the ATP content. The age of animal is indicated on the left side of the 
spectra. Assignm ents: PME, phosphomonoesters; Pi, inorganic phosphate; PDE, phosphodiesters; 
PCr, phosphocreatine; ATP, adenosine triphosphate. (B) The PCr over ATP ratio as a function of the 
age for CK--/-- (•) and control (□) mice. The PCr over ATP ratio is similar for CK--/-- and wild-type control 
mice until the age of 30 days. Thereafter, the PCr/ATP ratio levels off in control mice, but decreases in 
CK--/-- mice. Each data point represents the average of four different mice. Standard deviations are 
only indicated when outside the symbol sizes.
13(3 injections), this resulted in a well-resolved signal in the C MR spectrum for Cr and PCr in 
muscles of wild-type mice (Fig. 4 A). Strikingly, uptake and phosphorylation of 13C labeled Cr 
were also detectable in CK”"  mice (Fig. 4B). The phosphorylated fraction of the Cr pool re­
mained constant during the three weeks of creatine injection in both mouse strains.
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Figure 2 Creatine levels in hind limb skeletal m uscle a s a function of m ouse age.
Values for CK--/-- mice are indicated by open boxes and for wild-type control by closed boxes. Data 
points at 200 days of age were obtained by quantitative H MRS of the gastrocnemius muscle (n = 3). 
The other data points have been obtained by biochemical means from the GPS complex and are av­
erages of at least 2 mice for each point. Standard deviations are indicated if extending beyond the
symbol size. The overall increase in the total Cr pool for the CK 
and levels off at the sam e value at age 3 months and older.
and wild-type control mice is similar
The fractions of PCr over total Cr were 0.58 ± 0.07 in CK---- and 0.73 ± 0.08 in wild­
type mice, respectively. These values did not differ significantly from the values determined 
by chemical extraction of the PCr fraction from the total Cr pool in CK---- (0.55 ± 0.06) and 
control mice (0.66 ± 0.04) as we reported previously (5) (Fig. 4C).
13To verify whether the C-labeled PCr in muscle was metabolically active (Fig. 4D),
13we applied ischemia to the hind limb muscle. C MR spectra were acquired at a time 
resolution of 10 minutes, during a total ischemic period of 20 minutes. In wild-type mice we 
observed a clear conversion of PCr to Cr during this time interval, and full recovery of PCr 
levels occurred after reperfusion. In CK-- /- -  mice, no changes in PCr and Cr levels could be 
observed in this relatively brief period, within limits set by the signal to noise ratio.
Postmortem de-phosphorylation of phosphocreatine as a function of age
Having demonstrated that Cr phosphorylation can occur in both developing and mature 
muscle of CK- - /- -  mice at rest, we next investigated to which extent also the converse reaction,
i.e. de-phosphorylation of the PCr pool, could still ensue in these animals. We therefore 
quantified this activity as a function of age by measuring the rate of PCr signal decay in hind 
limbs after a maximal physiological challenge, the onset of death in the MR magnet. Post­
mortem PCr breakdown occurs at the same rate in 21 days and 12 months old wild-type mice 
(Fig. 5). In contrast, CK---- mice showed significantly delayed depletion of PCr at the age of
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Figure 3 (A) CK isoenzyme and adenylate kinase 1 (AK1) distribution in skeletal muscle as a function 
of the age of the mouse. Zymogram analysis of extracts from wild-type (left panel) and CK--/-- mouse 
muscle (right panel) reveals presence of trace levels of BB-CK activity during the first two weeks of 
life, but not thereafter. Note the high levels of MM-CK in wild-type, and the complete absence of activ­
ity in CK--/-- animals. The apparent differential staining of AK1 activity during the entire maturation pe­
riod in wild-type and CK--/-- animals is an artifact of staining due to presence of high local MM-CK activ­
ity on the wild-type zymogram. Staining of (low) ScCKmit activity is not visible under the conditions 
used for enzyme staining. (B) CK enzyme activity measured as a function of age in wild-type muscle 
(U/mg protein; left panel) and in muscle of CK--/-- mice (right panel). The latter is the non MM- 
CK/ScCKmit activity.
21 days, w h ile  de-phosphorylation o f  PCr w as further slow ed  down at 3, 9 and 12 m onths o f  
age (Fig. 5). In these latter measurem ents, PCr signal intensities did not drop to zero, but
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reached a plateau at approxim ately 50% o f  the initial concentration, indicating that a sign ifi­
cant portion o f  PCr w as com pletely  rendered m etabolically  inert.
DISCUSSION
The increase o f  the CK activity and o f  the PCr/ATP ratio during postnatal develop­
m ent o f  skeletal m uscle in w ild-type m ice confirm s results o f  previous studies in rodents (e.^. 
21, 22). In the present study, w e  also observed a postnatal increase for muscular creatine lev ­
els, w h ich  occurs in parallel w ith  increasing CK activity and PCr/ATP ratios. In general, there 
appears to be a positive correlation betw een CK activity and Cr content for different tissues  
(2). H ow ever, it is clear that this correlation does not hold strictly, as a steadily increasing Cr 
level paralleled a m inor but steadily decreasing CK activity in our double knock-out m ice. 
Surprisingly, the PCr/ATP ratio in skeletal m uscle o f  CK ---- m ice increased in a very similar 
fashion as in w ild-type m ice during the first four w eek s after birth, despite the fact that the 
CK activity differed profoundly betw een  mutants and controls. It appears that these changes 
in (relative) PCr leve ls  relate to postnatal variations in the total Cr pool, w hich  are largely  
identical in w ild-type and CK--/-- m ice. Remarkably, w h ile  PCr/ATP becam e constant in w ild ­
type or even decreased in CK --/-- m ice beyond 30 days o f  age, the total muscular creatine con­
tent still increased until about 80 days in both m ice types. Uptake o f  Cr is an active process 
regulated by specific  Na+/Cr cotransporters (2, 23), the activity o f  w hich  is coupled to energy, 
Na+, K+ and Ca2+ hom eostasis, and presum ably serum Cr concentration. The activity o f  the 
creatine transporter show s regional and developm ental d ifferences (24, 25), but is apparently 
not severely affected in CK mutants.
O nce CK ---- m ice becom e mature (older than four w eek s), they display low er  
PCr/ATP and PCr/Cr ratios than w ild-type m ice. It m ay be that at extrem e lo w  levels  o f  CK  
activity (<  1% o f  w ild-type), the rate o f  Cr phosphorylation is so slow  that the overall CK re­
action (integrated over the entire m uscle) is not at equilibrium anymore. This m ay occur when  
CK m olecules, at very lo w  expression levels, are no longer in (continuous) open contact w ith  
the entire m uscular pool o f  substrates, a situation that m ay be enhanced by compartmentation  
such as discussed  for the presumed role o f  satellite ce lls below . This w ould  contribute to local 
differences and different PCr/Cr and PCr/ATP ratios i f  averaged over all fibers in the entire 
m uscle. If, on the other hand, the residual CK isoen zym e level w ould  still be sufficient to  
keep the overall CK -reaction at equilibrium in the resting state, it fo llo w s that concentrations 
o f  som e com ponents involved  in the CK reaction w ill differ betw een w ild-type and mutant 
m uscle. A s m uscle tissue pH and total creatine lev e ls  are similar (5), either PCr, Cr, A D P  or 
A TP levels  could differ betw een w ild-type and mutant m uscle. Som ew hat low er A TP levels  
w ere found in CK---- m uscles after freeze-clam ping and extraction (5, 26), but this likely  is 
due to (faster) ATP breakdown during this procedure, as ATP buffering by the CK/PCr sys­
tem  is lacking and the total adenylate pool remains constant (4, 27). W ith a reduced PCr/ATP  
ratio, it seem s that the PCr level has decreased and the Cr level increased, and this is exactly
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Figure 4 13C-MR spectroscopy of hind limb muscle after administration of '3C-labeled Cr to follow up­
take and phosphorylation of Cr in muscles of wild-type control (A) and CK--/-- mice (B). The values for 
the PCr/Cr ratios in adult mice are in agreement with the chemically determined values for CK--/-- and 
control animals (C). Also changes in the PCr/Cr ration during 20 minutes of ischemia and the recovery 
were followed. Hydrolysis of PCr and phosphorylation of Cr is evident in spectra from wild-type mus-
13/-
cles, while in CK' 
(D).
--/-- muscles no activity can be detected within the limits set by the signal to noise ratio
13what is observed in the C MR spectroscopy experiments. Under the equilibrium state, we 
estimate that free ADP levels would have increased by about a factor o f three in CK -- /--  
muscle.
It is known that in skeletal muscles resting levels of PCr may vary with fiber type; e.g. 
rat and mouse slow twitch fibers contain lower PCr levels than fast twitch fibers (28). Thus, 
different PCr/Cr and PCr/ATP ratios might reflect an overall change in fiber type distribution 
in the mutant mouse compared to control. Indeed, there is a general shift towards a more oxi-
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dative character of mainly the type-II fast-twitch glycolytic muscles in CK--/-- mice (27, 29), 
and this may cause PCr homeostasis to be controlled within a different concentration range.
The rather unexpected presence of PCr in muscles devoid of both M-CK and ScCKmit 
gene products may now be better understood. Earlier (5), we speculated that (i) the PCr pool 
could originate from the postnatal period, when high amounts of BB-CK are still available, or 
that (ii) BB-CK activity in non-muscle cells, such as vascular endothelium may account for its 
presence. It is also conceivable that some unknown Cr phosphorylation activity is present in 
muscle cells. This latter possibility seems rather unlikely, as mice with combined deficiency 
of cytosolic BB-CK (brain-type cytosolic CK) and mitochondrial ubiquitous-CK (UbCKmit) 
isoforms completely lack PCr in the brain (C.R. Jost, C.E.E.M. van der Zee, H.J.A. in ’t Zandt 
et al., submitted). Unlike in muscle, no ‘non-brain-type’ CK isoforms are expressed in brain 
during development and therefore complications with persistence of ‘metabolic imprints’ 
from embryonic CK expression profiles do not exist. This provides indirect evidence for the 
supposition that Cr ^  PCr conversion in mammalian tissues will become fully blocked if ac­
tivity of all CK isoforms is completely ablated.
Therefore, we now think that the more plausible explanation for the build-up of a PCr 
pool in developing hind limb muscle is a gradual process that can be attributed to the low re­
sidual BB-CK activity in satellite cells or myocytes in the process of fusion (30). The newly
13introduced creatine C labeling method clearly showed that Cr uptake and phosphorylation 
still occurs in muscles of adult CK---- mice. If we assume that Na+/Cr cotransporters do not 
transport PCr (formed elsewhere and transported throughout circulation) directly into muscle, 
and that the negatively charged PCr (PCr2-) will not freely pass the membrane against a steep 
concentration gradient, we can explain our results most easily by assuming that even adult CK 
double mutant muscles still contain trace levels of enzymatic CK activity. Most likely, this 
originates from muscle satellite cells, which constitute about 30% of muscles in newborn 
animals. The size of the satellite cell population decreases with age (30) (4% at 8 months, 
2.4% at 30 months of age in mouse soleus muscle (31) and appears to be governed by muscle 
innervation and physiological demand. It is conceivable that low levels of BB-CK activity are 
deposited every time when satellite cells merge with myofibers. In the adult stage, a consider­
able fraction of myofibers may lack BB-CK entirely. This view is corroborated by the post­
mortem pool depletion data, which show that the rate of PCr de-phosphorylation is slower and 
does not affect more than 50% of the total PCr pool size in muscles at older age. If a signifi­
cant part of the total cellular Cr pool has no access to the enzyme, this would indeed explain 
the lower PCr/Cr ratio in adult mutants. We conclude that our CK- - /- -  mice could become a 
convenient model to study the role of satellite cells, using BB-CK and PCr as sensitive report­
ers for their fate under different physiological conditions.
Our study also provides new views on the issue of MR visibility of the total cellular Cr 
pool, and the presumed existence of significant free Cr pools that do not participate in the CK
13reaction. Based on experiments using C-labeled Cr in heart muscle (32) and in fish fast- 
twitch muscle (33) it has been proposed that a significant fraction of Cr (about 30%) is not
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31Figure 5 P-MR monitoring of the d ecrease in PCr signal intensity in skeletal m uscle p o st­
mortem.
The decay is similar in control mice at 21 days and 12 months of age. In muscle of CK--/-- mice, the 
ability to hydrolyze PCr decreases with age. In skeletal muscle of 21-day-old CK--/-- mice, PCr is com­
pletely depleted. In mice at 3, 9 and 12 months of age, PCr levels decrease only to 50%, at a much 
lower rate. ■ : 21 days (wild-type; n = 1 ); •: 12 months (wild-type; n = 2 ); □: 21 days (CK--/--; n = 3); V: 
3 months (CK--/--; n = 1); A : 9 months (CK--/--; n = 2); o: 12 months (CK--/--; n = 1).
im m ediately available for the CK reaction in these tissues. O bviously, participation o f  Cr in 
the ‘inert’ pool w as correlated to states o f  low ered m etabolic rate (see  for d iscussion  also  
(34)). Proton M R  m agnetization transfer experim ents on rat skeletal m uscle indeed revealed a 
pool o f  Cr w hich  m ay be bound to matrix or cellular m acrom olecules, how ever, the estim ate 
o f  the size o f  this pool is m uch low er (about 2.5% ) (35) com pared to estim ates from the 14C 
labeling studies. The observation that in human skeletal m uscle the m ethylene resonance o f  
Cr in localized  1H  M R  spectra disappears during exercise (36) further stimulated the d iscus­
sion that a significant im m obile Cr pool can exist, w hich  m ay not be readily accessib le to the 
CK reaction. In another study, a decrease o f  the T2 o f  the m ethyl proton spins o f  creatine w as  
observed during ischem ic fatigue in humans (37). It w as suggested that this could be due to  
reduced m obility o f  this com pound possib ly, caused by reduction in the space betw een  actin 
and m yosin  chains. In contrast, 1H  M R S investigations o f  m ouse skeletal m uscle suggested  
that changes in Cr signals observed im m ediately after death o f  the animal m ainly result from  
altered d ipole-d ipole interactions related to rem oval o f  the phosphate m oiety o f  this com ­
pound and not from changes in the cyto-architectural environm ent o f  Cr (14). The spectral 
effect o f  these dipolar interactions could be elim inated by orienting the m uscle at the so-called  
m agic angle o f  55° betw een  the m ain m agnetic field  and the direction o f  its fibers, and under 
these conditions the Cr signals did not change in am plitude and w idth in the early post mor­
tem  phase. Interestingly, recent studies indicate that the electric charge o f  small m olecu les af­
fects dipolar coupling interactions in skeletal m uscle (38).
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A s quantification o f  muscular Cr content from 1H  M R  spectra is com plicated by di- 
pole-d ipole interactions (39), w e  performed m easurem ents on our m ouse m uscles placed at 
the m agic angle orientation. Estim ation o f  the Cr pool from localized  1H  M R  spectra o f  m ouse  
skeletal m uscle y ielded  similar values for w ild-type (35 ±  1 m M ) and mutant m ouse (36 ±  1 
mM ). These values are slightly (but not significantly) higher than values from chem ical 
measurem ents. O nly i f  values w ould  have been significantly lower, this could have been con­
sidered evidence for the existence o f  an M R  invisib le  Cr pool. Further circumstantial support 
for ‘full M R  v is ib ility ’ o f  the total Cr pool com es from the observation that the PCr/Cr ratios
13determined by C M R  spectroscopy resem ble the chem ically  determined values. It remains, 
how ever, d ifficult to assess the effects o f  m etabolic state on ‘Cr v isib ility ’ from sim ple com ­
parison o f  our study and literature reports, because entirely different physiological challenges  
and m uscle types w ere exam ined. Thus, although w e  have found no support for the existence  
o f  significant M R  invisib le Cr pools, it is still conceivable that a (sm all) part o f  the Cr pool 
does not participate in the CK reaction and has interfered w ith our overall m etabolite ratio 
m easurem ents. From com parison o f  m etabolite leve ls  in w ild-type and mutant m uscles w e  
m ay conclude, how ever, that the m ere presence o f  CK itse lf  is not a parameter affecting Cr 
pool distribution behavior.
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Creatine kinase-deficient cell lines
ABSTRACT
Our current knowledge of the physiological function of the creatine kinase (CK) 
system is largely based on studies using pharmacological inhibition or genetic knockout 
strategies in animal models. Genetic impairment of CK activity in vivo revealed that global 
adaptations in metabolic flux and cellular architecture occur in tissues with a high energy 
demand, like muscle. Here, we describe the isolation of immortalized muscle cell lines from 
wild-type and M-CK/ScCKmit double mutant (CK--/-- ) mice carrying a thermosensitive SV40 
large T-antigen (tsA58) gene. Upon shift to non-permissive temperature, cells with and 
without CK differentiated into multinucleated myotubes, assembled well-developed 
sarcomeres, and showed spontaneous contractions in vitro. Addition of creatine to the culture 
medium had a beneficial effect on this differentiation behavior. Both mutant CK---- and 
control myotubes were relatively rich in mitochondria, constituting an elaborate reticular 
network that surrounded the developing sarcomeres. Unlike in the in vivo situation (ruled by 
organismal adaptational mechanisms), the combined lack of the M-CK and ScCKmit 
members of CK gene family was not associated with increased mitochondrial volume in our 
cultured cells. This suggests that the mechanism for physiological regulation of mitochondrial 
design and volume is either under dominant control by culture conditions, or not active in our 
cells because it is switched on in a stage of differentiation that cannot be attained in vitro. By 
complementation of CK--/-- myoblasts with a plasmid vector expressing a EGFP-M-CK fusion 
protein, we demonstrated that the tagged M-CK locates preferentially to the sarcomeric M- 
band, as in wild type muscle. This indicates that the formation of structurally well-arranged 
myofibrils proceeds normally in the absence of M-CK.
We conclude that our CK--/-- myoblasts follow a normal program of early muscle 
differentiation. These cells are therefore an ideal new tool for study of the biological 
significance of the CK/PCr circuit.
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INTRODUCTION
Myogenic cell lines have been a helpful resource to study development, ultrastructural 
design, and physiological and metabolic characteristics of muscles during differentiation. 
Upon fusion into multinucleated myotubes, permanent cell lines such as C2C12 and L6 show 
typical features of developing mammalian skeletal muscle fibers, including the structural 
ordering of actin and myosin filaments, excitation-contraction coupling (ECC) and 
spontaneous contractile activity (1, 2). Also conditionally immortalized myogenic cells, 
generated from H-2Kb-tsA58 transgenic mice (carrying a thermosensitive mutant of the SV40 
large T-antigen (3)), exhibit these characteristics when differentiated. Breeding schemes with 
these ‘immorto-mice’ therefore facilitate the derivation of cell lines carrying specific 
mutations (4), thus enabling studies of early muscle differentiation under well-defined 
pathological conditions. However, for the interpretation of these studies, it is important to 
realize that despite the many structural and functional similarities, there are also profound 
differences between differentiating myoblasts in vitro and myoblasts in vivo. Cell lines in 
vitro differentiate into multinucleated myotubes and assemble myofilament protein structures 
with relatively well-developed sarcomeres, which have the capability to contract. ECC in
these cells is thought to involve a rather primitive functional coupling between the L-type
2+voltage-sensitive Ca channel (dihydropyridine receptor; DHPR) and the ryanodine receptor
2+(RyR), connecting the sarcolemma and the intracellular Ca stores of the sarcoplasmic 
reticulum (SR). In vivo, however, this coupling is based on much more elaborate structures, 
located at triadic junctions between the SR and the T-tubular system, structures which do not 
form to the same extend in vitro (5, 6). Also the induction of slow and fast myosin heavy 
chain (MHC) expression, which parallels the formation of fiber-type dependent cyto- 
architectural arrangements, occurs late in development and is usually only observed in 
postnatal systems in the organismal (i.e. whole muscle) context (7).
One eminent distinction between cultured myogenic cells in vitro and a population of 
myogenic cells in vivo is, that the latter population is not composed of identical myoblasts. 
They can be subdivided into pluripotent muscle stem cells and particular types of satellite 
cells that generate myogenic precursor cells, which eventually will terminally differentiate 
into myotubes (8, 9). Within the population of precursor cells, the existence of different sub­
types, called founder cells and fusion-competent cells, has been demonstrated (for example in 
Drosophila embryos). Each founder cell has the ability to recruit a number of fusion- 
competent cells to fuse with them and trigger differentiation into a muscle fiber. During ongo­
ing differentiation in vivo, primary embryonic myoblasts in primary fibers are replaced by 
fetal myoblasts, resulting in the formation of secondary fibers, which then become innervated. 
Each secondary fiber has adjacent satellite cells, which will eventually fuse and contribute to 
the transition of myotubes into fast- and slow-type muscles (10, 11). Ultimately, determina­
tion of fiber type is dependent on a variety of intrinsic and extrinsic parameters, like genotype 
(both mouse inbred strain differences and mutational effects have been shown), physiological
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constraints (e.g. innervation and/or workload) or hormonal (thyroid hormone) influences. 
Thus, an optimal relationship between structural features and physiological and metabolic 
demand is established.
In previous studies, our group has demonstrated that mouse muscles undergo adapta­
tion and remodeling in response to mutation-induced stress in the creatine kinase 
(CK)/phosphocreatine (PCr) system for high energy phosphoryl transfer (12, 13). We have 
shown that CK deficiency evokes mutation- and cell-type dependent changes in the structural 
arrangement of the myofibers, in mitochondrial volume and design, and in fluxes through
energetic-metabolic pathways (12-16). Although involvement of metabolic stress signaling by
2+AMP-activated protein kinase (AMPK) and/or altered Ca homeostasis (analogous to models 
for chronic electrical stimulation) have been suggested (13, 17), virtually nothing is known 
about the regulation of this remodeling.
One important question arising is, when during development the lack of flux through 
the CK reaction is actually sensed and translated by the metabolic signaling machinery. Study 
of this question in CK-deficient mice remains difficult, because superposition of compensa­
tory changes at the cellular and organismal level makes it difficult to distinguish between 
primary and secondary effects of CK deficiency (18). In addition, genetic background hetero­
geneity in the CK knockout mouse lineages may form a complicating factor (19, 20).
Here, we describe the generation and characterization of CK-proficient and -deficient 
myogenic cell lines, which enable us to compare effects that occur at the single cell level in 
vitro in the first stages of development with those in the animal context in vivo. As cells in 
vitro are not exposed to any (known) physiological challenge, we expected them to require 
less tight metabolic regulation, and perhaps to show a simpler -  if  any -  picture of remodeling 
and adaptation. Our results support the suggestion that myogenic cell lines with and without 
the CK system are capable of developing a fully functional aerobic glycolysis and excitation- 
contraction coupling machinery. Thus these cell lines may provide a unique tool for further 
study of the signaling mechanisms that couple metabolic activity in the CK/PCr circuit and
cellular energetics to late events in differentiation involved in specifying maturation of the
2+contractile and ion (Ca ) homeostatic systems in muscle.
MATERIALS AND METHODS 
Animals
Mice harboring the H-2Kb-tsA58 allele (3, 21) were obtained from Charles River 
Laboratories (Wilmington, MA). The generation of M-CK and/or ScCKmit deficient mice 
was described previously (12, 13).
Allele-specific PCRs
The presence of the wild-type or targeted M-CK and ScCKmit alleles was assessed by 
allele-specific PCR reactions (13). The presence of tsA58 large T antigen gene was also tested
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by PCR analysis, using oligonucleotides 5’-CCTGGAATAGTCACCATG-3’ (forward 
primer, hybridizes to the sequence between nucleotide positions 3234-3251 of the SV40 ge­
nome) and reverse primer 5’-CAATGCCTGTTTCATGCC-3’ (reverse primer, hybridizes to 
nucleotide positions 2828-2845 of the SV40 genome) as described by Whitehead and Joseph 
(22).
Generation of cell lines
CK---- mice were crossed to tsA58 immorto-mice, and heterozygous offspring (CK- 
M+/-; ScCKmit+-; tsA58+/-) was subsequently crossed to CK--/-- mice, with four out of 32 pups 
in the progeny that were M-CK--; ScCKmit--; tsA58+-. From two of these animals (at the age 
of 14 days), satellite cells were isolated by ring cloning according to the method described by 
Morgan et al. (4). In total, 38 clonal lines were isolated and characterized. For wild-type cell 
lines, 25 clonal lines were isolated from hindlimb muscles of a C57Bl/6 x immorto-mouse 
cross (generating tsA58+/- offspring). Ultimately, three CK--/-- lines (4c6, 4c9 and 4c10) and 
three wild-type cell lines (3c7, 3b10 and 3b11) were selected based on ‘fusion index perform­
ance’ (see Results) and used for subsequent studies.
Culture of immortalized cell lines
Culture conditions were identical to those of Morgan et al. (4). In brief, myoblasts 
were cultured at low density at the permissive temperature (33°C, 10% CO2) in DMEM me­
dium (Invitrogen, Breda, The Netherlands), supplemented with 20% FCS (Integro, Zaandam, 
The Netherlands), 2% Chicken Embryo Extract (Invitrogen) and 20 U/ml recombinant murine 
IFN-y (kind gift of Dr. G. Entrican, Moredun Research Institute, Edinburgh, UK; Invitrogen). 
For differentiation at non-permissive conditions (37°C, 5% CO2), cells were cultured in dif­
ferentiation medium at high density on Matrigel (Becton Dickinson, Heidelberg, Germany) 
coated culture dishes or seeded on plastic Aclar coverslips (Allied-Signal, Pottsville, PA). 
Cell proliferation and differentiation were normal on plastic coverslips when compared to 
culture flasks, but were significantly impaired on glass coverslips (data not shown). Differen­
tiation medium used was DMEM supplemented with 5% Horse Serum (Invitrogen). To this 
medium, creatine (20 mM final concentration; Sigma, Zwijndrecht, The Netherlands) was 
added where indicated.
Creatine kinase activity and iso-enzyme analysis
Extracts were prepared from myogenic cultures at 0-7 days of differentiation. Myo- 
tubes were washed and scraped in a buffer containing 250 mM sucrose, 2 mM EDTA, 10 mM 
Tris-HCl (pH 7.4) and a mixture of protease inhibitors (Boehringer Mannheim, Germany)
(23). After homogenization, the suspension was diluted 1:1 in a 30 mM phosphate buffer (pH 
7.4), containing 0.05% (v/v) Triton X-100, 0.2 mM DTT and a mixture of protease inhibitors 
(Boehringer Mannheim), incubated for 20 min at room temperature, and subsequently centri­
fuged at 14,000 rpm for 10 min at 4°C. The supernatant containing the CK enzymes was ana­
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lyzed for enzyme activity, using the CK NAC activated kit (Boehringer, procedure 475742). 
For zymogram isoenzyme analysis, total protein extracts (3-5 ^g) were resolved on a 0.7 % 
(w/v) Seakem ME agarose gel (FMC Bioproducts, Rockland, ME). Enzyme activities were 
visualized using the CK isoenzyme colorimetric detection kit (Sigma Diagnostics, procedure 
715 EP). The gel was run in Tris-barbital buffer (pH 8.6) to allow separation of the mitochon­
drial CK isoenzymes (13).
Western blotting
Cell homogenates, prepared as described above, were diluted 1:1 in protein sample 
buffer (0.062 M Tris-HCl pH 6.8, 2.5% (w/v) SDS, 10% (v/v) glycerol, 0.7 M p- 
mercaptoethanol, 0.01% (w/v) bromophenol blue). Western blotting was performed as de­
scribed by De Groof et al. (15), using rabbit polyclonal antibodies directed against EGFP
(24), and antibodies 34C (anti-RyR) and CaF2-5D2 (anti-SERCA1) (Hybridoma Bank, John 
Hopkins University, Baltimore, MD).
Generation of constructs and transfections
Full-length mouse M-CK cDNA was isolated from EST AA014646 (clone 440577, 
Genbank X03233, NM_007710, in vector pT7T3D-pac) from the Resource Center of the 
German Human Genome Project at the Max Planck Institute for Molecular Genetics (Berlin), 
and re-sequenced using a standard sequencing protocol. The EcoRI-NotI fragment spanning 
the entire coding sequence (bp 1-1208, exon 1-8) and 205 bp of the 3’ UTR was cloned into a 
modified pCMVSport vector (Invitrogen). The coding sequence of enhanced green 
fluorescent protein (EGFP, from pEGFP-N3 Clontech, Palo Alto, CA) was cloned into the 
EcoRI-NotI sites of pCMVSport. For generation of 5’ EGFP tagged M-CK, a 5’ NotI 
restriction site was placed in front of the M-CK ATG codon. To this end, the cDNA insert in 
plasmid AA14646 was used as template for a PCR reaction using the primer 5’- 
ATAAGAATGCGGCCGCC^rGCCGTTCGGCAACACCCACAAC-3’, the 3’ T3 primer 
(5’-AATTAACCCTCACTAAAGGG-3’), and Pfu DNA polymerase (Stratagene, La Jolla, 
CA). The PCR product was purified and cloned into the NotI site of the pCMVSport-EGFP in 
the appropriate orientation.
The pCMVSport-EGFP and pCMVSport-EGFP-M-CK were used for transient trans­
fections in cultured CK---- 4c6 myoblasts (passage 16). Plasmid DNA was purified on a 
Sephacryl S500 column (Amersham-Pharmacia, Uppsala, Sweden) prior to transfection using 
DAC30 (Eurogentech, Seraing, Belgium) in Optimem (Invitrogen). Cells were transfected at 
70% - 90% confluency at day -1 of differentiation and fixed at day 4 of differentiation using 
2% (w/v) paraformaldehyde. Immunofluorescence assays were performed using polyclonal 
antibody against EGFP (24).
For stable transfection, the puromycin resistance cassette in pPGK-PURO was excised 
by HincII and cloned into the HpaI site of pCMVSport-EGFP-M-CK and pCMVSport-EGFP 
in the opposite orientation of the CK reading frame. The plasmids were linearized using DrdI,
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purified by exclusion chromatography on a small Sephacryl S500 column (Amersham- 
Pharmacia), and tested for EGFP and EGFP-M-CK expression in COS-1 cells. Cultured 4c6 
myoblasts (passage 7) were transfected using DAC-30 (Eurogentech) in Optimem (Invitro­
gen). Prior to transfection, puromycin sensitivity of the recipient cells was checked, revealing 
that 6 ^g/ml puromycin was sufficient to kill non-transfected cells. Positive colonies were not 
cloned individually, but pooled and kept as a population of positive cell lines. EGFP fluores­
cence was checked in culture in living cells at 488 nm and by using FACS analysis.
Visualization of mitochondria and nuclei
Mitochondrial morphology was assessed by adding 500 nM Mitotracker Red CM- 
H2XROS (Molecular Probes, Leiden, The Netherlands) onto 5 day-old living myotubes. Cells 
were washed in PBS and loaded for 30 minutes with Mitotracker Red. After 2 washes in PBS, 
mitochondrial morphology was visualized on a Bio-Rad MRC1000 CLSM (BioRad, Rich­
mond, CA) using excitation with the 488 nm line of the Krypton/Argon laser. Rhodamine-123 
(Molecular Probes) staining of mitochondria in living cells (50-100 ^M) was visualized on an 
Oz CLSM (Noran, Naarden, The Netherlands) real time confocal system to facilitate video­
speed recording of the mitochondrial membrane potential. Emission was recorded using a 
500LP filter after excitation at 488 nm. Mitochondrial membrane potential (and OXPHOS) 
was collapsed by applying 50 nM of the protonophore carbonyl cyanide p-trifluoromethoxy- 
phenylhydrazone (FCCP) to the medium. Nuclei were visualized using propidium iodide 
staining (5-10 minutes, 2 ^g/ml) after methanol fixation on a Nikon Diaphot microscope at 
580 nm.
Electron microscopy
Cultured myotubes at 5 days of differentiation were processed for electron microscopy 
following standard procedures. Briefly, cells were fixed in 2% glutaraldehyde in 0.1 M caco- 
dylate buffer for 60 min, post fixed with 1% osmium in 0.1 M cacodylate buffer for 60 min 
and dehydrated with 50, 70, 80, 96, and 100% ethanol. The cells were then embedded in Epon 
812 on the plastic coverslip. Pieces of Epon containing the cells were broken from the culture 
slides and re-embedded in beem capsules. Ultrathin sections were cut with a diamond knife, 
stained with uranyl-acetate and lead-citrate and examined in a JEOL JEM1010 electron mi­
croscope operating at 60 KV.
RESULTS
Proliferation and differentiation of H-2Kb-tsA58 myoblast lines
Individual muscle satellite cell clones were obtained from cell cultures of dissociated 
cell suspensions of limb muscles of wild type and CK--/-- immorto-mice harboring the H-2Kb- 
tsA58 allele. Cells were kept at permissive temperature, cultured and picked as described in 
Materials and Methods. All cell lines isolated (25 from wild-type; 38 from CK----) exhibited
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E F
Figure 1 Growth and differentiation of wild-type 3b11.
(A, B) and CK""7"" 4c6 myoblasts (C, D) kept at the permissive temperature (33°C) in proliferation me­
dium (A, C; 1 day before switch to differentiation medium) or under non-permissive conditions in dif­
ferentiation medium (day 3 after switch; B, D). Cultures show the typical appearance of multinucleated 
myotubes: Myotubes formed from wild-type 3b11 cells were fixed using methanol (E) and nuclei were 
stained using propidium iodide (F). All panels: Hoffman Contrast 20x.
m yogenic characteristics, as they fused  into m ultinucleated m yotubes w hen  sw itched to non­
perm issive conditions. C ells w ere allow ed to fuse for 5 days, before a subset o f  clones w as  
selected  on the basis o f  fusion  index (defined as the number o f  nuclei in m ultinucleated m yo- 
tubes as a percentage from the total number o f  nuclei in a culture, v isualized  by propidium  
iodide staining). Three w ild-type cell lines 3c7, 3b10 and 3b11, and three CK ---- cell lines 
4c6, 4c9  and 4c1 0  w ere further characterized. Typically, none o f  these cell lines had a normal 
karyotype, w ith  m ost m yoblasts having 4n chrom osom es (G iem sa stain on metaphase 
spreads, data not shown).
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Figure 2 (A) Zymogram isoenzyme separation of wild-type 3b11 (day 1-4-7, left) and CK"-/"" myotubes 
4c6 (day 1-4-7, right) confirms absence of both M-CK and ScCKmit subunits in CK--/-- cell lines. Be­
tween day 4 and day 7, the isoenzyme shift towards MM-CK isoenzymes occurs in wild-type cultures. 
(B) CK activity of the sam e cultures as in (A) (in U/mg protein) is shown from day 1-7 in culture. Val-
ues are mean ± SD of duplicate experiments. Wild-type: open bars, CK""7"": gray bars.
Figure 1 shows wild-type (panel A) and CK”"  (panel C) myoblasts kept at permissive 
conditions, when cells still proliferate. Panel B  (wild-type) and D (CK”" )  show the same cul­
tures after switching to non-permissive conditions. The fusion index of both wild-type and 
CK”"  cultures varied between 40 - 90%, depending on the clone, passage number, and the 
extent of confluency at the time of medium switching (data not shown). The fusion index de­
creased upon prolonged cultivation (passage number > 20 and higher) and therefore, cells 
were used between passage number 3 and 20. Fusion of myoblasts was complete after 3 days, 
and from 3 - 4 days onwards, spontaneous contractile activity (twitching) started in both types
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Figure 3 (A) Confocal pictures of Rhodamine 123 stained mitochondria in intact 3b10 (left) and 3b11 
(right) wild-type myotubes at day 5 of differentiation, showing a reticular network of mitochondria, 
whereas nuclei are excluded. (B) Stained 4c6 (left) and 4c10 (right) CK--/-- myotubes. (C) FCCP appli­
cation on 4c6 myotubes (left panel, see  (B)) destroys mitochondrial membrane potential and induces 
subsequent leak of Rhodamine 123 into the cytosol. (D) Level of Rhodamine 123 fluorescence over 
time, before and after application of FCCP. Right panel in (C) shows CK--/-- myotubes stained with 
Mitotracker Red CM-H2XROS.
of cell lines. A typical example of spontaneous contractions, an indication of formation of 
functional myotubes in vitro, is available as a movie at http://www.ncmls.kun.nl/celbio. We
107
Chapter 5
observed no differences between CK-proficient and -deficient cell lines regarding the occur­
rence and the time of onset of these contractions, which are first indications that both cell 
lines developed to similar differentiation levels in vitro. Most myotubes exhibited well- 
organized cross-striations and sometimes peripheral nuclei. Figures 1E and F  show a metha­
nol-fixed 3b11 myotube at day 3 of differentiation, and propidium iodide staining of the same 
myotube, confirming incorporation of multiple nuclei into the myotube syncytium. At this 
level, we found no overt differences in myotube morphology between wild-type and CK--/-- 
cell lines.
CK isoenzyme analysis
Zymograms of wild-type and CK---- myotubes confirm absence of both M-CK and 
ScCKmit subunits in CK---- cell lines (Fig. 2A). Isoenzymes MM-CK, MB-CK and BB-CK 
increased in expression level between days 1-4 of differentiation in wild-type myotubes 
(compare day 1 and 4). Thereafter, between days 4-7, an isoenzyme transition characterized 
by a decrease in BB-CK and MB-CK, and an increase in muscle-specific MM-CK dimers 
(compare day 4 and 7) occurred, as anticipated. Also in CK---- myotubes, BB-CK enzyme 
levels increased between days 1 and 4, and decreased between days 4 and 7, suggesting nor­
mal regulation of B-CK gene transcription.
In 4c6 CK---- myotubes, after 2 days, biochemically determined cumulative total CK 
activity (all isoenzymes) was 33% of 3b11 wild-type activity (0.19 U in wild-type vs. 0.06 U 
in CK--/--), and after 7 days of differentiation 16% (0.20 U in wild-type vs. 0.03 U in CK--/--, 
Fig. 2B). Other cell lines (4c10, 3b10) gave identical results. It is noteworthy that the total CK 
activity, expressed as activity units (U)/mg protein, in wild-type myotubes in culture was sig­
nificantly lower than in wild-type muscles in vivo. Typically, activity was 0.2 U/mg protein in 
cellular extracts, whereas in extracts of fast-twitch gastrocnemius and intermediate diaphragm 
muscle normal CK-activities were 23 and 5 U/mg protein, respectively.
Ultrastructural characteristics of wild-type and CK"7" myotubes
To determine whether M-CK and ScCKmit absence in myotubes had any ultrastruc- 
tural consequences and would affect mitochondrial volume and activity, like in CK--/-- mus­
cles in vivo (13), we studied mitochondrial morphology in the cells at the light microscopical 
and EM level. In both wild-type and CK---- myotubes, we noticed an elaborate reticular mito­
chondrial network using the mitochondrial membrane potential-sensitive dye Rhodamine 123 
(Fig. 3A, wild-type; and 3B, CK--/--). Also staining with Mitotracker-Red (Fig. 3C, right panel, 
CK--/-- ; wild-type not shown) revealed widespread development of a mitochondrial network in
Figure 4 EM photographs confirm the developm ent of the contractile apparatus in 3b11 wild­
type (facing page).
Wild-type 3b11 (A, C) and 4c6 CK""7" myotubes (B, D) at day 4 of differentiation. Mitochondria are 
present between the developing myofibrils. Mitochondrial morphology is comparable in wild-type and 
CK--/-- myotubes (see also Table 1). Scale bar equals 1 |j.m.
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both types o f  cell lines. The reticular m itochondrial structures clo sely  aligned the contractile 
apparatus that assem bled in the m yotubes (see  below ), w ith  similar arrangement in w ild-type  
and CK---- cells. Importantly, the fluorescence intensity o f  the m itochondrial membrane po­
tential-sensitive dye R hodam ine 123 also show ed c lose  resem blance betw een  both cell types. 
Rhodam ine 123 fluorescence did not change during spontaneous contractions in both cell 
types (see  http://w w w .ncm ls.kun.nl/celbio  for m ovie files).
In order to investigate whether m itochondria show ed a normal coupling status and 
w ere capable o f  providing the energy for sustaining spontaneous contractile activity, w e  
applied the protonophore FCCP to the m yotubes. Application o f  50 nM  FCCP uncoupled the 
m itochondria and fu lly  destroyed the Rhodam ine 123 fluorescence in both w ild-type (not 
show n) and CK---- m yotubes (com pare Fig. 3B, left panel, and Fig. 3C, left panel). 
U ncoupling led to dye leakage into the cytosol, indicating that both w ild-type and CK ---- 
m yotubes show ed a normal coupling status in culture. Furthermore, spontaneous contractions 
ceased im m ediately after application o f  FCCP, show ing that the presence o f  actively respiring  
m itochondria w as necessary to m eet the energy requirem ents for contractile activity. From  
these data, w e  conclude that CK proficiency or deficiency  has no effect on functional integrity  
and membrane potential o f  m itochondria under normal culture conditions. A s CK pro- or 
d eficiency is also not coupled to regulation o f  the volum e and cytoso lic  arrangement o f  
mitochondria (unlike in the in vivo situation: see further), w e  surmise that the mitochondrial 
network can easily  sustain energy production for housekeeping functions and spontaneous 
contractile activity at this stage o f  developm ent o f  our cells in culture.
N ext, to investigate the im portance o f  g ly co ly sis  and a low er energy threshold in the 
cultured m yotubes, w e  investigated whether replacem ent o f  g lucose by 2 -d eoxy-g lu cose had 
any effect on m yotube growth. M yoblasts differentiated in culture m edium  w ithout g lucose  
show ed severely impaired differentiation and growth characteristics (data not shown), sug­
gesting that normal coupling betw een  g ly co ly sis  and T C A -cycle activity is essential in both  
w ild-type and mutant cells.
Finally, to study the possib ility  that CK d eficiency  w ould  affect m itochondrial shape 
instead o f  arrangement and/or subcellular location, w e  exam ined m itochondrial ultrastructural 
appearance. M orphom etric analysis o f  electronm icrographs o f  w ild-type and C K -deficient 
cells revealed that m itochondrial cross-sectional areas w ere 0.21 ±  0 .02  |im  (m ean ±  SEM, 
n  =  95) and 0.18 ±  0.01 |im  (n  =  142), respectively. Thus, m itochondrial vo lum es w ere com ­
parable in both cell types. Again, this suggests that the effect o f  C K -deficiency on the in ­
crease in m itochondrial vo lum e seen in  vivo  (12, 13) m ay require additional signals w hich  are 
either not available or not activated in cell lines in  vitro , because they are intrinsically late 
events.
Additional EM  analyses w ere performed to exam ine other aspects o f  cellular ultra­
structure. This confirm ed that contractile proteins did assem ble into sarcom eres w ith  an ap­
parently normal skeletal m uscle-like banding pattern and an appearance w hich  w as absolutely
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Table 1 CK isoenzyme expression in myogenic cultures in standard medium (DMEM + 5% horse s e ­
rum), and standard medium supplemented with 20 mM creatine.
Isoenzym e % Isoenzym e expression  
- Cr + Cr
Wild-type MM: 15 3 CO *
(3b11, 3b10) MB: 79 69 *
BB: 6 1 *
CK--/-- BB: 100 100
(4c6, 4c10)
* p < 0.05 -Cr vs. +Cr
indistinguishable betw een  w ild-type (Fig. 4, panels A and C) and C K "" ce lls  (Fig. 4, panels B 
and D).
M yotubes in vitro norm ally do not show  the ultrastructural terminal differentiation  
characteristics observed in vivo, such as a T-tubule system  and triads. H ow ever, excitation- 
contraction coupling is present in cultured m yotubes, and it invo lves a premature functional
coupling betw een  the D H PR  and the R yR  on the SR membrane. W e found sm ooth ER
2+structures around the develop ing m yofibrils. In our detailed studies on Ca hom eostasis in 
the CK proficient and deficient cell lines (25) w e  show ed that ECC is indeed responsible for 
the contraction profiles, as the SER CA  blocker thapsigargin and the R yR  blocker ryanodine
com pletely  blocked the spontaneous and electrically  induced contractions. A ssessm ent o f
2+amplitude and frequency o f  Ca transients show ed no overt differences betw een w ild-type
/  /  2+ and CK-- -- cells, but CK-- -- m yotubes show ed a slow er Ca rem oval rate and impaired SR
refill after spontaneous and electrically induced depolarizations.
Effects of supplementation of 20 mM creatine
Creatine (Cr) is needed as substrate for the CK reaction, how ever, m uscle ce lls do not 
synthesize Cr (26) and therefore can only rely on the uptake from circulation in vivo. In vitro, 
uptake m ust occur from the culture m edium , w here Cr concentration is at approxim ately 2 
and results from the addition o f  horse serum (w hich  contains approxim ately 40  ^M  
creatine (27)).
B ased  on the study o f  Fry et al. (27), w h o reported a 20-fo ld  difference in intracellular 
[Cr] w hen extracellular [Cr] w as increased to 7 .4  mM , w e  expected  that changes in culture 
conditions w ou ld  affect substrate availability. In turn, this could possib ly  m odify  effects o f  
CK proficiency or d eficiency  in our cell lines. Indeed, for w ild-type cultures in the presence 
o f  high [Cr] w e  found both increased m yotube size (com pare Fig. 5A, B) and increased  
tendency for m yotube formation, as w as clear from a higher fusion  index and the occurrence 
o f  less round, non-fused cells. D ifferentiation o f  these m yotubes w as also m ore com plete, as 
demonstrated by the relative increase in the level o f  the M M -C K  isoen zym e (Table 1), at the 
expense o f  B B -C K  and B M -C K  expression. Surprisingly, sim ilar effects w ere seen in CK----
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- 20 mM Cr + 20 mM Cr
A B
C D
Figure 5 Effect of creatine supplem entation on cultures of wild-type.
(A, B) and CK""7"" (C, D) myotubes. Supplementation of creatine during the differentiation process 
increases viability and differentiation in both cell lines (compare A,C (0 mM Cr) to B, D (20 mM Cr).
myotubes. Here, CK isoenzyme distribution could not be used as a reporter, but other 
characteristics like improved fusion index, increased size of the myotubes and a significantly 
decreased presence of round, non-fused cells in culture were identical to the situation in wild­
type cells. Furthermore, expression levels of SERCA1 and RyR, proteins involved in EC-
2+coupling and Ca -homeostasis, were increased in parallel in cultures of wild-type and CK 
deficient myotubes supplemented with Cr. It is of note that Cr supplementation did not have 
any noticeable effect on the size or shape-distribution of mitochondria (measured by EM; data 
not shown) in either of the two types of cell lines.
Expression of an EGFP-M-CK fusion construct in the 4c6 CK""7"" cell line
In order to study whether the maturation of the elaborate cellular environment in 
which the MM-CK normally resides (e.g. in the cytosol, with preferential localization at the 
cytosolic M- and I-bands, (28, 29)) depends on the continuous presence of M-CK, we
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examined the subcellular distribution of MM-CK in cultured C K "" myotubes after functional 
complementation. To this end, CK---- myotubes were transfected with an expression vector 
which expressed an enzymatically active EGFP-tagged version of the M-CK polypeptide. We 
used N-terminal tagging to avoid disruption of the mRNA’s 3’UTR, which may be involved 
in subcellular localization of CK mRNA and therefore in routing and localization of the 
cytosolic CK isoenzymes (30). Prior to use in myoblasts/myotubes, expression of the EGFP 
tagged M-CK pCMVsport vector was tested in COS-1 cells and compared to the level of 
production of EGFP or native M-CK from control pCMVsport vector plasmids. Zymogram 
isoenzyme analysis demonstrated that pure M-CK dimers and tagged EGFP-M-CK dimers 
were produced at identical levels, showed identical enzymatic activity, and had the anticipated 
molecular weight (43 and 69 kDa, respectively; Fig. 6A). Spectrophotometric enzyme activity 
analysis and Western blot analysis confirmed these results (not shown).
Next, we used the pCMVsport EGFP-M-CK expression plasmid to transiently 
transfect 4c6 CK---- myoblasts and follow protein distribution. Unfortunately, after myotube 
formation (day 4-5) only a very small percentage of the fused cells (< 0.1%) showed positive 
EGFP-M-CK staining, even after enhancement with immunofluorescence staining with anti- 
EGFP antiserum (Fig. 6B). Since the generation of stably transfected myoblasts also failed, 
we decided to constitutively express EGFP-M-CK, and keep positive cells as a pooled 
collection of clones. In this manner, we avoided potential loss of fusion competence by clonal 
selection, which would occur if our myoblast cell lines were composed of a mixture of 
founder- and fusion competent cells (31). Indeed, this strategy worked and we obtained a 
collection of proliferating complemented CK-deficient 4c6 myoblasts (passage 7; 40 pooled 
clones) after transfection with pCMVsport EGFP-M-CK (puro). These cells were still capable 
of forming multinucleated myotubes, although a significant fraction of cells (between 80 - 
90%) still never engaged in this process. To facilitate fluorescence microscopical analysis, we 
enriched for the subset of myoblasts with the highest EGFP-M-CK expression (12.3% of cells 
positive in the original pool) by FACS sorting. Positive cells were then cultured for an 
additional 2 passages before they were mixed in a 70% : 30% ratio (EGFP-M-CK positive to 
EGFP-M-CK negative myoblasts) and allowed to differentiate and fuse. This approach was 
chosen because the population of 100% EGFP-M-CK positive cells showed severely impaired 
fusion characteristics, presumably due to the selection and pooling procedure. Now, in a small 
number of myotubes, EGFP-M-CK fluorescence was detectable in living myotubes (Fig. 6C) 
and showed a typical cross-striated pattern. Appearance of this banding pattern suggested that 
M-CK is preferentially captured in preexisting structures, occurring at specific locations in the 
highly organized acto-myosin sliding machinery of individual sarcomers. From measurement 
of the sarcomere length (which was 2.4 ± 0.23 ^m [measured from n = 10 sarcomeres in EM 
pictures, see Fig. 4]) and the distance between cross-striations in Figure 6C (2.69 ± 0.27 ^m, 
n = 11), we conclude that in our cells the banding involves the M-band only and not the I- 
band. This suggests that the supra-molecular arrangement at the M-band that serves as a 
platform for direct binding of M-CK (as established by Wallimann et al. (28)) is already fully
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functional. In contrast, the structural and functional characteristics necessary for (indirect) 
binding to the I-band, which are mediated by glycolytic enzymes (29), are maybe not formed 
under in vitro differentiation conditions. Other explanations are that we may lack the 
sensitivity for showing the presence of M-CK at the I-band (also Western blot assays failed; 
see legend Fig. 6B), or that its binding is loose and does not survive our fixation and 
incubation protocol. Furthermore, we show here that EGFP-M-CK distributes equally 
throughout the entire myotube, and that expression is not restricted to nuclear domains, i.e. 
areas around positive nuclei.
DISCUSSION
We successfully generated H-2Kb-tsA58 immortalized cell lines from CK-deficient 
animals for in vitro studies at the cellular level. Like wild-type myoblasts, CK-deficient 
myoblasts grew normally under permissive conditions. More importantly, they also retained 
the normal ability for terminal differentiation when culture conditions were switched to non­
permissive conditions. This treatment drives cells into the fusion process and into the G0 
phase of the cell cycle, a phase when expression of M-CK and ScCKmit isoenzymes normally 
commences. From comparing the terminal differentiation characteristics of our wild-type and 
CK-deficient myoblasts to those of other well-described muscle cell lines, such as tsA58- 
derived (4) and C2C12 (1) cells, we also conclude that they exhibit the ‘normal’ in vitro dif­
ferentiation properties, including spontaneous twitching. At the light microscopical level, 
clear cross-striation of the myotubes became visible after 4 days. At the EM level, our cell 
lines showed developing sarcomers of approximately 2 ^m in length. CKs are expressed at 
relatively low levels compared to the in vivo situation with a relatively high percentage of 
MB-CK, indicative of a rather immature differentiation status in vitro. Although myotubes 
have not developed a T-tubular system and triad junctions between the SR and the T-tubular
system are not present, a premature functional ECC is present in the myotubes, with compa-
2+rable frequencies of Ca signals (25).
Figure 6 Expression of N-terminally EGFP-tagged M-CK fusion  proteins in m yotubes.
(A) Zymogram analysis of CK products produced in untransfected COS1 cells (lane UTF) or cells 
transfected with pCMV-EGFP, pCMV-M-CK or pCMV-EGFP-M-CK vector plasmids. Enzymatically 
active dimeric MM-CK protein appears at the expected position, whereas active EGFP-M-CK fusion 
protein is capable of dimerizing into functional homo- and heterodimers that have a distinct migration 
behavior. (B) Indirect immunofluorescence using anti-EGFP antibodies at day 4 of differentiation. 
CK--/-- 4c6 myoblasts were transiently transfected at day -1 of differentiation using a pCMV-EGFP-M- 
CK construct. A skeletal muscle-like banding pattern is apparent in both transiently and stably trans­
fected cell lines, but protein expression could not be confirmed on Western blot due to lack of sensitiv­
ity. (C) EGFP fluorescence signal in rare intact 4c6 CK--/-- myotubes transfected with a pCMV-EGFP- 
M-CK (puro) construct at day 5 of differentiation (see text). From the scale bar included (10 |j.m), we 
determined the distance between the bands to equal 2.7 |j.m.
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Differentiation of C2C12 myoblasts into myotubes is accompanied by mitochondrial 
biogenesis, with increases in mtDNA copy number, marker enzyme activity and mRNA levels 
of mitochondrial proteins (32, 33). Concomitantly, lactate production decreases and oxygen 
consumption increases, indicating greater reliance on mitochondrial pathways, coupled with a 
decrease in glycolytic rate. Mitochondrial ATP generation via OXPHOS accounts for 60% of 
the energy production in differentiated myotubes (33). Also in our myotubes, glycolysis is 
important in the differentiation process and in growth. Contractions in differentiated myo- 
tubes are dependent on functional mitochondria, since disruption of the mitochondrial mem­
brane potential stops contractions. In our cells, we found proliferation of an elaborate reticular 
network aligning contractile proteins. The mitochondria appeared normal at the EM level and 
no ultrastructural differences were found between CK--/-- and wild-type mitochondria. The 
major adaptational responses observed in CK---- mice in vivo, namely proliferation of mito­
chondria (twofold increase in volume and activity), was not recognizable in cultured myo- 
tubes in vitro, which indicates that proliferation of mitochondria is an in vivo organismal 
event. The lack of hyperproliferation of mitochondria in CK--/-- muscles in vitro indicates that 
hyperproliferation in vivo could be a result of activity related alterations in cellular signaling 
cascades affecting mitochondrial size and activity, similarly to mitochondrial proliferation 
evoked by chronic muscle stimulation (34). The relatively high expression of residual BB- 
CK, capable of regenerating ATP, could be an alternative explanation for the lack of hyper­
proliferation, albeit that BB-CK does not target to similar subcellular locations as MM-CK 
does. Furthermore, the amount of cellular stress (i.e. the rate of ATP turnover) in cultured 
myotubes possibly does not reach the threshold for induction of compensatory mechanisms 
such as mitochondrial proliferation. The fact that the cultured myotubes are highly oxidative 
(33) could mimic the defect in CK, since the ATP generating capacity of mitochondria could 
be sufficient to buffer cellular ATP levels. In this respect, cultured myotubes could represent 
slow muscle fibers, which show less elaborate upregulation of mitochondrial genes and pro­
teins in vivo (15, 16).
It is important to note that specific stimulation of muscles as occurs under 
physiological conditions is absent in cultures, although in vitro myotubes are spontaneously 
active. Signals involved in initiating proliferation of mitochondria in vivo arise from
combinations of accelerations in ATP turnover, imbalances between mitochondrial ATP
2+synthesis and cellular ATP demand, and Ca fluxes (34). In an accompanying study on the
present cell lines, we showed that patterns of spontaneous contractile activity, and the
2+ --/-­underlying Ca signals, are identical for wild-type and CK-- -- myotubes, except that SERCA-
2+ --/-­mediated sequestration of Ca and SR refilling are impaired in CK-- -- tubes (25).
Based on the results of Pulido et al. (35), we anticipated that supplementation of 20 
mM creatine (Cr) to the differentiation medium would increase the differentiation rate and 
viability of the wild-type cultures. We added Cr in the differentiation medium for two rea­
sons. First, based on previous studies (27), we realized that the total cellular Cr concentration 
in cultured myotubes could be much lower than the Cr concentration in muscles in vivo (26).
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By application of extracellular Cr, this concentration can be elevated approximately 20-fold 
(27). Functional aspects of the CK/PCr system should be studied in a model system were the 
substrate availability for enzymatic reactions is not potentially limited. Secondly, application 
of 20 mM Cr has been reported to improve myotube differentiation and viability in C57Bl/10 
primary myotubes (35). We showed this in our cell system for wild-type, but interestingly 
also for CK---- myotubes. In CK-deficient cell lines, Cr will be phosphorylated by BB-CK, 
most likely also explaining why PCr is still present in CK deficient adult skeletal muscle, al­
though it is functionally inert (36).
Finally, we expressed the EGFP-M-CK fusion construct to study the subcellular local­
ization of MM-CK in cultured myotubes. Transient and stable transfections of myogenic cells 
were complicated by the fact that the transfected cells still needed to differentiate into multi­
nucleated myotubes. This differentiation process is accompanied by a drastic change in gene 
expression profile, and involves large-scale chromatin remodeling. Under our conditions, 
transfected immortalized cells lost part of their capacity to differentiate, which rendered the 
transfection experiments highly inefficient. However, on the basis of the distance between the 
bands, which equals approximately 2 ^m, one sarcomere length, we were able to show prefer­
ential localization of EGFP-M-CK at myofibrillar structures, specifically at the M-bands, 
similar to the situation in vivo. When substantial amounts of the fusion construct would local­
ize at the I-band, or both at the M- and I-bands, this distance would be 1 ^m (i.e. half the 
length of the sarcomere) or less. Wallimann et al. (28, 29) have shown that M-CK is localized 
to the muscular M-band, and indirectly also to the I-band, via interactions with glycolytic en­
zymes. Possibly, complex formation between glycolytic enzymes and the MM-CK has not 
taken place yet in cultured myotubes. Alternatively, the EGFP moiety could be responsible 
for steric hindrance in the complex formation. Since there is still free MM-CK in the cytosol, 
we do not believe that MM-CK is only visible at the M-band simply because the M-band sites 
have a higher avidity for binding. We anticipated that expression of the protein could be re­
stricted to the nuclear domains in close vicinity of the EGFP-M-CK expressing nucleus in the 
myotube. However, MM-CK distributes throughout the entire myotube, showing that the pro­
tein diffuses through the entire cytosol.
Functional expression of M-CK and ScCKmit in CK---- myotubes is important, be­
cause studies on rescued cell lines can reveal insight into CK function at the (sub)cellular 
level in a system in which possible confounding effects caused by the heterogenetic back­
ground of knockout mice are absent. Future experiments should concentrate at finding an al­
ternative and more efficient transfection methods for myoblasts and myotubes, possibly via 
adenoviral or retroviral vectors that leave the differentiation capacity of myobasts intact. In 
addition, we should also investigate the putative existence of two separate subpopulations of 
myoblasts as reported in Drosophila, founder cells and fusion-competent cells (31), which 
could complicate differentiation experiments. The fact that clonal selection of transfected 
cells resulted in an inability to differentiate, and that mixed populations showed better dif­
ferentiation characteristics, may be indicative for the existence of similar populations in our
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cell lines.
The study of the CK/PCr system in vivo in mouse knockout models revealed changes 
in muscle performance, that reflect a combination of gene deficiency and functional adapta­
tions, rather than effects of genetic ablation alone (18). By additional studies on the CK/PCr
system in vitro, part of this limitation can be overcome, since we have now generated a sys-
2+tem that we can use for single-cell studies on Ca homeostasis. Ultimately, the combination 
of in vivo studies on intact muscles and in vitro studies on cultured cells will give us insight 
into the physiological function of the CK/PCr system.
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Creatine kinase and SERCA function
ABSTRACT
M uscle function depends on an adequate A TP supply to sustain the energy
2+consum ption associated w ith Ca cycling  and acto-m yosin  sliding during contraction. In this 
regulation o f  energy hom eostasis, the creatine kinase (CK ) circuit for high energy phosphoryl
transfer betw een  ATP and phosphocreatine (PCr) plays an important role. W e earlier
2+established a functional connection betw een  the activity o f  the CK system  and Ca
hom eostasis during depolarization and contractile activity o f  m uscle. H ere, w e  show  how  CK
2+activity is coupled to the kinetics o f  spontaneous and electrically induced Ca2+ transients in
2+the sarcoplasm  o f  m yotubes. U sin g  the U V  ratiometric Ca probe Indo-1 and videorate
confocal m icroscopy in C K -proficient and -deficient cultured cells, w e  found that
2+spontaneous, and electrically induced transients w ere dependent on ryanodine-sensitive Ca
2+release channels, sarcoplasm ic/endoplasm ic reticulum Ca2+-AT Pase pumps, extracellular
calcium  and functional m itochondria in both cell types. H ow ever, at increasing sarcoplasm ic
2+  2+Ca load (induced by electrical stim ulations at 0 .1, 1 and 10 H z), the Ca rem oval rate and
2+the amount o f  Ca released per transient w ere gradually reduced in C K -deficient (but not in
w ild-type) m yotubes. W e conclude that the CK/PCr circuit is essential for efficient delivery o f
2+ATP to the sarcoplasm ic/endoplasm ic reticulum Ca2+-A T Pase pum ps and thereby directly
2+influences sarcoplasm ic reticulum refilling and the kinetics o f  the sarcoplasm ic Ca signals.
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INTRODUCTION
2+Ionic Ca regulates numerous cellular processes such as contraction, synaptic trans-
2+mission, gene expression, metabolism and cell death (1). In skeletal muscle, Ca is a key
regulator of contractile activity and glycolytic (activation of phosphorylase) and mitochon-
2+drial (activation of Ca -sensitive dehydrogenases) ATP production (2, 3). This is especially
important during cycles of repetitive muscle contractions, when myosin ATPase activity is
2+high and large Ca2+ loads have to be actively extruded from the cytosol by the sarcoplas-
2+  2+ mic/endoplasmic reticulum Ca -ATPase (SERCA) and/or plasma membrane Ca ATPase.
To achieve robust buffering of cellular ATP levels and to optimize its transport
between the sites of production and consumption by ATPases, excitable tissues such as
muscle and brain utilize high energy phosphoryl (~P) transfer and ATP regenerating
pathways, such as the creatine kinase (CK; EC 2.7.3.2) and adenylate kinase (AK; EC 2.7.4.3)
systems (4-6). In adult muscle, two CK subunits are expressed: cytosolic M-CK, which is
active as a muscle-muscle isoform dimer, and ScCKmit, which is present as inactive
homodimeric and active homo-octameric molecules in the mitochondrial intermembrane
space. In newborn or embryonic muscle, expression of also BB- or BM-CK is seen, but
expression of these proteins gradually decreases when the muscle matures. The presence of
CK at the sarcomeric M- and I-bands and at the sarcoplasmic reticulum (SR) membrane is
important for regenerating adequate amounts of ATP for the myosin ATPase (contraction)
2+and the SERCA pump (Ca homeostasis) (7, 8). CK in mitochondrial protein complexes, 
together with the voltage-dependent anion channel and the adenine nucleotide transporter, is 
important in regulating intramitochondrial ATP/ADP ratios (9). In previous studies, we 
observed that cellular calcium homeostasis in primary cultures of CK-deficient myotubes 
(referred to as CK----; M-CK-- x ScCKmit--) is abnormal. It has been speculated that these 
alterations could be responsible for the anomalous contractile properties of these muscles in 
vivo (10). Apart from the changes in contractile properties, we also observed extensive
remodeling of muscle ultrastructure and a rewiring of fluxes through metabolic pathways as a
2+response to gene deficiency (10-15). Given the effects of local [Ca ] on metabolic activity (3, 
16-18) and its importance as a general signaling molecule in the highly plastic muscle cell
(19), the ultrastructural and physiological adaptation in our CK-deficient mice may (at least in
2+part) result from changes in Ca signaling (1, 19, 20).
Indeed, various studies point to a direct involvement of CK in optimization of SERCA
function and calcium homeostasis in skeletal muscle (8, 21-23), suggesting a direct link be-
2+tween regulation of appropriate (local) ATP/ADP ratios and Ca handling. To obtain a better
2+understanding of this connection and its coupling to different Ca2+ signaling pathways, we
2+need a more detailed picture of amplitude and frequency behavior of Ca2+ transients in CK-
2+deficient muscles. Here, we studied mechanistic and kinetic aspects of Ca homeostasis in 
immortalized myotubes using the UV ratiometric probe Indo-1 and video-rate confocal mi­
croscopy. CK-proficient and -deficient immortalized cell lines were derived from wild-type
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and CK---- mice crossed to H-2Kb-tsA58 transgenic mice (24, 25) and differentiated in vitro.
2+By analysis of spontaneous and electrically induced sarcoplasmic Ca2+ transients we found
that in contrast to wild-type tubes, CK-deficient myotubes displayed a gradual reduction of
2+the Ca removal rate and SR refilling with increasing stimulation intensity. We conclude that
the CK/PCr circuit is essential for an efficient SERCA-mediated refilling of the SR and there-
2+fore in the shaping of sarcoplasmic Ca signals.
MATERIALS AND METHODS
Culture of immortalized cell lines
The generation of immortalized cell lines, the growth of myotubes, and culture 
conditions were described by Morgan et al. (26). We derived immortalized cell lines from 
wild-type and CK--/-- mice (25). Myoblasts were cultured at low density at the permissive 
temperature (33 °C, 10% CO2) in Dulbecco’s modified Eagle’s medium (Invitrogen, Breda, 
The Netherlands) supplemented with 20% fetal calf serum (Integro, Zaandam, The 
Netherlands), 2% chicken embryo extract (Invitrogen) and 20 units/ml recombinant murine 
interferon-y (Invitrogen). For differentiation at nonpermissive temperature (37°C, 5% CO2), 
cells were cultured at high density on Matrigel (Becton Dickinson, Heidelberg, Germany)- 
coated plastic Aclar coverslips (Allied-Signal, Pottsville, PA) in Dulbecco’s modified Eagle’s 
medium supplemented with 5% horse serum (Invitrogen) in the presence of 20 mM creatine 
(Sigma, Zwijndrecht, The Netherlands), which improves myoblast fusion characteristics in 
both wild-type and CK-deficient cell lines (25).
Confocal calcium measurements
Myotubes (at 5 days of differentiation) were washed with physiological salt solution
(125 mM NaCl, 10 mM NaHCO3, 1 mM NaH2PO4, 5 mM KCl, 2 mM MgSO4, 1.8 mM
2+CaCl2, 10 mM HEPES and 10 mM glucose, pH 7.4). For Ca recordings, myotubes were ex­
posed for 30 min at 37°C to 10 ^M  Indo-1/AM in the presence of 0.025% (w/v) Pluronic
F127 (Molecular Probes, Inc., Leiden, The Netherlands) in physiological salt solution, washed
2+twice, and allowed to equilibrate for 15 min. Use of the ratiometric Ca probe Indo-1 in myo-
tubes has been described earlier (27, 28), and largely circumvents problems associated with
2+non-ratiometric Ca2+ probes (like dye compartmentalization, leakage and photobleaching). 
After an additional wash to remove residual traces of Indo-1/AM, coverslips were put in a 
Leiden chamber (volume of 700 |il) (29) and placed on a Nikon Diaphot inverted microscope 
attached to an OZ confocal laser scanning microscope (Noran Instruments, Naarden, The 
Netherlands). Indo-1 was excited at 351 nm using a modified high power Argon ion laser 
(Coherent Enterprise, Santa Clara, CA). Indo-1 emission light was collected using a Nikon 
x40 water immersion objective (NA1.2) with high UV transmission, separated by a 455 
DCLP dichroic mirror and quantified at 405 ± 45 nm and 485 ± 45 nm using photomultipliers. 
To increase signal-to-noise ratio, no confocal slit was used. This maximized the confocal de­
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tection volum e (section  thickness ~ 5 -8  ^m ) (30) and enabled running the laser at m inim al 
leve ls  (output 15 m illiw atts, equivalent to 28 m icrowatts at the back o f  the objective lens).
Basal ratio signals w ere stable, and no U V -induced  deterioration in cell viability  w as  
observed during experim ents. In long  experim ents (>5 m in), the U V  laser and recordings w ere  
stopped betw een m easurem ents to prevent U V  damage. The OZ hardware w as controlled by  
Intervision V ersion  1.5 acquisition software running under IRIX 6.5 on an Indy workstation  
(S ilicon  Graphics, Inc., M ountain V iew , C A ) equipped w ith 256  Mb internal m em ory. B efore  
recording im ages, a custom  m em ory m anagem ent script w as used to ensure optimal tim ing  
efficiency. W hen im age storage w as not required, raw Indo-1 ratio signals w ere v isualized  in 
real-tim e using a softw are plotting application and su ccessive ly  stored in A SC II format. 
E m ission  signals w ere separately background-corrected before calculating ratio (405 /485) 
signals.
Superfusion and electrical stimulation
Inhibitors (S igm a) w ere either directly d issolved  in physiological salt solution or di­
luted from a concentrated stock solution in M e2SO and used at the concentrations indicated
(final M e2SO concentrations never exceeded  0.1%  (v/v)). Chem ical depolarization w as per-
2+form ed using physiological salt solution containing 125 m M  K Cl. To generate Ca -free m e­
dium, CaCl2 w as omitted, and 500 ^M  E G T A  w as added. A ll solutions w ere administered to  
the Leiden chamber using a custom -m ade superfusion setup (1.5 m l/m in), except for thapsi- 
gargin (pipetted). Temperature w as held constant by a T C -102 temperature controller (M edi­
cal System s Corp., G reenvale, N Y ). For electrical stimulation, tw o platinum electrodes w ere  
fixed  to both sides o f  the chamber and connected to a Grass SD 9 stimulator. M yotubes w ere  
stimulated (16 V  over 10 m s) at frequencies indicated below .
Data analysis
For quantitative analysis, ratio signals w ere norm alized relative to the basal resting  
Indo-1 ratio. W e used arbitrary units for these norm alized Indo-1 ratios (30, 31). O ff-line  
analysis o f  num erical data w as performed w ith Origin Pro 6.1 (M icrocal, Northam pton, M A ). 
Im ages w ere analyzed using Noran 2D  softw are (Noran Instruments) and Im age Pro Plus 4.1 
(M edia Cybernetics, Silver Spring, M D ). N um erical data obtained from m ultiple recordings
2+
Figure 1 Spontaneous [Ca ]s transients in wild-type m ouse m yotubes (facing page).
Myotubes were loaded with Indo-1 and imaged at 30 Hz with a UV confocal laser-scanning micro­
scope (A) Three successive pictures of a propagating [Ca2+]s wave associated with a single sponta­
neous Ca2+ transient (for video, see  www.ncmls.kun.nl/celbio). The wave traversed the full length of 
the myotube (~100 ^m) within 100 ms (see ‘Results’ for details). (B) Normalized Indo-1 signal aver­
aged across the total area of the myotube. The rising phase consisted of three data points, which 
correspond to the three images in (A). Removal of Ca2+ was adequately described by a 
monoexponential function. (C) Patterns of continuous firing (upper panel) and bursting (lower panel) 
(both also observed in CK--/-- [knockout] tubes). (D) Localization of sarcoplasmic ROIs used in (E). (E) 
The decay phase of the Ca2+ transient is identical for different sarcoplasmic ROIs (colors correspond 
with ROIs in panel D).
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are expressed as average ± S.E. unless stated otherwise. Statistical significance (tested using a 
t test) is expressed as p  < 0.05, p  < 0.01, or p  < 0.001. During curve fitting, we used Pear­
son’s correlation coefficient R (or product moment correlation coefficient) as an estimate of 
the population correlation coefficient. Values of -1  or +1 indicate a perfect linear relationship 
between the two variables. The coefficient of determination (R2) was used to express the pro­
portion of the total variation that is explained by the regression. In analogy to R, if  R2 = ±1, 
the total variation in the /-variable can be explained in terms of the regression curve.
RESULTS
2+Spontaneous contractions and [Ca ]S transients in myotubes
After 3-5 days of differentiation, both wild-type and CK-deficient (CK----) myotubes 
displayed periods of spontaneous contractions in culture, separated by silent periods. Video­
rate (30 Hz) confocal microscopy of myotubes loaded with Indo-1 revealed, as anticipated,
2+that these contractions were paralleled by transient rises of the sarcoplasmic Ca concentra-
2+ 2+ tion ([Ca ]S transients). At the subcellular level, these [Ca ]Stransients appeared as unidirec­
tional waves with a sharp front. Figure 1A displays a typical example of such a wave recorded 
from a wild-type myotube (but this figure is representative of both cell types). Three consecu­
tive Indo-1 ratio images (each 479 x 512 pixels, corresponding to 90.3 x 96.6 |im) taken from 
a 5-s recording are shown. For optimal visualization, the images taken at both Indo-1 emis­
sion wavelengths were first de-blurred using deconvolution software (Noran 2D analysis) and 
then background-corrected before ratios were calculated. Next, the resulting Indo-1 ratio sig­
nal was height-coded after color conversion using a linear look-up table. Analysis of the fig-
2+ure reveals that the [Ca ]S wave progresses about 550 pixels (~ 100 |im) within 100 ms,
roughly equaling a wave speed of 1000 |im/s (experiment performed at room temperature).
2+The change in average [Ca ]Swas investigated by analyzing a region of interest (ROI)
2+that encompassed the entire myotube. [Ca ]S reached its maximum within 99 ms (three data 
points obtained from the images in Fig. 1A), after which it rapidly declined to basal levels 
(Fig. 1B). This [Ca2+]S decline was adequately described (in Fig. 1B, R2 was 0.997) by a 
monoexponential function (Yt = Y0 + Ce-t/p), suggesting the involvement of one major re­
moval process described by a single rate constant ¡1 (31). We used this rate constant, which is
2+ 2+ inversely proportional to the rate of [Ca ]S decline, as a quantitative readout of the Ca re-
2+moval kinetics. For fitting the [Ca ]S decline, we applied the robust Levenberg-Marquard al­
gorithm (32). In the trace shown, the decay constant equaled 0.220 s. Because the residence
time at maximal amplitude was only 33 ms (i.e. one data point), no attempt was made to
2+quantify the amplitude of the [Ca ]S transients. When recording full resolution images at 30 
Hz, the size of the frame store memory limited total recording time to 5 s. To allow longer 
recordings, we disabled image collection, and only stored numerical data for different sar­
coplasmic ROIs (Fig. 1D). It was found that different sarcoplasmic ROIs within a single myo
2+tube exhibited identical [Ca ]Skinetics (Fig. 1E). This finding enabled random comparison of
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2+Figure 2 Role of SERCAs and extracellular Ca during sp ontaneous transients in wild-type 
m yotubes.
(A) Application of the SERCA blocker thapsigargin (Ts) instantaneously reduced the Ca2+S removal 
rate (panel B) and ultimately abolished spontaneous [Ca2+]S transients. (B) Shown is a magnification 
of a pre-thapsigargin (I in panel A) and post-thapsigagin (II) burst of [Ca2+]S transients. (C) Thapsigar­
gin treatment increased the interval between transients and reduced the Ca2+S removal rate (as re­
flected by the increase in exponential decay constant p; s e e  ‘Results’ for details). (D) Spontaneous 
[Ca2+]S transients were observed in the presence of 1.8 mM extracellular Ca2+ (labeled 1.8 Ca2+). Re­
moval of extracellular Ca2+ (labeled 0 Ca2+/EGTA) ultimately abolished spontaneous [Ca2+]S transients 
after ~200 s. Re-admitting extracellular Ca2+ resulted in reappearance of the spontaneous [Ca2+]S 
transients (insets show the frequency and kinetics of the transients during the experiment). Results 
were similar in CK--/-- myotubes. **,p < 0.01; ***, p  < 0.001. a.u., arbitrary units.
sarcoplasm ic RO Is betw een  different m yotubes. U sin g  this approach, w e  observed (n  =  114,
/  2+ equally distributed betw een  w ild-type and CK "" genotypes) that (i) [Ca ]S transients occur
either continuously or as discrete bursts (Fig. 1 C, exam ples from w ild-type m yotubes); (ii)
amplitude and frequency o f  these transients w ere remarkably constant w ithin  the sam e m yo-
tube; and (iii) betw een different m yotubes, the frequency w as variable (ranging from <0.1 to
10 H z) and increased w ith temperature (1 .6  ±  0.1 H z (n  =  55) and 3.4 ±  0.1 H z (n  =  59) at
22°C  and 37°C , respectively). N o  d ifferences in distribution o f  the firing frequencies, firing
pattern, and temperature sensitivity w ere found betw een w ild-type and CK---- tubes. During
the tim e course o f  the m easurem ents (5 m in o f  continuous recording at 30 H z), no significant
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2+ /Figure 3 Comparison of Ca s removal kinetics in wild-type and CK"" m yotubes during sp onta­
n eous activity.
Ca2+S was removed mono-exponentially, but more slowly in CK""7"" myotubes (n indicates the amount of 
individual tubes averaged; see  ‘Results’ for details). *, p  < 0.05; **, p  < 0.01; ***, p  < 0.001. a.u., arbi­
trary units.
change in decay constant was observed (data not shown). This indicates that ¡1 also is a reli-
2+able parameter for the quantification of [Ca ]S removal kinetics during prolonged recordings.
Role of CK, SR and SR Ca2+-ATPase in spontaneous [Ca2+]5 transients
In mature skeletal muscle, depolarizations of the plasma membrane are sensed by the
dihydropyridine receptor in the T-tubule membrane. This protein directly interacts with the
2+ryanodine-sensitive Ca2+ release channel RyR in the SR membrane to promote the release of
2+  2+ Ca from the SR into the sarcoplasm (2). SERCA pumps in the SR membrane pump Ca
from the sarcoplasm back into the SR (41).
Because the excitation-contraction coupling apparatus of skeletal muscle is known to
2+develop over time (33), we analyzed the source of the Ca during spontaneous activity in
wild-type and CK”"  myotubes. For both preparations, a specific block of the SERCA pumps
2+with thapsigargin (2 ^M) did not lead to immediate cessation of the spontaneous [Ca ]S tran-
2+sients. Indeed, it took ~4 min until the spontaneous [Ca ]S transients were extinguished (Fig.
2A, representative of 25 experiments in wild-type myotubes). On the other hand, thapsigargin
2+immediately reduced (within 30 s after application) the [Ca ]S removal rate and increased the
interval between the [Ca2+]S transients (Fig. 2, B, C). In agreement with this finding, also the
2+  2+ removal of extracellular Ca did not result in immediate cessation of the spontaneous [Ca ]S
transients in either wild-type or CK-- -- myotubes (Fig. 2D, data from wild-type tube, total of
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2+ /Figure 4 Kinetics of KCl-induced [Ca ]s transients in wild-type and CK"" m yotubes.
Extracellular KCl application was used to depolarize myotubes chemically (wild-type myotubes are 
shown in (A-C). (A) In the absence of extracellular Ca2+, a high amplitude [Ca2+]s transient was in­
duced (area, 10.3 arbitrary units (A.U) s ; and duration, 38 s). We used the maximum Indo-1 ratio 
reached (Rmax) to analyze the amplitude of the transient. Because an exponential function did not ade­
quately describe the [Ca2+]s decay, a linear fit (Linear decay) was calculated to the steepest part of the 
decline phase. (B) When extracellular Ca2+ was removed directly after the first KCl stimulation (area, 
13.3 arbitrary units s; and duration, 33 s), a second KCl application induced a much smaller [Ca2+]s 
transient (area, 3.5 arbitrary unitss; and duration, 31 s). For comparison the first (/) and second (II) 
transients were magnified and superimposed (inset). Whereas the decay kinetics appeared similar, 
transient II displayed a reduced rising speed (see magnification). (C) Re-admittance of extracellular 
Ca2+ fully restored the amplitude of the KCl-induced transient within 10 min (note the different kinetics 
of spontaneous and KCl-induced [Ca2+]s signals and the burst of rapid [Ca2+]s transients superim­
posed on the large KCl-induced rise). (D) The linear [Ca2+]s removal rate is plotted as a function of 
amplitude (Rmax) of the KCl-induced [Ca2+]s transient. For statistical analysis, we re-scaled the x axis 
by subtracting 1 from the recorded Rmax values. In CK--/-- tubes myotubes (O; each from an individual 
myotube), the removal of Ca2+ was slower than in wild-type preparations ( • )  (for details, see  ‘Re­
sults’).
eight w ild-type and CK ”"  genotypes analyzed). Importantly, in the m yotube shown (in w hich
the spontaneous [Ca2+]S transients occurred at a m uch higher frequency than in Fig. 2A) it
2+  2+ took  again ~4  m in for the [Ca ]S transients to extinguish. The spontaneous [Ca ]S transients
2+reappeared, although at a som ew hat low er frequency, w hen Ca2+ w as re-added to the medium.
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2+To determine whether CK plays a role in the spontaneous [Ca ]S transients, we com-
2+  / pared the [Ca ]S removal kinetics between wild-type and CK” "" myotubes that displayed
[Ca2+]S transients of similar frequencies (3.1 ± 0.3 Hz [n = 23] and 3.6 ± 0.4 Hz [n = 17] for
wild-type and CK"7” myotubes, respectively) measured at 37°C. For analysis, one transient
was randomly chosen from each myotubes (using random numbers generated with Origin Pro
6.1). Next, the maximum amplitudes of the transients were temporally aligned to allow calcu-
2+lation of the average decline kinetics. Figure 3 shows that the Ca removal was significantly 
faster (indicated at the corresponding time points by asterisks) in wild-type myotubes (wild­
type, p  = (0.051 ± 1.8) x 10-3 s and R  = 0.998; and CK--/--, p  = (0.094 ± 4.6) x 10-3 s and R  =
0.996). Taken together, the findings presented in Figures 2 and 3 suggest that CK is required
2+for an optimal SERCA-mediated refill of the SR and that only little Ca is extruded across
2+the plasma membrane during spontaneous [Ca ]S spiking. Given the results obtained with
2+  2+ thapsigargin, we expect that the SR Ca store contains sufficient Ca to maintain spontane-
2+ous [Ca ]S release events for prolonged periods of time, even in the absence of functional 
SERCAs.
Ca2+ storage capacity of the SR
2+To investigate the amount of Ca present in the SR, we performed experiments in 
which we chemically depolarized wild-type and CK---- myotubes by application of an iso-
osmotic medium containing 125 mM KCl (Fig. 4, A-C, wild-type myotubes). This high KCl
2+medium induced a large [Ca ]S transient that was independent of the presence of extracellular
Ca2+ (Fig. 4, compare A and B). When extracellular Ca2+ was removed directly following KCl
2+treatment, a second KCl application failed to induce a [Ca ]S transient of the same amplitude 
(Fig. 4B; the area under the second transient (marked II) was reduced by 75%, whereas the
duration was similar to that of the first (I) transient: 33 s versus 31 s). This indicates that dur-
2+ing the first transient, Ca was mainly extruded across the sarcolemma and not re-sequestered
into the SR by SERCA pump action. The enlarged inset shows that the rising speed of the
2+small second transient was markedly reduced, whereas the [Ca ]S decay rate remained virtu­
ally unaltered. Figure 4C  shows that the KCl-induced [Ca2+]S transient was fully restored
within 10 min following re-addition of Ca2+ to the medium (same tube as in Fig. 4C). In
2+summary, these data show that high KCl stimulates the extrusion of Ca across the plasma
2+membrane, leading to depletion of the SR Ca store. Therefore, under these conditions, the
2+removal process is entirely dominated by the action of the plasma membrane Ca2+ extrusion 
mechanisms (i.e. plasma membrane Ca2+-ATPase and/or Na+/Ca2+ exchange).
In Figure 4C, the KCl-induced transient was preceded by spontaneous [Ca2+]S tran-
2+sients. A qualitative comparison of the kinetic characteristics of these two types of [Ca ]S 
signal revealed that, in general, the amplitude was lower, the duration was shorter, and the
removal rate was more rapid for spontaneous transients. The decline of the KCl-induced
2+  2+[Ca ]S transient was also monoexponential. In the typical trace shown, the [Ca ]S removal
rate was ~200 times slower following KCl treatment compared with spontaneous transients,
132
Creatine kinase and SERCA function
2+Figure 5 Electrically induced [Ca ]s transients in wild-type m yotubes.
Myotubes were stimulated (marked by black lines) using extracellular electrodes connected to an elec­
trostimulator. (A) Shown is an example of [Ca2+]s transients evoked by a typical pulse protocol of three 
consecutive 2-s stimulations at 0.1, 1 and 5 Hz. At 5 Hz, the basal [Ca2+]s was elevated. (B) Applica­
tion of thapsigargin (Ts) markedly reduced the [Ca2+]s removal rate and elevated basal [Ca2+]s (the 
thapsigargin transient was recorded 2 min after thapsigargin application; see  ‘Results’ for numerical 
data). (C) Repetitive stimulation at 5 Hz in the absence of extracellular Ca2+ gradually reduced the 
amplitude of the transients. Application of ryanodine (panel D) or FCCP (panel E) increased basal 
[Ca2+]s and finally prevented electrical induction of [Ca2+]s transients. Because the duration of the ry­
anodine experiment was relatively long, recording was paused between stimulations to prevent arti­
facts caused by laser illumination.
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as reflected by an increase of the decay constant from 0.2 ± 0.030 s (spontaneous) to 38 ± 1.7
2+s (KCl). In addition, we compared the amounts of Ca that were released during both types of
2+[Ca ]S transients. For this purpose, we calculated the area under the curve as a measure for
2+ 2+ the total amount of Ca released into the sarcoplasm. We first set the basal [Ca ]S signal of
each normalized recording to zero by subtracting the value 1 from each data point. Subse-
2+quently, individual [Ca ]S transients were integrated to obtain numerical values (arbitrary
2+unitss). In doing so, we found that the relative amount of Ca released during KCl treatment
was 100 times larger than during a single spontaneous transient (15.16 versus 0.152 arbitrary
2+units s). Occasionally, a biphasic increase in [Ca ]S was observed upon application of KCl
(wild-type, n = 3 of 12; and CK----, n = 6 of 14) (Fig. 4C). This was the result of a fast burst of
2+ 2+ small [Ca ]Stransients superimposed on the rising phase of the large [Ca ]S signal.
2+Role of CK during KCl-induced sarcoplasmic Ca transients
2+ 2+ To investigate effects of CK deficiency on [Ca2+]S handling in KCl-induced [Ca2+]S
2+ / transients, we compared Ca removal kinetics between wild-type (n = 12) and CK---- myo-
tubes (n = 14). Automated exponential fitting was not possible for all experimental datasets 
due to the presence of noise. We therefore fitted a straight line to the steepest part of the de­
cline phase of the transients (Fig. 4A, Linear decay) and used the absolute slope of this fit as
2+an approximation of the (linear) [Ca ]S removal rate. The maximal Indo-1 ratio reached 
(Rmax) (Fig. 4A) was used as a measure for the amplitude of the transient. Plotting the linear 
calcium removal rate as a function of Rmax revealed a positive correlation between these pa­
rameters in wild-type and CK---- myotubes (Fig. 4D). In both cell types this correlation was
linear (wild-type: Pearson’s R  = 0.91; and CK----, R = 0.93). For both lines, the intercept dif-
2+fered not significantly from zero. If [Ca2+]S does not rise (i.e. if there are no observable
2+ 2+ changes in [Ca2+]S and therefore Rmax = 0), the linear Ca2+ removal rate in our experimental
trace will also be zero. This means that by subtracting 1 from each Rmax value to correct for
the normalization (thereby setting base-line ratio signals to zero), both regression lines can be
forced through the origin (0,0). We observed that, independent of amplitude, the removal rate
was higher in wild-type than in CK--/-- myotubes (Fig. 4D, •  versus O, respectively). This is
reflected by an increased slope of the fitted line in wild-type cells (wild-type, slope = 0.09 ±
0.005 s-1; and CK--/--, slope = 0.065 ± 0.002 s-1; p  = 0.05) (Fig. 4D, inset).
2+ --/-­Therefore, wild-type myotubes remove Ca2+ faster than CK--/-- tubes during KCl-
induced [Ca2+]S transients. This, combined with interpretation of Figure 4 (A-C) described
2+above, reveals that CK is important in the supply of ATP to plasma membrane Ca2+-ATPases
2+in KCl-induced Ca transients.
Electrical stimulation of myotubes
2+Having noted the profound differences in Ca handling during spontaneous and KCl-
2+induced events, the effect of CK deficiency on sarcoplasmic Ca2+ handling was analyzed in 
more detail. To this end, we developed an experimental setup that allowed us to electrically
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2+ /Figure 6 [Ca ]s removal and store refilling in wild-type and CK"" m yotubes.
[Ca2+]s removal was studied after stimulation at 0.1 (panel A), 1 (panel B) and 5/10 Hz (panel C) in 
wild-type ( • )  and CK--/-- (O ) myotubes. For each trace, several individual recordings were averaged 
(see ‘Results’ for numerical values). A progressive decrease in removal rate and elevation of basal 
Ca2+ was observed with increasing stimulation frequency. (D) Average decay constant (u) obtained 
from exponential fits to the individual recordings used for panels A-C at different stimulation frequen­
cies (of note: p  is inversely proportional to the Ca2+ removal rate). (E) Total Ca2+ released per transient 
(determined by numerical integration of the [Ca2+]s trace; see  ‘Results’) for wild-type (black bars) and 
CK--/-- (white bars) as a function of stimulation frequency. (F) Relation between fractional amount of 
Ca2+ released per transient (x axis) and Ca2+ removal rate (both expressed as percentage of the cor­
responding control values) at different stimulation frequencies (see ‘Results’ for details). *, p  < 0.05; **, 
p  < 0.01; ***, p  < 0.001. a.u., arbitrary units.
2+  2+ induce [Ca ]S rises in silent myotubes (i.e. temporarily not displaying spontaneous [Ca ]S
transients). To prevent cell damage, we first determined the minimal stimulation voltage re-
2+quired for the induction of a transient [Ca ]S rise. In doing so, we found that a 10-ms pulse of
2+16V was optimal to induce a sarcoplasmic Ca rise with kinetics resembling that of a sponta­
neous [Ca2+]S transient (Fig 5A; see also Flucher et al. (34). To mimic increasing workloads, 
we used pulse protocols with frequencies ranging from 0.1 to 10 Hz.
2+ 2+Role of SR and SR-Ca -ATPase in electrically induced sarcoplasmic Ca transients
2+As observed for spontaneous [Ca ]S transients, application of thapsigargin (2 ^M)
2+significantly reduced the Ca2+ removal rate following a 2-s period of stimulation at 5 Hz in 
wild-type myotubes (duration of thapsigargin presence of 2 min) (Fig. 5B). This was reflected
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by an increase of the decay constant from 0.242 ± 0.0006 s (R2 = 0.979) to 0.806 ± 0.0003 s 
(R2 = 0.973), and an elevated post-stimulatory basal Ca2+ level (experiment performed at room 
temperature).
2+In the absence of extracellular Ca , periodic electrical stimulation (at 5 Hz over 2 s)
resulted in a progressive decrease of the amplitude of the induced [Ca2+]S transients (Fig. 5C,
2+wild-type data shown). However, it took 3 minutes before the electrically mobilizable Ca
2+store was depleted. This finding is compatible with an efficient re-uptake of Ca into the SR
2+and a minimal loss of Ca across the plasma membrane.
2+Ryanodine (10 ^M) gradually abolished the electrically induced [Ca ]S transients
2+(Fig. 5D). In addition, this drug slowly increased the base-line [Ca ]S. To assess the possible
2+involvement of mitochondria in the generation of Ca transients in the myotubes, we applied 
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) to the cells. This protonophore
dissipates the mitochondrial membrane potential and abolishes mitochondrial ATP synthesis.
2+Figure 5E shows that FCCP (50 nM) elevated the base-line [Ca ]S and ultimately prevented
2+electrical induction of [Ca ]S transients within 1-2 min. Qualitatively, no differences
2+concerning excitability, effects of thapsigargin, omission of extracellular Ca , ryanodine 
treatment, and FCCP application were observed between wild-type and CK---- myotubes 
(wild-type, n = 10, and CK--/--, n = 13).
2+Role of CK during electrically induced sarcoplasmic Ca transients
We used the stimulation protocol shown in Figure 5A to estimate Ca2+ removal rates in 
wild-type and CK-- -- myotubes as a function of workload. For each cell, the individual 
transients obtained at 0.1 Hz (wild-type, 19 myotubes; and CK----, myotubes) were aligned on 
their maximum amplitude, after which the average ratio signal was calculated for each time 
point. Similarly, individual transients evoked at 1 Hz were averaged (at least three
transients/myotubes) (wild-type, 20 myotubes; and CK--/--, 17 myotubes). Because at 5/10Hz
2+the transients were superimposed on an elevated basal [Ca ]S, only declines at the end of 
each burst were analyzed. The average traces obtained after 5- and 10-Hz stimulation were
identical. Therefore, data were pooled for these stimulation frequencies (wild-type, 25
-- /- -  2+ myotubes; and CK----, 22 myotubes). We found that [Ca ]S returned more slowly to pre­
stimulatory levels in CK---- myotubes (Fig. 6, A-C). This effect became more pronounced at
higher stimulation frequencies and resembled that evoked by thapsigargin treatment (Fig. 5B).
2+The difference in removal rate was quantified by analysis of the individual [Ca ]S transients 
used for the construction of Figure 6 (A-C). This analysis revealed decay constants of 0.097 ± 
0.002 s (R2 = 0.998) and 0.137 ± 0.006 s (R2 = 0.989) for wild-type and CK---- myotubes, 
respectively, at 0.1 Hz (Fig. 6D). This increase in decay constant became more prominent at 
stimulation frequencies of 1 Hz (wild-type, 0.103 ± 0.003 s and R2 = 0.994; and CK----, 0.160 
± 0.005 s and R2 = 0.995) and 5/10 Hz (wild-type, 0.111 ± 0.008 s and R2 = 0.996; and CK----, 
0.162 ± 0.006 s and R2 = 0.993).
136
Creatine kinase and SERCA function
2+To assess whether this reduced Ca removal was associated with a reduced filling
state of the SR, the area under each transient (arbitrary unitss) was calculated and used as an
2+estimate of the amount of Ca released (see above). To allow comparison, the average
2+amount of Ca released per transient at 0.1 Hz was set at 100%, a value to which all other
values were related. Figure 6E shows that in CK"""" (but not wild-type) myotubes, gradually
2+less Ca was released with increasing stimulation frequency. The values presented were ob­
tained from three wild-type and three CK"""" myotubes that displayed stable base-line signals
2+during the whole experiment. The number of [Ca ]S transients included in the analysis was 
similar for wild-type (0.1 Hz, 9; 1 Hz: 80; and 5/10 Hz, 137) and CK"""" (0.1 Hz, 9; 1 Hz, 95;
and 5/10 Hz, 133) myotubes. Combination of the data presented in Figure 6 (D and E) re-
2+vealed a correlation between the amount of Ca2+ released per transient and the removal rate
2+(Fig. 6F). The slower this rate, the less Ca was released. The figure nicely demonstrates that 
CK"""" myotubes, in contrast to wild-type tubes expressing this kinase, are unable to maintain
an adequate removal rate at higher workloads (1 and 5/10 Hz). As a consequence, these myo-
2+tubes release less Ca per transient during high-frequency stimulation.
DISCUSSION
2+In skeletal muscle, Ca is an important physiological mediator of contraction, signal 
transduction, protein metabolism, differentiation, and growth (19). As far as contractile
properties are concerned, speed of muscle contraction and relaxation critically depend on the
2+  2+ spatial arrangement of components belonging to the Ca handling apparatus. Moreover, Ca
directly stimulates mitochondrial ATP production in primary cultures of skeletal muscle
myotubes (35), regulates myoblast fusion during myogenesis (36, 37), and is involved in the
reprogramming of muscle gene expression via calcineurin (38). This means that presence,
2+functioning, and regulation of proteins involved in Ca2+ signaling and handling are of 
paramount importance in muscle development and physiology. During excitation-contraction
coupling, considerable amounts of ATP are required for SERCA-mediated re-sequestration of
2+Ca into the SR (2). Because ATP is rapidly replenished by the CK/PCr circuit, we
2+hypothesized earlier (10) that the CK system has a direct role in the regulation of both Ca
sequestration and release in skeletal muscle.
2+Conversely, altered Ca2+ kinetics could be a factor to explain the effect that ablation of 
both M"CK and ScCKmit genes has on physiological (force/fatigue) performance and on the 
metabolic and cytoarchitectural properties of muscles in our mutant CK mouse model(s). 
CK"""" muscles undergo a general transition towards a ‘slow’ phenotype, illustrated by an in­
crease in mitochondrial volume in fast muscle fibers and ‘global’ changes in transcriptome 
and proteome profiles of both fast and slow fibers (for more details on the phenotypic charac"
terization of mutant CK mice, see (10), (14), and (15), and references therein). To better un-
2+derstand this putative role of Ca2+ in metabolic signaling cascades, we need to provide an
2+adequate picture of the kinetics and subcellular distribution of Ca2+ transients, especially un"
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der non-strenuous conditions of muscle use as will occur under normal housing conditions of
laboratory animals. In this study, we started to compare spontaneous and electrically induced
2+ --/-­[Ca ]s in wild-type and CK---- myotubes cultured in vitro. Furthermore, we drew parallels to
events that occur when KCl is used for full depolarization of muscle cells to assess whether
2+ 2+CK-deficiency alters Ca sequestration and release. To visualize [Ca ]s in time, Indo-1-
loaded myotubes were subjected to high-speed (30 Hz) confocal laser scanning microscopy.
--/-- 2+In both wild-type and CK---- preparations, spontaneous [Ca ]s transients were observed that
2+were associated with fast unidirectional [Ca ]s waves, transecting the nucleoplasm. Because 
transients could be induced by KCl depolarization and displayed a higher frequency upon in­
creasing temperature, the membrane potential of the myotube likely controls the temporal fir­
ing pattern. Since the membrane potential in myoblasts changes concomitantly with fusion,
2+the temporal pattern of the [Ca ]s transients might be important for myogenesis (39). We 
showed earlier that the ultrastructural composition and mitochondrial volume are similar in
wild-type CK-deficient myotubes (25). This, combined with our current finding that the tem-
2+poral Ca pattern of CK-deficient and wild-type myotubes are similar, strongly suggests that 
the in vitro differentiation of myotubes is not influenced by CK absence.
2+The presence of spontaneous contractions in tubes displaying Ca transients, com-
2+bined with the dependence on functional SERCAs, extracellular Ca , and ryanodine recep­
tors, indicates that a functional excitation-contraction coupling mechanism is present in our
2+myotube preparations (19). Given the homogeneous Ca kinetics throughout the sarcoplasm
2+in a single myotube, comparison of Ca removal rates between individual tubes was possible. 
Because this removal was monoexponential, we conclude that the action of a single major re­
moval process is responsible for the decline. The exponential decay constant p, inversely pro-
2+ 2+ portional to the rate of Ca removal, was used to quantify the Ca removal rate. During
2+ --/-­spontaneous activity, Ca removal was significantly slower in CK---- preparations. This
2+shows that a functional CK system is essential for optimal Ca2+ removal during spontaneous 
activity.
2+Because the rate of Ca removal was rapidly reduced by thapsigargin treatment and
2+correlated with the amount of Ca released from the SR during electrical stimulations, we 
considered it to be a quantitative readout for SERCA pump activity. This approach is sup­
ported by other studies presenting evidence that (i) the SERCA pump takes primacy over 
Na+/Ca2+ exchange and plasma membrane Ca2+-ATPase action at the plasma membrane in 
both cardiac and skeletal muscle (40, 41); (ii) SERCA pumping rate directly depends on ATP
supply (19); and (iii) CK is of paramount importance in mediating this supply (6). The SR
2+has a large Ca storage capacity, which is effectively maintained by SERCA pumps because
2+neither thapsigargin treatment nor omission of extracellular Ca acutely abolished spontane-
2+ous or electrically induced [Ca ]s transients.
2+ 2+KCl depolarization induced large [Ca2+]s transients. This Ca2+ originated from the SR
2+because the amplitude and duration of the transients were independent of extracellular Ca .
2+ 2+In KCl-induced [Ca ]s transients, Ca was mainly extruded across the plasma membrane
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2+because a second KCl challenge under Ca -free conditions induced a 75%  sm aller transient,
2+featuring a low er Ca release rate. These findings reveal that the fillin g  state o f  the SR is re-
2+duced during KCl-treatment, in agreem ent w ith other studies show ing that the amount o f  Ca
released from the SR by a stim ulus directly depends (probably in a h ighly non-linear fashion)
2+(42) on its fillin g  state (43). The amount o f  Ca released during a single spontaneous tran-
2+sient w as ~100  tim es sm aller than during KCl treatment. Therefore, the Ca storage capacity
o f  the SR, com bined w ith  effective SER CA -m ediated refill, is sufficient to a llow  sustained
2+ --/-­spontaneous activity. A lso  during KCl-treatm ent, Ca2+ w as rem oved m ore slow ly  in CK--/--
m yotubes. B ecause this rem oval primarily occurs across the plasm a membrane, this points to
2+an impaired plasm a membrane Ca -AT Pase function.
2+To allow  study o f  the effects o f  CK deficiency  on Ca signaling at increasing w ork­
loads, a setup for active electrical depolarization w as developed. Each electrical stimulation
2+induced a single rapid [Ca2+]s  transient that displayed kinetics similar to spontaneous tran-
2+sients. R esults obtained w ith thapsigargin, Ca -free m edium , and ryanodine w ere similar to 
those in spontaneously active tubes, again dem onstrating the presence o f  a functional excita­
tion-contraction coupling and predom inance o f  SER C A-m ediated SR refilling. B y  increasing
2+the stim ulation frequency, cells w ere subjected to higher Ca loads. In w ild-type m yotubes,
2+ 2+ neither the Ca2+ rem oval rate nor the amount o f  Ca2+ released per transient changed as a func­
tion o f  stim ulus intensity. This show s that ATP demand and supply are w ell balanced also at
2+ --/-- 2+ high Ca loads. In contrast, CK-- -- m yotubes alw ays had a low er Ca rem oval rate than w ild ­
--/-- 2+ 2+ type tubes. Strikingly, in CK---- tubes, both Ca rem oval rate and amount o f  Ca released
decreased progressively w ith  higher stim ulus intensity. This correlation strengthens the va lid ­
ity o f  our analysis m ethod, and show s that the SR fillin g  state is reduced in CK---- m yotubes at
higher stim ulation frequencies. This reduced fillin g  could have direct consequences for m yo-
2+tube maturation (w hich  is associated w ith the occurrence o f  spontaneous Ca transients) (44)
2+ 2+ given  the hypothesized  role o f  Ca as an intra-SR m essenger (45). The observation that Ca
rem oval becom es progressively impaired in CK---- m yotubes as a function o f  stim ulus inten­
sity show s that the CK system  is especially  important under conditions o f  high ATP demand. 
In the latter case, the cytoso lic  phosphorylation potential can be buffered at a higher level in 
w ild-type m yotubes than in ce lls devoid o f  the CK system .
B ecause m itochondrial ATP generation accounts for 60%  o f  the energy production in 
differentiated m yotubes (46), the observed m etabolic and cytoarchitectural rem odeling in CK- 
deficient m uscle m ight serve as an effort to counterbalance the CK defect (10, 11, 14, 15). 
Our FCCP results show  that functional m itochondria are essential during excitation- 
contraction coupling; and in this respect, the rem odeling likely  functions as a m eans to reduce 
the distance betw een  sites o f  A TP production (m itochondria) and ATP consum ption (e.^.
SER C As). To proof this hypothesis and provide further evidence for a functional connection
2+betw een energy transfer, Ca signaling and the adaptational changes in our mutant CK m us­
cles, w e  need also m ore insight in the cellular com partm entalization o f  A TP and A D P  and the 
local A D P/A T P ratio in direct v icin ity  o f  the SER CA  pumps. O f importance in this respect is
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2+  2+the proposed existence o f  functional com plexes o f  m itochondria w ith Ca , M g A TPases 
and SR in m uscle cells (47).
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Discussion

Discussion
Creatine kinases and plasticity in metabolic design
Classically, the creatine kinase/phosphocreatine system is considered to be a funda­
mental component in energy homeostasis of tissues with high and fluctuating ATP turnover, 
such as muscle and brain. Gene-function studies carried out via targeted gene disruption in 
mouse embryonic stem cells and phenotyping of the knockout animal models generated from 
these cells have shed new light on the role of cytosolic and mitochondrial creatine kinases in 
muscle. Initially, the general lack of overt phenotypic effects in different CK gene knockout 
models suggested that the role of the CK/PCr circuit in cellular energy homeostasis might be 
less elementary than put forward in biochemistry and physiology textbooks. Subsequent stud­
ies by our group (1-3) and many others, however, have provided us with a more sophisticated 
picture. It became clear that CK deficiency induces a variety of changes in the cellular net­
work for energy homeostasis, which may mask or rescue the effects of the genetic defect(s), 
and have a role in remodeling. Thus, the rationale was born for studying the global picture of 
compensatory changes evoked by CK deficiency much more thoroughly in order to separate 
primary and secondary effects.
The work described in this thesis provides specific information on the exact nature of 
only some of the remodeling responses evoked by genetic stress in the CK system. These re­
sponses include alterations in cellular ultrastructure, qualitative and quantitative changes in 
mRNA and protein expression, as well as alterations of metabolic fluxes and ion homeostasis. 
Obviously, the responses can be modulated by organismal constraints in vivo or by conditions 
of cell culture in vitro. Thus, a complete picture of the responses in the entire system for en­
ergy homeostasis under different conditions will be needed to properly understand the true 
biological significance of the CK enzymes, their cell biological environment, and their role in 
integral physiology.
7.1 CK deficiency is coupled to the expression profile of nuclear 
and mitochondrial genes
Based on earlier studies on skeletal muscle of CK-deficient mice (1, 2), we anticipated 
that the changes in glycolytic and mitochondrial activity and in cellular ultrastructure could be 
the result of a multigene/multitranscript/multiprotein response, inducing profound changes in 
cellular design. To analyze this in detail, we adopted medium-throughput methods based on 
the use of cDNA arrays for mRNA profiling, and semi-quantitative Western blot procedures 
for protein analysis. As high-throughput methods with complete arrays for all mouse genome 
products (i.e. cDNAs or proteins) were either not affordable, not suitable, or not available at 
the start of our studies, we chose to limit ourselves to the quantitative study of the expression 
levels of a relatively small number of representative mRNA transcripts and proteins. These 
transcripts and proteins are directly coupled to mitochondrial and glycolytic energy produc­
tion and cellular structure. By studying the steady-state levels of these mRNAs and proteins,
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we were able to show small but significant changes in expression levels, primarily in CK---- 
mice. Changes fluctuated between 0.5 to 4-fold (protein, chapter 2 and 3) and 0.7 to 2.5-fold 
(mRNA, chapter 3) of that in wild-type mice.
Proteins
CK-deficient gastrocnemius muscle showed concomitant upregulation of both mito­
chondrial- and nuclear-encoded COX subunits, ANT, and VDAC, components involved in 
ATP generation and ATP/ADP shuttling between the cytosol and mitochondria. Interestingly, 
there was also a significant upregulation of the Pi carrier protein, a transporter with a pivotal 
role in phosphate import in mitochondria. The CK reaction is regarded as a net producer of Pi, 
and indeed Pi levels do not rise during fatiguing muscle stimulation in CK---- mice, although 
basal Pi levels are elevated in these animals (4). This lack of rise of Pi levels upon stimulation 
could be caused by the absence of CK and thus of net Pi production, but our results show that 
increased Pi shuttling via mitochondria during stimulation, which inevitably causes produc­
tion of Pi, could also play a role. At the same time, more Pi could be consumed in glycolysis 
during muscle activity, as glycolysis is stimulated by Pi. Both increased rates of (aerobic) gly­
colysis and OXPHOS could facilitate augmented mitochondrial ATP production. Initial indi­
cations for enhanced mitochondrial ATP production in gastrocnemius muscle came from the 
work of Steeghs (2) and Van Deursen (1), who both showed increased activity of key mito­
chondrial enzymes in CK---- mice and M-CK- - mice respectively.
In conjunction with these changes, the observed LDH isoenzyme switch from LDH-M 
to LDH-H (chapter 2) could be an indication for the necessity to generate higher levels of 
pyruvate (instead of lactate) to facilitate increased oxidative ATP production. It is of note here 
that we saw neither an effect on total LDH enzyme activity in vitro, nor on total LDH protein 
levels in our assays of tissue samples (De Groof, unpublished observations). Thus, solely a 
shift in LDH isoenzyme composition seems to be associated with increased oxidative ATP 
production. It is tempting to speculate that also the slight downregulation of UCP2 and UCP3, 
observed at the RNA level in CK---- mice (chapter 3), might serve to increase the efficiency of 
ATP production. This fits well in the concept of an overall improvement in the efficiency of 
proton import coupled to H+-ATP synthase activity (subunit C of this enzyme is upregulated 
at the mRNA level, chapter 3) in CK-deficient mice. Increased coupling of mitochondria and 
a higher proton motive force were also shown in skeletal muscles of UCP3 knockout mice (5, 
6). Studies by Samec et al. (7) and Bezaire (6), however, suggested another concept, namely 
that UCP2 and UCP3 could be involved in the regulation of fatty acid metabolism instead of 
proton leak. They demonstrated that down regulation of UCP2 and UCP3 mRNA levels is 
linked to impaired fatty acid oxidation. Interestingly, this correlates with the observation of 
lipid droplets in CK---- skeletal muscle (8, 9). To distinguish between various possibilities, the 
consequences of downregulation of UCP mRNAs (please note: downregulation was not tested 
and confirmed at the protein level!), and their possible role in rewiring metabolite flow and
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lipid metabolism in CK---- mice, have to be studied in the context of integral muscle 
physiology.
Additional indirect evidence for increased OXPHOS activity was obtained from the 
observed increase in the level of oxygen buffer myoglobin, a protein serving to safeguard an 
adequate oxygen gradient supporting OXPHOS in mitochondria (chapter 2). Myoglobin has 
been known as an O2 buffer for a long time, and also facilitates O2 transport from the periph­
ery of the cell to the mitochondria. Taken together, the combination of increased buffering 
and diffusion of oxygen via myoglobin, shift in LDH isoenzyme profile, increased potential 
for mitochondrial Pi delivery and changes in expression level of mitochondrial proteins COX 
(nuclear and mitochondrial subunits), ANT, VDAC are strong indices for a higher oxidative 
ATP production rate in gastrocnemius of CK---- mice, corroborating the findings of Steeghs 
and Van Deursen. While it is well known that this response requires co-regulation of nuclear 
and mitochondrial DNA, the metabolic signaling mechanisms and transcriptional mediators, 
which sense the primary or secondary effects of CK absence and translate this into a compen­
satory response, are less clear.
In CK---- soleus, only a relatively moderate upregulation of Pi carrier was visible, but 
again a shift towards more oxidative LDH pattern was observed (chapter 2). This indicated 
that also in this muscle metabolism changed in the direction of oxidative ATP production. We 
have to keep in mind, however, that soleus is ‘already’ an oxidative type of muscle with a 
relatively high dependence on lipid oxidation compared to gastrocnemius. Exactly this differ­
ence in metabolic background makes that adaptations to CK deficiency differ in nature and in 
the magnitude of the response. A particularly interesting observation in CK---- soleus is a pos­
sible change in Pi carrier protein itself, as concluded from its small but reproducible shift in 
band size on a Western blot (chapter 2). We surmise that this may be related to possible post- 
translational modifications or alternative splicing of the Pi carrier mRNA.
In comparison to CK---- mice, the adaptive responses in M-CK-- mice were less 
elaborate. Changes in mitochondrial and glycolytic protein content were observed in M-CK 
deficient mice, but their changes were significantly less than in M-CK- - x ScCKmit-- double 
mutants. Since PCr can still be converted into ATP by ScCKmit in these animals, this likely 
contributes to a mitigation of the metabolic stress. Here, the twofold higher ScCKmit content 
in M-CK- - mice (chapter 2), associated with the upregulation of mitochondrial content and 
volume, could also play an important role. Concomitantly, signaling pathways involved in 
inducing the adaptive responses may also be activated to a lesser extend, or thresholds for 
their activation may not be reached at all.
mRNA
To obtain a better picture of the remodeling responses in different muscles with differ­
ent CK mutant genotypes, we adopted a macro-size cDNA array method for simultaneous de­
termination of quantities of mRNAs in the muscle transcriptome (chapter 3, and references 
therein). The design of this array, the spotting procedure (cDNA concentration), the proce-
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32dures for the generation of 32P labeled RT-probe, the hybridization and washing procedures, 
and the computational method for data analysis had to be optimized for use with distinct mus­
cle types. Compared to the commercially available ‘gene chip’ microarray, ours was a ‘poor 
man’s’ version of this methodology for a variety of reasons. At the time when our studies 
were started, cDNA chip- or microarrays that contained 5,000 or larger sets of genes for 
mouse studies were not available. Later, when the first large mouse chips and arrays appeared 
on the market, they were simply not affordable for use in serial measurements of different 
muscle types with different CK mutant backgrounds. Moreover, one important drawback of 
the array procedures available in the public or commercial domains was that they did not pro­
vide the appropriate cDNAs, the reliability and sensitivity needed to determine relatively 
small fluctuations of mRNA concentrations (i.e. concentration shifts within the range of 50­
400% of that in wild-type: we already knew this from our protein work). As a consequence, 
we decided to restrict ourselves to the analysis of the small subset of genes that encode prod­
ucts with a clearly annotated role in the cellular network for energy homeostasis. In the meas­
urements we avoided probe amplification procedures to suppress experimental variation and 
tested an appropriate number of animals to increase the significance of our findings.
Combining data for mRNA and protein levels gave the most valuable new information 
(chapter 3). For several genes, we noticed a clear discrepancy between the extent of upregula­
tion at the RNA level and the protein level. For example the Pi carrier, which was upregulated 
2.4-fold at the protein level in CK---- gastrocnemius muscles, showed no appreciable upregu­
lation at the RNA level. In general, changes at the RNA level were less elaborate than at the 
protein level. This phenomenon may be of importance for plasticity, since protein modulation 
is usually a quicker process as there is no (or perhaps better: not always) need for extensive 
transcriptome reprogramming in order to meet altered muscle use or performance. Yet, small 
changes in mRNA expression levels should certainly not be neglected because they could 
have important physiological significance.
Our gene-product quantification studies demonstrated that for evaluation of remodel­
ing responses we have to take into account the possible changes in isoenzyme expression pat­
tern and mRNA splicing. For example, the LDH isoenzyme profiling results in chapter 2 
clearly illustrates how shifts in protein characteristics, resulting in distinct enzymatic proper­
ties with possibly important consequences for metabolic flux rates, would have been missed if 
only the cDNA array data would have been taken into account, which showed now effect. At 
present, it is highly questionable whether cDNA or recently developed ‘protein arrays’ (or 
Western blots) are at all suited for the analysis of splice variants and isoenzymes. For most 
variant gene products, there will be a high degree of cross-hybridization on cDNA arrays. 
Likewise, there will be substantial cross-reactivity with polyvalent antibodies. Although this 
problem could theoretically be tackled more efficiently by using oligonucleotide chips or pro- 
tein-arrays with highly specific monoclonal antibodies, our knowledge of (dynamic) splice 
variation and protein modification is still in its infancy.
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At this point it is important to note that the apparent inconsistency between mRNA 
and protein up- or downregulation (illustrated for the Pi carrier above) could also be related to 
the fact that we analyzed total cellular steady-state levels of mRNA with our array procedure. 
Measurement of total cellular mRNA quantities is not a reliable indicator of the amount of 
mRNA that is actually being translated, but rather shows the global balance between mRNA 
transcription and decay (10). Studies by other groups have revealed that it may be important 
to analyze polysomal RNA versus total RNA, to account for the fraction of mRNA that is 
actively engaged in the translation process. Finally, one should also not forget that profiling 
data yield no clues about the dynamics of intracellular mRNA distribution. The actual 
localization of mRNA may be important for local protein production speed. Cytoplasmic 
mRNA localization is a key post-transcriptional mechanism of establishing spatially restricted 
protein synthesis (11).
7.2 CK deficiency affects the (supra)molecular design of functional modules
After finding that the system for energy homeostasis as a whole responds to CK defi­
ciency, we now discuss the implications of this finding for our understanding of CK function. 
We know that many, if  not all, cell functions are carried out by large higher-order macromo- 
lecular complexes or structures, which assemble and disassemble according to cellular needs. 
The possibility to dynamically change the level, type or nature of individual components in 
these structures provides organisms with the ability to live in different environments, and to 
maintain metabolic homeostasis. Hartwell (12) described molecular and supramolecular ma­
chines, modules, as the critical components of biological organization. These complexes of 
proteins keep individual macromolecules with different catalytic functions in close proximity, 
so that intermolecular collisions are confined to a small subset of possibilities. Thus, both the 
speed and the fidelity of a multistep pathway are greatly improved (13, 14). These modules 
are typically composed of many types of molecules (proteins, RNA, DNA and small mole­
cules). They have diverse functions that arise from interactions among their components, and 
these functions cannot easily be predicted by studying the properties of the isolated compo­
nents (12).
This entails an important message for our studies, as it implies that the function of CK 
should be considered in the specific context of the cell and the molecular environment it re­
sides in. Ultimately, to understand CK function, we must have an adequate understanding of 
cellular design, the specific physiological function of the tissue involved, and the exact nature 
of other proteins in the direct environment of CK, acting as modules for cellular energy pro­
duction. Thus, in this view, the differences in adaptational responses between fast- and slow- 
type muscles can be explained by intrinsic differences in the immediate cellular environment 
of the CK circuit between these muscles, or by global differences in their machinery for sens­
ing and translating the stress in the high energy ~P-transfer system. Supportive evidence for
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this hypothesis comes from knockout mouse models of other genes in skeletal muscle, ANT, 
myoglobin, and parvalbumin, models which also show adaptational responses (15-18).
Embedding specific cellular functions in separate modules allows the core function of 
a module to be robust to change, but also allows for changes in the properties and functions of 
a cell (its phenotype) by altering the connections between different modules. It is in this regu­
latory network where changes in isoenzyme composition, such as described for the connective 
role of LDH isoenzymes at the interface between glycolysis and OXPHOS (chapter 2), could 
play an important role. Strikingly, only subtle alterations in proteins seem to be sufficient to 
optimally match changes in external needs. When we realize that many genes undergo alter­
native splicing, this indicates that specific protein machines can be created for a variety of 
physiological needs. Integral physiological need is by definition very dynamic in nature. The 
studies in this thesis suggest that effects of genetic stress can be considered the equivalent of 
an extreme (pathological) physiological condition, which creates the need for extensive re­
modeling.
7.3 Finding possible regulatory mechanisms involved in genetic stress- 
induced remodeling of muscle design
An important goal for the immediate future is to complete the global inventory of 
adaptive and remodeling changes, both at the mRNA and protein level, induced by M-CK or 
M-CK/ScCKmit deficiency. Once all changes, including alternative splicing and posttransla- 
tional protein modifications, have been charted, it will be possible to categorize primary and 
secondary events, and find underlying regulatory principles. An important tool will be the 
comparison of regulatory elements (promoter-enhancer-silencer regions) of genes which are 
coordinately affected by CK deficiency. This requires powerful bioinformatic information- 
retrieval and prediction systems, and availability of detailed knowledge on the physiological 
significance of DNA elements and binding factors.
DeRisi et al. (19) were the first to apply genome-wide analysis of gene expression to 
find genes that are co-regulated in the metabolic shift from fermentation to respiration in Sac­
charomyces cerevisiae. These studies in yeast have been further extended, and now integrated 
genomic and proteomic approaches are being used for systematic analysis of metabolic net­
works. In a recent study, Ideker et al. (20) described a systematic way in which the structure, 
function and common principles for regulation of metabolic networks can be studied in yeast. 
They proposed that first all genes in the genome should be defined, and classified in subsets 
of genes, proteins and other molecules that constitute a specific pathway. Next, each pathway 
component should be perturbed by genetic (deletion/overexpression) or environmental 
(growth conditions) manipulation, followed by a quantification of global responses to each 
perturbation using large-scale mRNA and protein expression measurements. The data ob­
tained should be integrated in the current models for known metabolic pathways using bioin­
formatics, and subsequently new hypotheses to explain the observations can be formulated. In
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yeast, such experiments are already feasible, and in distant future, similar approaches may be 
followed in higher eukaryotes. However, such approaches will be extremely laborious, will 
require enormous efforts in time and money, and will need an entirely new integrated ‘system 
sciences’ approaches.
In addition to these steps, we could perform other experiments to validate the in­
volvement of (already known) transcriptional or post-translational regulatory circuits. There­
fore, the use of cell-imaging methodology in combination with the use of genetically encoded 
reporter or responder systems (i.e. luciferase or green fluorescent protein based) in transfected 
cell lines or animal models should be exploited. The CK-deficient cell lines, described in 
chapter 5, could serve as a valuable tool for these analyses as they will enable the study of 
possible links between the CK bioenergetic system and the regulation of cell growth or ultra- 
structural design in the in vitro context. It is important to note, however, that the cell lines 
lack several of the adaptive responses that are known to occur in animals in vivo. Most easily 
this can be explained by assuming that the threshold level of ‘cellular stress’, necessary to in­
duce adaptive responses, cannot be reached in vitro and will only be attained in vivo during
the performance of ‘labor’. Despite their abnormal CK activity there seem to be no qualitative
2+differences in the regulation of Ca homeostasis in our cells (chapter 6). Moreover, the ex­
tend of differentiation achieved in vitro is comparable to -  or even better than -  that described 
for other myogenic cell lines. Also the myofibrillar organization in our cell lines is still 
largely intact, as demonstrated by the binding of EGFP-tagged MM-CK to myofibrils. We 
therefore think that our cells could therefore provide a reliable background for further studies. 
Still, it becomes imperative to find conditions that will augment the physiological stress dur­
ing cultivation. Only then we may be able to provoke differential effects from CK deficiency 
or proficiency.
Ultimately, these studies should reveal common features in regulatory regions in genes 
that respond to CK deficiency. As a next step to test putative pathways involve in this re­
sponse we could design specific drugs which act as agonists or antagonists on the physiologi­
cal stress induced by CK deficiency, and study their effects on integral physiology in animal
1 13 31models. In vivo H, C or P MR spectroscopy (chapter 4) will then become once more valu­
able for studying the effects on metabolite levels or conversion rates of metabolites under dif­
ferent levels of intrinsic and extrinsic stress in the living animal. Presumably, there will be 
also future need for computational models for the design of -  and prediction of responses in -  
the pertinent bioenergetic pathways.
Based on the studies in this thesis it is tempting to speculate on a few possible signal­
ing mechanisms that may be involved in remodeling of muscle design in our CK mutant mice.
2+Many studies pointed already to the importance of Ca as a regulatory molecule in muscle 
design and, as detailed below, our data entirely leave open (i) the involvement of regulation 
by Ca2+ signaling. Also, (ii) regulation via direct ATP/ADP/AMP sensing (by AMPK (21)), 
(iii) the recently identified ATP-sensor mTOR (22), (iv) redox regulation by (NAD+/NADH), 
(v) sensing of O2 levels, and/or the (vi) coupling with other phosphoryl transfer circuits such
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as glycolysis and AK1 could be involved in the adaptational response.
2+Our findings in chapter 6 demonstrate that the shape of Ca transients in the cytosol is 
directly influenced by CK absence, due to impaired SERCA function and altered SR refill. 
Moreover, they suggest that the magnitude of effects depends on the intensity of muscle
stimulation (i.e. is correlated to the level of ATP demand). Earlier, it was published that al-
2+ / tered Ca signaling is the most likely cause for impaired muscle performance in CK-- -- mice.
Steeghs et al. (8) showed impaired force production during high intensity fatigue, under con­
ditions of high ATP turnover. However, studies under low intensity fatigue described by
2+Dahlstedt et al. (4) showed that Ca homeostasis and force production are maintained under 
these conditions. If one extrapolates these results to the situation in vivo, where highly fluctu­
ating rates of ATP hydrolysis do occur, different adaptational responses in different fiber 
types could be attributed to differences in neuronal firing profiles, differences in the mito­
chondrial and glycolytic content of the actual cell type involved, or to cell-type specific dif-
2+ferences in the shape of Ca signals under conditions of intense work performance. Indeed, 
the fact that the expression of slow myofiber specific genes, including myoglobin, is enhanced
in our CK-mutants, could be an argument for involvement of calcineurin-dependent pathways.
2+In these pathways, calcineurin (PP2B) is activated by Ca and will dephosphorylate NFATc,
which will subsequently translocate to the nucleus and serve as transcription factor to enhance
2+target gene expression (23-26). Furthermore, in this Ca effect, retrograde communication 
between mitochondria and nucleus, such as demonstrated by Biswas et al. (27) could be in­
volved. This mechanism entails the disturbance of cellular ATP levels upon metabolic stimu-
2+lation, a subsequent rise in cellular Ca levels, and activation (and/or inactivation) of specific 
genes, partially again via the calcineurin pathway. The fact that COX subunit V expression is 
enhanced in our CK--/-- mice indirectly supports the possible involvement of retrograde com­
munication. Calcineurin and retrograde signaling activate signals that support ‘oxidative 
genes’ and mitochondrial biogenesis.
Ablation of CK enzyme activity results in increased fluxes through the AK reaction, 
and subsequently leads to increased levels of AMP, activating AMP-activated kinase. Indirect 
support for an AMPK-regulated adaptational response come from recent studies on contrac­
tion- and hypoxia-regulated glucose transport in muscle (28). These studies link glucose 
transporter protein levels (which we found upregulated in CK-deficient gastrocnemius; chap­
ters 2,3) to AMPK enzyme activity. Also pharmacological activation of AMPK via the use of 
AICAR increases the concentration of glycogen, GLUT4, hexokinase and mitochondrial en­
zymes in skeletal muscle approximately twofold (29, 30). Both the extend of upregulation and 
the classes of enzymes affected (GLUT4, mitochondrial enzymes) are reminiscent with our 
findings. Even stronger circumstantial evidence comes from the observation that AMP- 
activated kinase is also chronically activated in P-GPA (a creatine analogue) fed rats. 
Bergeron et al. (31) showed that this activation of AMPK in skeletal muscle results in the in­
duction of NRF1, increased cytochrome c content and an onset of mitochondrial biogenesis. 
Wiesner et al. (32) also observed an upregulation of mitochondrial gene expression and pro­
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liferation of mitochondria in P-GPA fed rat hearts. Nuclear encoded mitochondrial genes were 
elevated 1.5 to 2-fold, and the mRNA for mTFA (Tfam) was significantly increased. Prelimi­
nary studies in skeletal muscle of our CK-deficient mice yielded no evidence for the involve­
ment of NRF1 or mTFA, but this possibility should be studied in much more detail in future.
Ponticos et al. (33) have provided evidence for a direct physical and physiological link 
between AMPK and CK in skeletal muscle. They demonstrated that AMPK inhibits CK by 
phosphorylation. In turn, AMPK activity itself is regulated by PCr/Cr ratios and pH level. The 
PCr/Cr ratio does not change in CK--/-- muscles upon stimulation, which could inhibit AMPK 
activation and the subsequent stimulation of fatty acid oxidation in mitochondria, thereby ex­
plaining the presence of lipid droplets. In conclusion, the role of AMPK in the regulation of 
CK and the adaptational responses in CK-mutant muscle is highly suspect and needs further 
study. In these studies we should include the role of glucose and lipid metabolism and mito­
chondrial OXPHOS-coupling via UCPs (UCP2 and UCP3).
An important alternative mechanism involves the sensing of (intra)cellular oxygen 
levels. Metabolic and ultrastructural adaptations, with upregulation of slow fiber specific 
genes and OXPHOS components, have been described in models of intermittent hypoxia. The 
extend of response is usually dependent on the severity of the hypoxia (34). Possibly, hy­
poxia-like episodes arise during periods of high energy demand in CK-deficient muscles, 
when mitochondrial O2 demand exceeds O2 supply capacity, which occurs by diffusion from 
circulation. Clearly, the upregulation of myoglobin is important in maintaining an appropriate 
O2 gradient within the muscle cell. The sensory systems that are activated by hypoxia have 
recently been identified. They involve posttranslational modification by prolyl hydroxylation 
as a key regulatory event that targets H IF1a subunits for proteasomal destruction via the Von 
Hippel-Lindau ubiquitination complex (35, 36). This hydroxylation is facilitated by a con­
served family of HIF prolyl hydroxylases (HPH) enzymes. Suppression of HPH in cultured 
Drosophila melanogaster cells by RNA interference resulted in the expression of a hypoxia- 
inducible gene, lactate dehydrogenase (37).
Alternatively, redox sensing and regulation (or redox potential) via NAD+/NADH 
levels could be an interesting candidate mechanism for explaining the remodeling responses. 
Almost surely, the enhanced glycolytic rate and change in balance between pyruvate and 
lactate production evoked by changes in LDH isoenzyme expression, together with the 
presumed increase in mitochondrial OXPHOS activity, will affect local balances in 
NAD(P)+/NAD(P)H ratio. Similar effects might be expected from altered flux rates in use of
metabolites like oxygen and glucose. In turn, altered NAD+ and/or NADH concentrations
2+could evoke changes in signaling pathways that connect to transcriptional or cytosolic Ca2+ 
regulation (38).
Other work in our group, in close collaboration with the group of Dr. A. Terzic (Mayo 
Clinic, Rochester, Minnesota) has shown that ablated CK flux is associated with upregulated 
AK phosphotransfer and a redistribution of fluxes through glycolysis (39, 40), although we do 
no know the regulatory mechanisms involved. Glycolysis is stimulated by increasing ADP
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(AMP) levels, increasing Pi levels (strikingly, Pi levels do not increase in CK--/-- animals upon 
muscle stimulation!), and changes in NAD+/NADH ratio. Again, this rewiring of metabolic 
pathways could influence any of the pathways for coupling between energetics and muscle 
design discussed above. Finally, recently entirely new regulatory principles that relate bio- 
energetic activity (glycolysis and OXPHOS) to the location of hexokinase (related to mito­
chondrial OXPHOS output (41)) or the induction of a relatively unknown glycolytic enzyme 
6-phospofructo-2-kinase (generates fructose-2,6-biphosphate which stimulates PFK-1 and 
thus glycolysis) have been discovered (42). It is clear that a study of the significance of all 
these mechanisms in our CK mutants could easily fill up a few other Ph.D. project periods.
7.4 Concluding remarks
Cells adapt their metabolism and structural characteristics after interpreting intrinsic 
and extrinsic signals from genetic stress and environmental perturbations. Cellular metabo­
lism and cellular design are linked via a variety of signaling pathways with largely unknown 
characteristics. The use of whole-system studies with knockout models in combination with 
sophisticated gene- and protein-profiling analyses may help to unravel the molecular steps 
involved in this metabolic signaling. From our work it has become clear that knowledge of 
remodeling pathways in CK-mutant muscle will also provide important clues for a better un­
derstanding of the relationship between energy metabolism and the high plasticity of muscle 
ultrastructural composition and biochemical infrastructure. Numerous studies point to an even 
more important connection, namely to the existence of molecular circuits that link energy me­
tabolism to cell survival or apoptosis signaling. In this cascade, the Akt/PKB signaling path­
way connects to glucose metabolism via the regulation of subcellular distribution of 
hexokinase. In turn, this pathway connects to PTP pore opening and cellular defense against 
apoptosis (41).
I conclude that muscles are surprisingly robust systems in the sense that they are quite 
insensitive to mutations in the CK circuit, mainly because CK loss can be compensated for by 
other metabolic pathways in this cell type. Vice versa, CK enzymes are major players in 
maintaining this physiological robustness via their role in safeguarding the fidelity of the en­
ergy production machinery under a variety of environmental challenges (9). We consider it 
most likely that CK absence is already sensed during transient periods of cellular work output 
that occur during muscle activation under normal laboratory housing conditions. One of the 
challenges for future will be to find out how distinct physiological stress conditions are corre­
lated to the intensity (e.g. magnitude) and the type of metabolic signaling involved in the 
metabolic remodeling response.
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Summary
SUMMARY
Optimal balancing of production, distribution and consumption of cellular energy, in 
the form of adenosine triphosphate (ATP), is of pivotal importance for every cell in the body. 
Therefore, all cells possess an elaborate network of enzymes that help in safeguarding energy 
homeostasis. In addition, tissues like muscle and brain possess special systems that serve to 
warrant optimal energy supply during periods of high, and with sudden fluctuations in, energy 
demand. In this process, there is a special role for members of the creatine kinase (CK) family 
of enzymes, which reversibly convert the ‘energy carrier’ phosphocreatine (PCr) in ATP and 
creatine (CR) at specific locations in the cell. The creatine kinase circuit usually consists of 
pairs of cytosolic and mitochondrial CK isoforms, which are co-expressed, and together guar­
antee an optimal buffering and transport of ATP. This thesis describes the consequences that 
disruption of the CK gene(s) has on other enzymes and signaling molecules in the network of 
energy homeostasis in mouse skeletal muscle.
As a starting point for this study, we had various CK knockout mice to our disposal, 
which lacked either the cytosolic (MM-CK), mitochondrial (ScCKmit), or both muscle- 
specific CK proteins, due to targeted disruption of their genes in the genomic DNA. Earlier 
studies had already established that, contrary to our expectation, disruption of CK was not 
lethal and did not result in overt loss of muscle function. Functional impediments were no­
ticed under strenuous ex vivo conditions. However, the effects seen appeared dependent on the 
stimulation protocol used. Apparently, there is considerable flexibility within the network for 
energy homeostasis. Ablation of CK function can be compensated for to large extent before 
the system becomes maladaptive. Previous studies revealed that the compensatory changes 
involve alterations in energy fluxes, ion homeostasis and cellular ultrastructure.
The studies in this thesis provide further support for the concept of cellular adaptation 
to CK deficiency. Muscle cells are obviously capable of ‘sensing’ the genetic defect and 
‘translating’ this into an altered expression profile of mRNAs and proteins with a role in cel­
lular energetics, presumably serving to sustain adequate levels of cellular ATP. In chapter 2, 
we show that various distinct clusters of proteins, active in mitochondrial oxidative phos­
phorylation, glycolysis, glucose transport, but also cellular oxygen supply, are involved. Fur­
thermore, the results in chapter 2 demonstrate that adaptive changes are dependent on the 
‘metabolic design’ of the muscle involved, whether it is a ‘fast-‘ or ‘slow-type’ muscle. As a 
direct follow-up of this study, we simultaneously determined the expression levels of mRNAs 
from more than one hundred genes (chapter 3). The results obtained show a small but signifi­
cant upregulation of genes encoding proteins involved in the production, transport and con­
sumption of ATP. Together, chapters 2 and 3 show that muscle-type specific reprogramming 
occurs as a response to CK deficiency, and that the response affects the expression of both 
nuclear as well as mitochondrial DNA encoded genes.
In chapter 4, the consequences of CK deficiency were studied using in vivo magnetic 
resonance spectroscopy. This enabled us to obtain information on the Cr-PCr metabolite
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levels in skeletal muscles of mice that lack both the cytosolic and mitochondrial isoform of 
muscle-type CK. Surprisingly, PCr is still present in these muscle, which is most likely 
explained by residual brain-type (BB-) CK activity, present in myoblast satellite cells. 
However, BB-CK activity is not sufficiently widespread in muscle myotubes to assist in 
buffering sudden ATP pool depletion events when challenged, or maybe it is not present at 
the right cellular locations.
The observation of cellular reprogramming (metabolic responses) raises the question 
which signaling mechanisms are responsible for this effect. The introduction of this thesis 
summarizes a number of possible candidate signaling mechanisms. Chapter 5 describes the 
isolation and characterization of new CK-deficient muscle cell lines. The principle of these 
permanently transformed cell lines is based on the presence of the gene encoding a thermo­
sensitive variant of the SV40 large T antigen, which confers an immortalized phenotype on 
the cells when grown at the permissive (33oC) temperature. Chapter 6 describes the use of 
these cells, which display normal potential for formation of multinuclear myotubes when 
switched to non-permissive conditions (37oC), for the study of the amplitude and frequency of 
calcium transients (as a candidate signaling mechanism) using video speed confocal laser 
scanning microscopy. This technique facilitates visualization of local cellular calcium levels
in real time. We show that CK optimizes the function of the sarcoplasmic/endoplasmic
2+reticulum (SR/ER) Ca -ATPase and is directly involved in the refill of the SR. The results in
chapter 6 furthermore demonstrate a relationship between the frequency of in vitro generated
2+contractions (this is the level of ATP turnover), Ca removal speed from the cytosol, and SR 
refill.
The MM-CK/ScCKmit system plays a pivotal role in the regulation of cellular ATP 
homeostasis in muscle, in the fine regulation of energy production and consumption, but this 
role can be compensated for by other enzyme systems. The studies in this thesis point to the 
importance of ‘whole system’ approaches for studying CK in the context of its dynamic 
(tissue specific) cellular environment (proteins, and presumably other molecules such as 
metabolites). Only by combining information obtained from different scientific approaches, 
we can elucidate the true function of the CK circuit, and the (many) regulatory principles that 
underlie its flexible role in muscle cell bioenergetics and physiology. Similar studies will be 
needed to address the role of the other CK family members, BB-CK and UbCKmit, in energy 
homeostasis in other tissues like kidney, pancreas, white and brown fat tissue and brain.
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SAMENVATTING
Optimale balancering van productie, distributie en consumptie van cellulaire energie, 
in de vorm van adenosine trifosfaat (ATP), is van essentieel belang voor elke cel in het 
lichaam. Daarom beschikken alle cellen over een verfijnd netwerk van enzymen die helpen bij 
de veiligstelling van energiehomeostase. Bovendien zijn weefsels als spier en brein uitgerust 
met speciale systemen die een optimale energietoevoer waarborgen gedurende periodes van, 
en met plotselinge fluctuaties in, energievraag. In dit proces is een speciale rol weggelegd 
voor leden van de creatine kinase (CK) enzym familie, welke op specifieke locaties in de cel 
de ‘energiedrager’ fosfocreatine (PCr) reversiebel omzetten in ATP en creatine (Cr). Het 
creatine kinase circuit bestaat gewoonlijk uit paren van cytosolische en mitochondriële CK 
isovormen, welke worden geco-expresseerd en samen een optimale buffering en transport van 
ATP garanderen. Dit proefschrift beschrijft de gevolgen die uitschakeling van het (de) CK 
gen(en) heeft voor andere enzymen en signaleringsmoleculen in het netwerk van energie 
homeostase in skeletspieren van de muis.
Als uitgangspunt voor deze studie stonden verschillende creatine kinase ‘knockout’ 
muizen tot onze beschikking, welke ofwel het cytosolische (MM-CK), het mitochondriële 
(ScCKmit), of beide spierspecifieke CK eiwitten misten door gerichte verstoring van de 
corresponderende genen op het genomisch DNA. Uit eerdere studies was reeds gebleken dat, 
in tegenstelling tot onze verwachting, uitschakeling van CK niet dodelijk was en niet leidde 
tot duidelijk functieverlies van de spieren. Functionele beperkingen werden wel waargenomen 
bij extreme ex vivo condities. De waargenomen effecten bleken echter afhankelijk te zijn van 
het gebruikte stimulatiepatroon. Kennelijk bestaat er substantiële flexibiliteit binnen het 
netwerk voor energiehomeostase. Uitschakeling van de CK functie kan in grote mate worden 
gecompenseerd voordat het systeem maladaptief wordt. Eerdere studies toonden aan dat de 
compensatoire veranderingen aanpassingen omvatten in energiefluxen, ionhomeostase en 
cellulaire ultrastructuur.
De studies in dit proefschrift bieden een verdere onderbouwing van het concept van 
cellulaire adaptatie aan CK deficiëntie. Spiercellen zijn kennelijk in staat het genetische defect 
‘waar te nemen’ en te ‘vertalen’ in een veranderd expressieprofiel van mRNAs en eiwitten 
met een rol in de cellulaire energievoorziening, meest waarschijnlijk met als functie adequate 
niveaus van cellulair ATP te handhaven. In hoofdstuk 2 laten we zien dat verschillende 
separate clusters van eiwitten, actief in mitochondriële oxidatieve fosforylering, glycolyse, 
glucose transport, maar ook in cellulaire zuurstofvoorziening, hierbij betrokken zijn. Verder 
tonen de resultaten in hoofdstuk 2 aan dat adaptieve veranderingen afhankelijk zijn van het 
‘metabole ontwerp’ van de betreffende spier; of het een ‘snelle’ of ‘langzame’ spier is. Als 
een direct vervolg op deze studie hebben we in hoofdstuk 3 de expressieniveaus van mRNAs 
van meer dan honderd genen bepaald. De verkregen resultaten laten een geringe maar 
significante opregulatie zien van genen die de eiwitten coderen welke betrokken zijn bij 
productie, transport en consumptie van ATP. Hoofdstuk 2 en 3 tonen aan dat spiertype-
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specifieke herprogrammering optreedt als respons op CK deficiëntie, en dat de respons de 
expressie van zowel nucleaire als op mitochondriëel DNA gecodeerde genen beïnvloedt.
In hoofdstuk 4 zijn de consequenties van CK deficiëntie bestudeerd met behulp van in 
vivo magnetische resonantie spectroscopie. Dit maakt het mogelijk informatie te verkrijgen 
over de Cr-PCr metabolietniveaus in skeletspieren van muizen die zowel de cytosolische als 
de mitochondriële isovorm van spiertype CK missen. Verrassenderwijs is PCr nog steeds 
aanwezig in deze spieren, wat meest waarschijnlijk kan worden verklaard door residueel brein 
type (BB-)CK activiteit, aanwezig in de myoblast satellietcellen. Niettemin is brein type CK 
niet voldoende wijdverspreid in de spier myotubes om plotselinge reducties in ATP voorraad 
mede te kunnen compenseren tijdens inspanningen, of misschien is het niet aanwezig op de 
juiste cellulaire locaties.
De waarneming van cellulaire herprogrammering (metabole responsen) roept de vraag 
op welke signaleringsmechanismen verantwoordelijk zijn voor dit effect. De introductie van 
dit proefschrift vat een aantal mogelijk kandidaat signaleringsmechanismen samen. Hoofdstuk 
5 beschrijft de isolatie en karakterisering van nieuwe CK-deficiënte spiercellijnen. Het 
principe van deze permanent getransformeerde cellijnen is gebaseerd op de aanwezigheid van 
het gen dat een temperatuurgevoelige variant van het SV40 groot T antigen codeert, wat een 
geïmmortalizeerd fenotype geeft in de cellen wanneer ze op de permissieve temperatuur van 
33oC gegroeid worden. Hoofdstuk 6 beschrijft het gebruik van deze cellen, welke een normale 
potentieel voor formatie van veelkernige myotubes laten zien wanneer ze overgezet worden 
naar niet-permissieve condities (37oC), voor de studie van amplitude en frequentie van 
calcium transiënten (als een kandidaat signaleringsmechanisme) met behulp van
videosnelheid confocale ‘laser scanning’ microscopie. We laten zien dat CK de functie van
2+het sarco-/endo-plasmatisch reticulum (SR/ER) Ca -ATPase optimaliseert en direct 
betrokken is bij hervulling van het SR. De resultaten in hoofdstuk 6 tonen verder een relatie
aan tussen de frequentie van in vitro gegenereerde contracties (dit is het niveau van ATP
2+omzetting), Ca wegpompsnelheid uit het cytosol en SR hervulling.
Het MM-CK/ScCKmit systeem speelt een essentiële rol in de regulatie van cellulaire 
ATP homeostase in de spier en in de fijnafstemming van energieproductie en -consumptie. 
Maar haar rol kan worden gecompenseerd door andere enzymsystemen. De studies in dit 
proefschrift wijzen op het belang van een benadering vanuit het ‘complete systeem’ voor de 
studie van CK in de context van haar dynamische (weefselspecifieke) cellulaire omgeving 
(eiwitten en waarschijnlijk andere moleculen zoals metabolieten). Alleen door informatie van 
verschillende wetenschappelijke aanpakken te combineren, kunnen we de werkelijke functie 
van het CK circuit ophelderen, evenals de (vele) regulerende principes die haar flexibele rol in 
spiercel bio-energetica en fysiologie onderliggen. Vergelijkbare studies zijn nodig om de rol 
van de andere CK familieleden, BB-CK en UbCKmit, in energie homeostase van andere 
weefsels als nier, alvleesklier, wit en bruin vetweefsel en brein op te helderen.
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ABBREVIATIONS
AhR : dioxin receptor/aryl hydrocarbon receptor
AK : adenylate kinase
AMPD : AMP deaminase
AMPK : AMP-activated kinase
ANT : adenine nucleotide translocator/transporter
ARNT : AhR nuclear translocator
ATP : adenosine 5’ triphosphate
a.u. : arbitrary units
B0  : static magnetic field strength
B-CK : cytosolic brain creatine kinase
bHLH : basic helix-loop-helix
[Ca2+]s : sarcoplasmic Ca2+ concentration
cADPR : cyclic ADP ribose
CHESS : chemical shift selective
CK : creatine kinase
CK---- : M-CK-- plus ScCKmit- - double knockout mice
CLSM : confocal laser scanning microscopy
COX : cytochrome c  oxidase
cpm : counts per minute
CPT : carnitine palmitoyltransferase
Cr : creatine
2+DHPR : dihydropyridine receptor, L-type Ca2+ channel
DNA : deoxyribonucleic acid
ECC : excitation-contraction coupling
EDL : extensor digitorum longus
EGFP : enhanced green fluorescent protein
EST : expressed sequence tag
ETC : electron transport chain
FACS : fluorescence activated cell sorting;
FADH2 : flavin adenine dinucleotide hydrogen
FCCP : carbonyl cyanide p-trifluoromethoxyphenylhydrazone
FRET : fluorescence resonance energy transfer
FWHM : full width at half maximum
GAPDH : glyceraldehyde 3-phosphate dehydrogenase
GLUT : glucose transporter
GPS : gastrocnemius-plantaris-soleus complex
HIF : hypoxia-inducible factors
HLSVD : Hankel Lanczos singular value decomposition
IMFmt : intermyofibrillar mitochondria
IMP : inositol monophosphate
LDH : lactate dehydrogenase
M-CK : cytosolic muscle creatine kinase
M-CK-/- : M-CK knockout mice
MEF : myocyte enhancing factor
Me2SO : dimethyl sulfoxide
MHC : myosin heavy chain
MLC2v/f : myosin light chain 2, ventricular/fast
mRNA : messenger RNA
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MRS : magnetic resonance spectroscopy
MRUI : magnetic resonance user interface
mtDNA : mitochondrial DNA
mTFA : mitochondrial transcription factor A (Tfam)
NAD+ : nicotinamide adenine dinucleotide
NADH : nicotinamide adenine dinucleotide hydrogen
NDPK : nucleoside-diphosphate kinase
NFATc : nuclear factor of activated T-cells
NMR : nuclear magnetic resonance
NRF : nuclear respiratory factor
NTP/NDP/NMP : nucleoside tri/di/mono-phosphate
OXPHOS : oxidative phosphorylation
~P : high energy phosphoryl
Pi : inorganic phosphate
PCr : phophocreatine
PDE : phosphodiesters
PFK : phosphofructokinase
PFK-M : 6-phosphofructo-1 kinase, muscle isoform
PGK : phosphoglycerate kinase
PK : pyruvate kinase
PMCA : plasma membrane Ca2+-ATPase
PME : phosphomonoesters
PMF : proton motive force
PP2B : protein phosphatase 2B, or calcineurin
PSS : phosphate buffered saline solution
PTP : permeability transition pore
pVHL : von Hippel-Lindau tumor suppression protein
RNA : ribonucleic acid
ROI : region of interest
RyR : ryanodine receptor
ScCKmit : sarcomeric mitochondrial creatine kinase
ScCKmit-- : ScCKmit knockout mice
SEM : standard error of the mean
SERCA : SR/ER Ca2+ ATPase
SR : sarcoplasmic reticulum
SSmt : subsarcolemmal mitochondria
STEAM : stimulated echo acquisition mode
T2 : transverse relaxation time
Tr, : repetition time in seconds
Ts : thapsigargin
TCA cycle : tricarboxic acid cycle or citric acid cycle
TE : echo time (in STEAM MR sequence)
TM : mixing time (in STEAM MR sequence)
Tfam : mitochondrial transcription factor A (mTFA)
UbCKmit : ubiquitous mitochondrial creatine kinase
UCP : uncoupling protein
3’UTR : 3’ untranslated sequence
VEGF : vascular endothelial growth factor
VDAC : voltage-dependent anion channel, porin
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EPILOOG
En dan komt de dag dat je een epiloog mag gaan schrijven, als sluitstuk van het 
proefschrift en van de promotietijd. Om maar heel eerlijk te zijn, toen ik ruim tien jaar 
geleden naar Wageningen vertrok, had ik zelf ook niet verwacht dat ik ooit zou promoveren 
op het gebied van de Medische Wetenschappen. Laat staan dat ik deze epiloog in New York 
zou schrijven. Tijdens mijn studententijd aan de Landbouwuniversiteit ontwikkelde mijn 
persoonlijke interesse zich echter meer en meer in de richting van de cellulaire en moleculaire 
aspecten van de biologie. Ik was dan ook erg gelukkig met de promotieplaats die ik kreeg 
aangeboden op het lab van Prof. Wieringa in Nijmegen.
Wat me het meest bij zal blijven, is de fantastische werksfeer binnen de vakgroep 
Celbiologie en Histologie, later Celbiologie, en de plezierige samenwerking met andere 
vakgroepen uit Trigon (‘van boven’) en ‘in de toren’. Het zal niemand verbazen dat met name 
de borrels erg plezant waren. Maar ook tijdens werktijd stond iedereen met raad en daad klaar. 
En ik mis de koffiepauzes... onze eigen dagelijkse evaluatie en oplossing van alle 
wereldproblemen. Ik wil graag een welgemeend dankjewel zeggen aan iedereen die door de 
jaren heen aan deze labvreugde heeft bijgedragen.
Een bijzonder dankjewel wil ik wensen aan de mensen die direct betrokken waren bij 
het creatine kinase onderzoek; als auteurs op de diverse hoofdstukken, of als zeer 
gewaardeerde collega’s in Nijmegen en in de buitendorpse samenwerking met Amsterdam. 
Het was vaak lachen, gieren, zingen, brullen, maar jullie kunnen ook beamen dat deze pieken 
werden afgewisseld met (behoorlijke) dalen. En een blot in de morgen is een dag zonder 
zorgen; zonder ‘array’ tel je niet meer mee. Sommige blots heb ik wel zeven keer gedaan: er 
is echt wel een groter genot dan een Western blot. Tja, als je  er achteraf op terugkijkt, kun je 
er toch wel weer om lachen. Ik kan, niet zonder trots, melden dat de piekjes, stipjes en bandjes 
uiteindelijk allemaal in publicaties terecht zijn gekomen!
Een bijzonder woord van dank wil ik uitbrengen aan mijn promotor Prof. Bé 
Wieringa. Bedankt voor je excellente wetenschappelijke ‘input’, vertrouwen, steun en geduld. 
Ik heb onze samenwerking als zeer leerzaam en plezierig ervaren.
Mijn ouders en Anja wil ik bedanken voor alle (vaak onuitgesproken) steun die ik van 
ze krijg.
Nu wordt het dan toch echt hoog tijd om, als werkelijk sluitstuk van de promotie, het 
glas te heffen op de goede afloop. Eerst nog de verdediging, maar als dat is afgerond, kunnen 
echt alle remmen los (het is dan bijna half vier . ). Mensen, hartstikke bedankt voor een 
geweldige tijd en we maken er een superfeest van!
New York, februari 2002
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CURRICULUM VITAE
Ad de Groof werd op 9 augustus 1973 geboren in Geldrop en groeide op in 
Leenderstrijp. Hij behaalde het VWO-diploma aan het Hertog Jan-College te Valkenswaard in 
1991. In datzelfde jaar startte hij de studie Dierwetenschappen (Zootechniek) aan de 
Landbouwuniversiteit in Wageningen. Tijdens deze opleiding verrichtte hij een 
afstudeerproject Immunologie onder leiding van Dr. Ir. H.K. Parmentier en Prof. Dr. J.P.T.M. 
Noordhuizen (vakgroep Veehouderij) en een afstudeerproject Genetica begeleid door Dr. J.J. 
van der Poel, Dr. M.A.M. Groenen en Prof. Dr. Ir. E.W. Brascamp (vakgroep Veefokkerij). 
Tussen augustus en december 1995 liep hij stage op het Moredun Research Institute in 
Edinburgh, Schotland, onder leiding van Dr. G. Entrican en Dr. M.G. Bruce. Ad behaalde het 
doctoraal diploma in augustus 1996 cum laude. Vanaf september 1996 was hij als 
promovendus werkzaam op de afdeling Celbiologie en Histologie van de Katholieke 
Universiteit Nijmegen, op het door NWO gefinancierde project ‘Cellular reprogramming in 
neuromuscular tissues as a response to genetic lesions in the cellular network for energy ho­
meostasis -  adaptation and (programmed) cell death’. De resultaten van dit onderzoek staan 
beschreven in dit proefschrift. Tijdens de promotietijd nam de auteur deel aan de ‘Spring 
school on calcium and signal transduction’ in Liverpool (1997) en aan het Keystone 
symposium ‘Mitochondrial dysfunction in pathogenesis’ in Santa Fe, New Mexico (2000). 
Sinds september 2001 is hij werkzaam als postdoctoraal onderzoeker aan de afdeling 
Neurologie van de Columbia Universiteit in New York, Verenigde Staten, onder leiding van 
Prof. Dr. E.A. Schon. Op deze afdeling doet hij onderzoek naar de moleculair-genetische 
achtergrond van disfunctioneren van de mitochondriën.
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